Saturday 31 August - European Society of Cardiology
Saturday 31 August - European Society of Cardiology
Saturday 31 August - European Society of Cardiology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ESC CONGRESS 2013<br />
SATURDAY <strong>31</strong> AUGUST<br />
SATURDAY<br />
Browse the most up-to-date Scientific<br />
Programme in the “ESC 2013” Mobile App.<br />
Missed a session? Need to see it again?<br />
Consult VOD & webcasts, slides, abstracts<br />
& reports on ESC Congress 365, yourfree<br />
access to ESC Congress content all year long.<br />
www.escardio.org/365<br />
Tweet about your favourite sessions: #ESCcongress2013
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
09:30–10:30 | Chisinau - Central Village<br />
CLINICAL CASES FOR PRACTITIONERS<br />
Special Session<br />
Chairperson(s): P.A. Sirnes (Moss, NO); R. Asteggiano (Turin, IT)<br />
A patient with hypertension. Vascular screening and newer echocardiography techniques alter the<br />
risk pr<strong>of</strong>ile and treatment strategy.<br />
09:30 Presenter. 1<br />
– P.A. Sirnes (Moss, NO)<br />
09:30 Panellists. 2<br />
– S.L.M.A. Beeres (Leiden, NL), P.R.M. van Dijkman (The Hague, NL), J. Van Melle (Groningen, NL)<br />
A very old and frail man with severe symptomatic aortic stenosis.<br />
10:00 Presenter. 3<br />
– R. Asteggiano (Turin, IT)<br />
10:00 Panellists. 4<br />
– S.L.M.A. Beeres (Leiden, NL), P.R.M. van Dijkman (The Hague, NL), J. Van Melle (Groningen, NL)<br />
11:00–12:00 | Chisinau - Central Village<br />
WHEN CURE IS NOT POSSIBLE: IMPROVING LIFE AND END-OF-LIFE<br />
Clinical Seminar<br />
Chairperson(s): D. Lehwaldt (Dublin, IE); P. Moons (Leuven, BE)<br />
11:00 Guideline on implantable cardioverter-defibrillator deactivation. 5<br />
– J. van Staaveren (Aalsmeer, NL)<br />
11:18 Enhanced external counter-pulsation for refractory angina. 6<br />
– E. Wu (Stockholm, SE)<br />
11:36 End-stage heart failure and palliative care. 7<br />
– J. Boyne (Maastricht, NL)<br />
11:54 Take home messages from the chairs. 8<br />
– D.Lehwaldt(Dublin,IE),P.Moons(Leuven,BE)<br />
11:00–12:30 | Damascus - Central Village<br />
THE HIGH-DENSITY LIPOPROTEIN STORY: WAITING FOR A HAPPY ENDING<br />
Symposium<br />
Chairperson(s): L. Tokgozoglu (Ankara, TR); J. Chapman (Paris, FR)<br />
11:00 Dysfunctional high-density lipoprotein as a diagnostic and therapeutic target. 9<br />
– M. Banach (Lodz, PL)<br />
11:22 Genetic determinants <strong>of</strong> high-density lipoprotein cholesterol and risk <strong>of</strong> myocardial infarction. 10<br />
– S. Kathiresan (Boston, US)<br />
11:45 Effects <strong>of</strong> high-density lipoprotein on vascular function. 11<br />
– U. Landmesser (Zurich, CH)<br />
12:07 High-density lipoprotein lowering trials: what went wrong? 12<br />
– J. Armitage (Oxford, GB)<br />
11:00–12:30 | Tunis (The Hub) - Central Village<br />
ELECTRICAL PROBLEMS – LOOK FOR THE UNDERLYING TRUTH<br />
Clinical Cases<br />
Chairperson(s): R. Hatala (Bratislava, SK); M. Pazdernik (Prague, CZ)<br />
11:00 Regression <strong>of</strong> sinus node dysfunction after treatment <strong>of</strong> obstructive sleep apnea. 13<br />
– N. Diaconu (Chisinau, MD)<br />
11:12 Ictal bradycardia syndrome: an underdiagnosed cause <strong>of</strong> recurrent syncope and sudden<br />
14<br />
unexpected death in epilepsy (SUDEP).<br />
– M.E.W. Hemels (Arnhem, NL)<br />
11:25 Risk stratification for sudden cardiac death in a patient with dermatomyositis: the predictive role 15<br />
<strong>of</strong> programmed ventricular stimulation.<br />
– A.-I. Vouliotis (Athens, GR)<br />
11:38 To ICD or not to ICD? 16<br />
– I. Merinopoulos (Ipswich, GB)<br />
11:51 A case <strong>of</strong> arrhythmia due to myocarditis treated by antiviral therapy: new diagnostic approaches 17<br />
using peripheral biomarkers.<br />
–E.M.Gupalo(Moscow,RU)<br />
12:04 Cardiac conduction and rhythm disturbances in a patient with postinfectious polyradiculoneuritis 18<br />
and unilateral diaphragmatic paralysis.<br />
– M.I. Dregoesc (Cluj-Napoca, RO)<br />
12:17 Severe right heart failure in a tunisian patient with thyrotoxicosis: a case report. 19<br />
– A. Tounsi (Sfax, TN)<br />
18
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
11:00–12:30 | Baku (The Hub) - Central Village<br />
RAPID FIRE – ACUTE CORONARY SYNDROMES IN THE FIRING LINE<br />
Rapid Fire Abstract<br />
Chairperson(s): M. Dalby (Harefield, GB); G. Dangas (New York, US)<br />
11:00 Direct comparison <strong>of</strong> high-sensitivity cardiac troponin I versus T for the early diagnosis <strong>of</strong> acute 20<br />
myocardial infarction.<br />
– M. Rubini Gimenez, R. Twerenbold, T. Reichlin, B. Moehring, K. Wildi, B. Meller, P. Haaf, C. Zellweger,<br />
S. Osswald, C. Mueller (Basel, CH)<br />
11:06 Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain<br />
21<br />
patients.<br />
– B. Meller, L. Cullen, W.A. Parsonage, J. Greenslade, S. Aldous, T. Reichlin, K. Wildi, R. Twerenbold,<br />
M. Than, C. Mueller (Basel, CH; Christchurch, NZ)<br />
11:12 Atrial fibrillation is an independent predictor <strong>of</strong> hospital mortality in STEMI but not in NSTE-ACS in 22<br />
clinical practice - results <strong>of</strong> the Euro heart survey ACS-registry.<br />
– A.K. Gitt, M. Hochadel, R. Zahn, U. Zeymer, W. Wojakowski, M. Tendera, F. Schiele, J.P. Bassand<br />
(Ludwigshafen am Rhein, DE; Katowice, PL; Besançon, FR)<br />
11:18 Impact <strong>of</strong> statin use before the onset <strong>of</strong> acute myocardial infarction on coronary plaque<br />
23<br />
morphology <strong>of</strong> the culprit lesion, inflammatory response, and viable myocardium.<br />
– H. Hikita, T. Shigeta, K. Kozima, K. Hishikari, Y. Oosaka, D. Akiyama, T. Sugiyama, S. Kimura,<br />
A. Takahashi, M. Isobe (Yokosuka and Tokyo, JP)<br />
11:24 Comparison <strong>of</strong> the efficacy <strong>of</strong> periprocedural rosuvastatin versus atorvastatin treatment in<br />
24<br />
patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary<br />
intervention.<br />
– T.Q. Zhu, Q. Zhang, F.H. Ding, J.P. Qiu, H.G. Jin, L. Lu, R.Y. Zhang, J. Hu, Z.K. Yang, W.F. Shen<br />
(Shanghai, CN)<br />
11:30 Manual thrombectomy with platelet glycoprotein IIb/IIIa blockade is associated with lower<br />
25<br />
mortality in patients treated with primary PCI (9266 patients from the london heart attack group).<br />
– M.M.Akhtar,B.N.Modi,D.A.Jones,A.Wragg(London,GB)<br />
11:36 One-year survival according to use <strong>of</strong> thrombus aspiration for primary PCI in the real-world. The 26<br />
FAST-MI 2010 registry.<br />
– E. Puymirat, Y. Cottin, G. Vanzetto, D. Carrie, K. Isaaz, F. Schiele, D. Tchetche, P.G. Steg, T. Simon,<br />
N. Danchin (Paris, Dijon, Grenoble, Toulouse, Saint-Etienne and Besançon, FR)<br />
11:42 Ischemic postconditioning in ST-elevation myocardial infarction. Results <strong>of</strong> the POSTEMI trial. 27<br />
– S. Limalanathan, G.O. Andersen, N.-E. Klow, M. Abdelnoor, P. H<strong>of</strong>fmann, J. Eritsland (Oslo, NO)<br />
11:48 Delayed stenting compared with immediate stenting in patients with ST-segment elevation<br />
28<br />
myocardial infarction.<br />
– M. Chettibi, K. Yayehd, C. Ricard, A. Ghorab, M. Bouraghda, S. Bertal, R. Nedjar, M.A. Bouzid,<br />
M.T. Bouafia, L. Belle (Blida, DZ; Annecy, FR)<br />
11:54 Impact <strong>of</strong> intraaortic balloon counterpulsation in patients with acute myocardial infarction and 29<br />
cardiogenic shock.<br />
– H.W. Lee, K.S. Cha, J.H. Ahn, J.H. Kim, J.H. Oh, J.H. Choi, H.C. Lee, T.J. Hong, J.S. Park, M.H. Jeong<br />
(Busan and Gwangju, KR)<br />
12:00 Discussions around plasma screens outside the room.<br />
SATURDAY – MORNING<br />
19
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
11:00–12:30 | Minsk (The Hub) - Central Village<br />
RAPID FIRE – SIGNALLING IN CARDIAC HYPERTROPHY AND REMODELLING<br />
Rapid Fire Abstract<br />
Chairperson(s): S. Engelhardt (Munich, DE); J. Hall (Minneapolis, US)<br />
11:00 Novel link between angiotensin II and Wnt signalling in myocardial fibrogenesis in inflammatory 30<br />
cardiomyopathy.<br />
– G. Kania, P. Blyszczuk, B. Mueller-Edenborn, S. Behnke, T.F. Luescher, U. Eriksson (Zurich and Eglisau,<br />
CH)<br />
11:06 Angiotensin-(1-9) antagonises cardiac remodelling via the angiotensin type 2 receptor. <strong>31</strong><br />
– M. Flores-Munoz, D. Graham, A.H. Baker, G. Milligan, S.A. Nicklin (Glasgow, GB)<br />
11:12 Early alterations <strong>of</strong> nuclear Ca2+-dependent signalling in cardiac hypertrophy. 32<br />
– S. Ljubojevic, S. Radulovic, S. Sedej, J. Kockskaemper, B. Pieske (Graz, AT; Marburg, DE)<br />
11:18 Secretoneurin regulates cardiomyocyte calcium homeostasis via CaMKII inhibition and is a potent 33<br />
marker <strong>of</strong> mortality in patients with acute heart failure.<br />
– A.H. Ottesen, W.E. Louch, C.R. Carlson, O.J.B. Landsverk, R.F. Johansen, M. Moe, M. Stridsberg,<br />
T. Omland, G. Christensen, H. Rosjo (Lørenskog and Oslo, NO; Uppsala, SE)<br />
11:24 Proliferative membrane changes <strong>of</strong> T-tubules and cell-wide network changes during cardiac<br />
34<br />
remodeling with orphaning <strong>of</strong> Ca2+ release sites are a general mechanism <strong>of</strong> heart failure.<br />
– S.E. Lehnart, E. Wagner, T. Kohl, V. Westphal, U. Parlitz, S. Luther, S.W. Hell, M.S. Jafri, W.J. Lederer<br />
(Göttingen, DE; Manassas and Baltimore, US)<br />
11:30 Abnormal calcium handling in the progeric mouse model Zmpste24-/- is linked to reduced<br />
35<br />
sarcoplasmic reticulum calcium loading and depression <strong>of</strong> SERCA2 and calsequestrin-2<br />
expression.<br />
– A. Llach, J. Rivera, A. Herraiz, N. Cabello, C. Gonzalez, A. Vallmitjana, R. Benitez, V. Andres,<br />
L. Hove-Madsen (Barcelona and Madrid, ES)<br />
11:36 The tumor suppressor RAS-association domain family protein 1A (RASSF1A) regulates TNF-alpha 36<br />
signaling in cardiomyocytes.<br />
– T.M.A. Mohamed, M. Zi, A. Maqsood, S. Prehar, L. Neyses, D. Oceandy (Manchester, GB)<br />
11:42 Calcineurin A stabilizes hypoxia-inducible factor-1 alpha via a heat shock protein (HSP) 90<br />
37<br />
dependent mechanism in myocardial hypertrophy.<br />
– S. Eschricht, K.U. Jarr, C. Kuhn, H. Katus, N. Frey, E. Chorianopoulos (Heidelberg and Kiel, DE)<br />
11:48 AMP-activated protein kinase dependent signaling pathways and modulation <strong>of</strong> autophagy are 38<br />
involved in the anti-hypertrophic effect <strong>of</strong> the human beta 3 adrenoreceptor.<br />
– E.Dubois-Deruy,J.Hammond,R.Gelinas,B.Manoury, J. Hamelet, I. Lobysheva, D. Langin, C. Dessy,<br />
L. Bertrand, J.L. Balligand (Brussels, BE; Toulouse, FR)<br />
11:54 G-protein coupled receptor kinase 2 (GRK-2), a new regulator in the pathological cardiac<br />
39<br />
hypertrophy by interacting NFAT signaling.<br />
– J. Reinkober, H. Tscheschner, P. Schlegel, T. Wieland, J. Backs, W. Koch, H. Katus, P. Most, P. Raake<br />
(Heidelberg and Mannheim, DE; Philadelphia, US)<br />
12:00 Discussions around plasma screens outside the room.<br />
11:00–12:30 | Vilnius - Village 1<br />
PACEMAKER THERAPY IN 2013<br />
Symposium<br />
Chairperson(s): B. Merkely (Budapest, HU); F. Gadler (Stockholm, SE)<br />
11:00 Can stroke prevention therapy be improved by atrial fibrillation burden detected by pacemaker 40<br />
interrogation?<br />
– P. Ritter (Pessac, FR)<br />
11:22 A safe magnetic resonance imaging with conventional and conditional pacemakers. 41<br />
– A.Roguin(Haifa,IL)<br />
11:45 Is there a role for alternative right ventricular apical pacing? 42<br />
– C. Butter (Bernau bei Berlin, DE)<br />
12:07 Telemonitoring <strong>of</strong> pacemaker patients: future or futuristic? 43<br />
– P. Mabo (Rennes, FR)<br />
11:00–12:30 | Lisbon - Village 1<br />
DIAGNOSTIC EVALUATION OF SYNCOPE<br />
Clinical Seminar<br />
Chairperson(s): R. Sutton (Monte Carlo,MC);G.Theodorakis(Athens,GR)<br />
11:00 Patients with bundle branch block. 44<br />
– A. Moya I Mitjans (Barcelona, ES)<br />
11:22 The role <strong>of</strong> tilt table testing and autonomic testing. 45<br />
– P. Flevari (Halandri, GR)<br />
11:45 Syncope in the elderly. 46<br />
– R.A. Kenny (Dublin, IE)<br />
12:07 Syncope unit: a new necessity? 47<br />
– M. Brignole (Lavagna, IT)<br />
20
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
11:00–12:30 | Ankara - Village 1<br />
BURNING QUESTIONS IN CARDIAC RESYNCHRONISATION THERAPY<br />
Abstract Session<br />
Chairperson(s): A.S. Revishvili (Moscow, RU); H. Burri (Geneva, CH)<br />
11:00 Cardiac resynchronization therapy in atrial fibrillation patients: a multinational registry: the certify 48<br />
study.<br />
– M. Gasparini, C. Leclercq, M. Lunati, M. Landolina, A. Auricchio, M. Santini, G. Boriani, A. Proclemer,<br />
C. Klersy, F. Leyva (Rozzano, Milan, Pavia, Rome, Bologna and Udine, IT; Rennes, FR; Lugano, CH;<br />
Birmingham, GB)<br />
11:15 Benefit <strong>of</strong> cardiac resynchronization therapy in patients without a history <strong>of</strong> advanced heart<br />
49<br />
failure symptoms enrolled in MADIT-CRT.<br />
– R. Herscovici, A.J. Moss, V. Kutyifa, A. Barsheshet, S. McNitt, W. Zareba, I. Goldenberg (Ramat Gan, IL;<br />
Rochester, US)<br />
11:30 Long-term outcome <strong>of</strong> cardiac resynchronization therapy in the elderly. 50<br />
– N. Ehara, Y. Furukawa, K. Ando, T. Arita, M. Nobuyoshi, T. Kimura, S. Shizuta, K. Inoue, S. Fujii, T. Isshiki<br />
(Kobe, Kitakyushu, Kyoto, Osaka, Kurashiki and Tokyo, JP)<br />
11:45 The clinical benefits <strong>of</strong> atrioventricular and interventricular intervals optimization at long-term 51<br />
follow-up in cardiac resynchronization therapy: results from CUBIC study.<br />
– Y. Toyoshima, K. Inoue, K. Fujii, T. Isshiki, T. Kimura, M. Nobuyoshi, K. Ando, S. Shizuta, T. Arita, S. Fujii<br />
(Osaka, Tokyo, Kyoto, Kitakyushu and Kurashiki, JP)<br />
12:00 Intraoperative right to left ventricular interlead delay predicts outcome in CRT recipients. 52<br />
– V.Kutyifa,E.Zima,S.Z.Szilagyi,A.Roka,G.Szucs,A.Kosztin,L.Molnar,G.Szeplaki,L.Geller,B.Merkely<br />
(Budapest, HU)<br />
12:15 Cardiac resynchronization therapy <strong>of</strong>fers no benefits in patients with narrow QRS (
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
11:00–12:30 | Kiev - Village 2<br />
HEART FAILURE: NEW MECHANISMS – NEW THERAPIES<br />
Abstract Session<br />
Chairperson(s): J.L. Tamargo (Madrid, ES); S. Momomura (Saitama, JP)<br />
11:00 Long-term therapy with Bendavia (MTP-1<strong>31</strong>), a novel mitochondria-targeting peptide, normalizes 63<br />
skeletal muscle fiber type composition in dogs with chronic heart failure.<br />
– H.N. Sabbah, S. Rastogi, R.C. Gupta, K. Zhang, M. Wang (Detroit, US)<br />
11:15 Mineralocorticoid receptor antagonists modulate ST2 signaling pathway in chronic heart failure. 64<br />
– M.C. Asensio-Lopez, J. Sanchez-Mas, D.A. Pascual-Figal, L. Caballero, M.J. Fernandez Del Palacio,<br />
G. Santarelli, S. Abenza, M.T. Perez-Martinez, M. Valdes-Chavarri, A.M. Lax (Murcia, ES)<br />
11:30 Carvedilol sensitizes cardiac beta1-adrenergic receptors by increasing subsarcolemmal cAMP 65<br />
levels through ligand-induced dissociation <strong>of</strong> PDE4 from beta1-adrenergic receptors.<br />
– C. Maack, I. Lee, C. Molina, W. Richter, N. Wannenmacher, A. Zimmer, E. Qvigstad, R. Fischmeister,<br />
M. Conti, M. Böhm (Homburg, DE; Chatenay-Malabry, FR; San Francisco, US; Oslo, NO)<br />
11:45 Pro-atrial natriuretic peptide1-126 is processed in the human circulation to a mature GC-A<br />
66<br />
activating peptide with therapeutic potential in heart failure.<br />
– T. Ichiki, B.K. Huntley, S.M. Sandberg, S.J. Sangaralingham, I.A. Anderson, J.C. Burnett (Rochester, US)<br />
12:00 Galectin-3 as indicator <strong>of</strong> oxidative stress and inflammation in patients with chronic heart failure. 67<br />
– E.A.Medvedeva,Y.V.Shchukin,E.I.Seleznev,I.I.Berezin(Samara,RU)<br />
12:15 MiR-21 and miR-133 levels in peripheral blood mononuclear cells associate with left ventricular 68<br />
diastolic dysfunction in patients with diastolic heart failure.<br />
– M. Marketou, J. Kontaraki, E. Zacharis, F. Parthenakis, S. Margkoudakis, J. Logakis, P. Vardas (Heraklion,<br />
GR)<br />
11:00–12:30 | Podgorica - Village 3<br />
CONTROVERSIES IN ANTITHROMBOTIC THERAPY<br />
Debate Session<br />
Chairperson(s): T.W. Weiss (Vienna, AT); D. Alexopoulos (Ekali, GR)<br />
Bivalirudin is the ideal anticoagulant in percutaneous coronary intervention for high-risk acute<br />
coronary syndrome.<br />
11:00 Pro. 69<br />
– H.J. Rupprecht (Ruesselsheim, DE)<br />
11:15 Contra. 70<br />
– G. Montalescot (Paris, FR)<br />
Rebuttal.<br />
11:30 Pro. 71<br />
– H.J. Rupprecht (Ruesselsheim, DE)<br />
11:35 Contra. 72<br />
– G. Montalescot (Paris, FR)<br />
11:40 Conclusion.<br />
New oral anticoagulants are an important addition to dual antiplatelet therapy after acute<br />
coronary syndrome.<br />
11:45 Pro. 73<br />
–C.Bode(Freiburg,DE)<br />
12:00 Contra. 74<br />
–S.Husted(Herning,DK)<br />
Rebuttal.<br />
12:15 Pro. 75<br />
–C.Bode(Freiburg,DE)<br />
12:20 Contra. 76<br />
–S.Husted(Herning,DK)<br />
12:25 Conclusion.<br />
11:00–12:30 | Moscow - Village 3<br />
WHAT IS NEW IN STENT THROMBOSIS?<br />
Symposium<br />
Chairperson(s): R.F. Storey (Sheffield, GB); A. Kastrati (Munich, DE)<br />
11:00 High on-treatment platelet reactivity. 77<br />
– D. Trenk (Bad Krozingen, DE)<br />
11:22 Optimal duration <strong>of</strong> dual antiplatelet therapy. 78<br />
– J.M. Ten Berg (Nieuwegein, NL)<br />
11:45 The role <strong>of</strong> intravascular imaging. 79<br />
– G. Guagliumi (Bergamo, IT)<br />
12:07 Stent thrombosis in the new stent era. 80<br />
– C. Varenhorst (Uppsala, SE)<br />
22
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
11:00–12:30 | Tirana - Village 3<br />
QUALITY INDICATORS FOR ACUTE CARDIAC CARE<br />
Chairperson(s): H. Bueno (Madrid, ES); P.M. Clemmensen (Copenhagen, DK)<br />
Symposium<br />
11:00 ESC-quality indicators for ST-elevation myocardial infarction; a work still in progress? 81<br />
– F. Schiele (Besançon, FR)<br />
11:22 ESC-quality indicators for acute heart failure: are we ready? 82<br />
–S.Price(London,GB)<br />
11:45 Quality indicators for acute coronary angioplasty: is it feasible? 83<br />
– U. Zeymer (Ludwigshafen am Rhein, DE)<br />
12:07 The dedicated <strong>European</strong> registry for quality assessment. 84<br />
– N. Danchin (Paris, FR)<br />
11:00–12:30 | Rabat - Village 4<br />
STRESS AND CARDIOVASCULAR DISEASE: WHAT CAN WE DO ABOUT IT?<br />
Chairperson(s): E. Prescott (Copenhagen, DK); S. Gupta (London, GB)<br />
Symposium<br />
11:00 Stress and cardiovascular disease: cause or trigger? 85<br />
– A. Steptoe (London, GB)<br />
11:22 The role <strong>of</strong> heart rate variability in evaluating stress. 86<br />
– E. Clays (Ghent, BE)<br />
11:45 Sleep patterns and cardiovascular health. 87<br />
– H. Tiemeier (Rotterdam, NL)<br />
12:07 Work related stress. 88<br />
– S. Puttonen (Helsinki, FI)<br />
SATURDAY – MORNING<br />
11:00–12:30 | San Marino - Village 4<br />
OUTCOME MEASURES IN SECONDARY PREVENTION – WHAT AND HOW TO MEASURE?<br />
Chairperson(s): U. Laufs (Homburg, DE); M. Cupples (Belfast, GB)<br />
Symposium<br />
11:00 How to measure the effects <strong>of</strong> the components <strong>of</strong> a multidisciplinary intervention? 89<br />
–K.Pieper(Durham,US)<br />
11:22 Problems with surrogates: why do they not always predict patient outcomes? 90<br />
– W.S. Weintraub (Newark, US)<br />
11:45 Combined endpoints - source <strong>of</strong> manipulation and misinterpretations? 91<br />
– K.K. Teo (Burlington, CA)<br />
12:07 What are the best intermediate endpoints? 92<br />
– T.F. Luscher (Zurich, CH)<br />
11:00–12:30 | Algiers - Village 4<br />
PERCUTANEOUS CORONARY INTERVENTION AND CORONARY ARTERY BYPASS GRAFTING:<br />
THE NEXT 5 YEARS<br />
Chairperson(s): A.P. Kappetein (Rotterdam, NL); H.K. Najm (Riyadh, SA)<br />
Symposium<br />
11:00 Is the absorable stent a real advance? 93<br />
– P. Widimsky (Prague, CZ)<br />
11:22 Which intervention and in whom? 94<br />
– M.C.Morice(Massy,FR)<br />
11:45 Hybrid revascularisation. 95<br />
– C. Muneretto (Brescia, IT)<br />
12:07 What further trials are needed? 96<br />
– A.H. Gershlick (Leicester, GB)<br />
23
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
11:00–12:30 | Algiers - Village 4<br />
THE SMOKING ROOM<br />
Chairperson(s): E.S. Froelicher (Menlo Park, US); C. Chen-Huan (Taipei, TW)<br />
Abstract Session<br />
11:00 Smoking and risk <strong>of</strong> vascular and non-vascular mortality in old age: 15-year follow-up <strong>of</strong> 7000<br />
men in the Whitehall resurvey.<br />
– J. Emberson, N. Bhala, M. Shipley, A. Fletcher, R. Clarke (Oxford, Birmingham and London, GB)<br />
11:15 Smoking influence on mortality: the 40 years’ follow up results <strong>of</strong> the Serbian cohorts <strong>of</strong> the seven<br />
countries studies.<br />
– B. Parapid, N. Milic, B. Obrenovic-Kircanski, V. Vukcevic, O.M.S. Nedeljkovic-Arsenovic, D. Simic,<br />
I. Nedeljkovic, B. Beleslin, M.C. Ostojic (Belgrade, RS)<br />
11:30 Cigarette smoking induces vascular damage <strong>of</strong> both conduit arteries and small vessels and<br />
persistent elevation <strong>of</strong> plasma serotonin unresponsive to 8 weeks <strong>of</strong> smoking cessation.<br />
– T. Sugiura, Y. Dohi, S. Yamashita, S. Tanaka, N. Ohte, Y. Hirowatari, S. Ito, S. Fujii (Nagoya and Ayase, JP)<br />
11:45 Tobacco smoking increases leukocyte activation and decrease regulatory T cells in healthy<br />
subjects.<br />
– R. Mila Garcia, N. Lluberas Gonzalez, S. Grille Montauban, A.I. Gruss, A. Brugnini, N. Trias, A.I. Galan,<br />
L. Llambi, D. Lens, R. Lluberas (Montevideo, UY)<br />
12:00 Long-term implications on the incidence <strong>of</strong> ST-Elevation Myocardial Infarction after<br />
implementation <strong>of</strong> a public smoking ban: a comparison between cantons in Switzerland.<br />
– A.P. Porretta, M. Di Valentino, S. Muzzarelli, C. Limoni, G. Pedrazzini, C. Kaiser, T. Moccetti, S. Osswald,<br />
A. Gallino (Bellinzona, Lugano and Basel, CH)<br />
12:15 Immediate effects <strong>of</strong> electronic cigarette use on coronary circulation and blood<br />
carboxyhemoglobin levels: comparison with cigarette smoking.<br />
– K. Farsalinos, D. Tsiapras, S. Kyrzopoulos, C. Stefopoulos, A. Spyrou, M. Tsakalou, E. Avramidou,<br />
D. Vasilopoulou, G. Romagna, V. Voudris (Athens, GR; Verbania, IT)<br />
97<br />
98<br />
99<br />
100<br />
101<br />
102<br />
11:00–12:30 | Belgrade - Village 5<br />
NEW ADVANCES IN THE TREATMENT OF CORONARY CHRONIC TOTAL OCCLUSION<br />
Symposium<br />
Chairperson(s): C. Di Mario (London, GB); T. Lefevre (Massy, FR)<br />
11:00 Indications. 103<br />
– G.S. Werner (Darmstadt, DE)<br />
11:22 Antegrade approach. 104<br />
– Y. Louvard (Massy, FR)<br />
11:45 Retrograde approach. 105<br />
– S. Rinfret (Quebec City, CA)<br />
12:07 Minimally invasive <strong>of</strong>f pump surgery. 106<br />
– D.M. Holzhey (Leipzig, DE)<br />
11:00–12:30 | Yerevan - Village 5<br />
PERCUTANEOUS CORONARY REVASCULARISATION IN ACUTE CORONARY SYNDROMES Abstract Session<br />
Chairperson(s): J.E.A. Appelman (Amsterdam, NL); M. Gilard (Brest, FR)<br />
11:00 Transradial coronary intervention versus coronary artery bypass grafting for unprotected left main 107<br />
and/or multivessel disease in patients with acute coronary syndrome.<br />
– F. Gao, Y.J. Zhou, Z.J. Wang, S.W. Yang, X.L. Liu, D.A. Jia (Beijing, CN)<br />
11:15 Efficacy <strong>of</strong> thrombus aspiration during percutaneous coronary intervention for stent thrombosis. 108<br />
– S. Kubo, K. Kadota, S. Habara, T. Tada, H. Tanaka, Y. Fuku, H. Katoh, T. Goto, K. Mitsudo (Kurashiki, JP)<br />
11:30 Non-achievement <strong>of</strong> TIMI-3-flow results in significant increase in hospital mortality <strong>of</strong> primary PCI 109<br />
for STEMI and PCI for NSTE-ACS - findings <strong>of</strong> the Euro Heart survey PCI-registry.<br />
– A.K. Gitt, T. Bauer, R. Zahn, U. Zeymer, C. Hamm (Ludwigshafen am Rhein and Bad Nauheim, DE)<br />
11:45 Use and outcome <strong>of</strong> radial versus femoral approach in patients with primary PCI for acute ST 110<br />
elevation myocardial infarction without cardiogenic shock: results <strong>of</strong> the ALKK PCI registry.<br />
– T. Bauer, M. Hochadel, J. Brachmann, V. Schaechinger, P. Boekstegers, B. Zrenner, R. Zahn, U. Zeymer<br />
(Ludwigshafen am Rhein, Coburg, Fulda, Siegburg and Landshut, DE)<br />
12:00 Radial versus femoral approach in patients undergoing percutaneous coronary intervention for 111<br />
acute coronary syndrome: meta-analysis and trial sequential analysis <strong>of</strong> randomized trials.<br />
– R. Piccolo, T. Niglio, G. Di Gioia, C. D’Anna, R. De Rosa, T. Strisciuglio, B. Trimarco, F. Piscione,<br />
G. Galasso (Naples and Salerno, IT)<br />
12:15 Long-term results <strong>of</strong> multivessel and left main coronary artery stenting in comparison with<br />
112<br />
surgical revascularisation in patients with NSTE-ACS: the MILESTONE registry.<br />
– P.P.Buszman,M.Gierlotka,A.Bochenek,K.Milewski,M.Gasiar,L.Polonski,R.S.Kiesz,M.Z.Zembala,<br />
P.E. Buszman (Katowice and Zabrze, PL; San Antonio, US)<br />
24
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
11:00–12:30 | Valetta - Village 6<br />
TRANSCATHETER AORTIC VALVE IMPLANTATION: AN ABC FOR THE GENERAL<br />
CARDIOLOGIST<br />
Chairperson(s): D. Messika-Zeitoun (Paris, FR); P. Kala (Brno, CZ)<br />
Clinical Seminar<br />
11:00 History <strong>of</strong> transcatheter aortic valve implantation. 113<br />
– A. Cribier (Rouen, FR)<br />
11:22 Referral pathways and pre-procedural evaluation. 114<br />
– P. Tornos Mas (Barcelona, ES)<br />
11:45 When is transcatheter aortic valve implantation appropriate and inappropriate? 115<br />
– P.A. MacCarthy (London, GB)<br />
12:07 Future perspectives. 116<br />
– N. Piazza (Montreal, CA)<br />
11:00–12:30 | Bratislava - Village 6<br />
INFECTIVE ENDOCARDITIS – GUIDELINES ON TRIAL<br />
Debate Session<br />
Chairperson(s): W.H. Yin (Taipei, TW); L.A. Pierard (Liège, BE)<br />
All patients with staphylococcal bacteraemia should undergo an urgent echocardiogram.<br />
11:00 Pro. 117<br />
– R.V. Rasmussen (Frederiksberg, DK)<br />
11:15 Contra. 118<br />
– N. Herring (Oxford, GB)<br />
Rebuttal.<br />
11:30 Pro. 119<br />
– R.V. Rasmussen (Frederiksberg, DK)<br />
11:35 Contra. 120<br />
– N. Herring (Oxford, GB)<br />
11:40 Conclusion.<br />
Early surgery is mandatory in left sided infective endocarditis.<br />
11:45 Pro. 121<br />
– C.A. Mestres (Barcelona, ES)<br />
12:00 Contra. 122<br />
– M.J. Antunes (Coimbra, PT)<br />
Rebuttal.<br />
12:15 Pro. 123<br />
– C.A. Mestres (Barcelona, ES)<br />
12:20 Contra. 124<br />
– M.J. Antunes (Coimbra, PT)<br />
12:25 Conclusion.<br />
SATURDAY – MORNING<br />
11:00–12:30 | Vienna - Village 6<br />
WHAT DETERMINES EXERCISE PERFORMANCE IN CONGENITAL HEART DISEASE<br />
Abstract Session<br />
Chairperson(s): L. Morales (Panama, PA); B.J.M. Mulder (Amsterdam, NL)<br />
11:00 Myocardial deformation as provided by CMR based feature tracking is related to exercise<br />
125<br />
capacity and outcome in patients with repaired tetralogy <strong>of</strong> Fallot.<br />
– S. Orwat, G.P. Diller, A. Kempny, R. Radke, B. Peters, P.B. Beerbaum, S. Sarikouch, H. Baumgartner<br />
(Münster, Magdeburg and Hannover, DE)<br />
11:15 Exercise capacity correlates with ventricle size in adult operated tetralogy <strong>of</strong> Fallot. 126<br />
– J. Yap, R.S. Tan, F. Gao, T.T. Le, L. Zhong, Y.Y. Go, R. Liew, J.L. Tan, S.Y. Tan (Singapore, SG)<br />
11:30 The impact <strong>of</strong> pulmonary valve replacement on left ventricular mechanical efficiency in adult 127<br />
patients with tetralogy <strong>of</strong> fallot: a study with cardiac energetics.<br />
– K. Yamamura, Y. Tanoue, I. Sakamoto, K. Uike, Y. Hirata, H. Nagata, Y. Shiokawa, K. Sunagawa,<br />
R. Tominaga, T. Hara (Fukuoka, JP)<br />
11:45 Exercise capacity in children after total cavopulmonary connection; lateral tunnel versus<br />
128<br />
extracardiac conduit technique.<br />
– S.S.M. Bossers, W.A. Helbing, N. Duppen, I.M. Kuipers, A.D.J. Ten Harkel, T. Takken (Rotterdam,<br />
Amsterdam, Leiden and Utrecht, NL)<br />
12:00 Impaired preload reserve during exercise limits exercise capacity in the better Fontan patients. 129<br />
– A. Van De Bruaene, A. La Gerche, G. Claessen, P. De Meester, S. Devroe, J. Bogaert, P. Claus,<br />
H. Heidbuchel, W. Budts, M. Gewillig (Leuven, BE; Melbourne, AU)<br />
12:15 Cardiac index, left ventricular longitudinal systolic function and atrialised right ventricle size affect 130<br />
exercise capacity in adults with Ebsteins anomaly.<br />
– Y.Shiina,W.Li,B.Bouzas,R.Rydman,A.Kempny,T.Karonis,O.Tutarel,M.A.Gatzoulis,P.J.Kilner,<br />
S.V. Babu-Narayan (London, GB)<br />
25
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
11:00–12:30 | Warsaw - Village 7<br />
HYPERTENSION AND THE HEART<br />
Chairperson(s): P. Sleight (Oxford, GB); R.O. Darabont (Bucharest, RO)<br />
Clinical Seminar<br />
11:00 Left ventricular hypertrophy. 1<strong>31</strong><br />
– G.deSimone(Naples,IT)<br />
11:22 Heart failure. 132<br />
– F. Ruschitzka (Zurich, CH)<br />
11:45 Ischaemic heart disease. 133<br />
– A.M. Heagerty (Manchester, GB)<br />
12:07 Atrial fibrillation. 134<br />
– G.Y.H. Lip (Birmingham, GB)<br />
11:00–12:30 | Madrid - Village 7<br />
THE HEART AND THE GUT. THE USE OF PROTON PUMP INHIBITORS IN PATIENTS WITH<br />
CARDIOVASCULAR DISEASE AND ANTITHROMBOTIC THERAPY<br />
Chairperson(s): S. Agewall (Oslo, NO); S. Levy (Marseille, FR)<br />
Symposium<br />
11:00 Bleeding risk associated with antithrombotic therapy. 135<br />
– S. Wassmann (Munich, DE)<br />
11:22 Acute coronary syndromes and proton pump inhibitors. 136<br />
– F.W.A. Verheugt (Amsterdam, NL)<br />
11:45 Platelet inhibition and proton pump inhibitors: pharmacokinetics and clinical evidence. 137<br />
– D. Tsekoura (Athens, GR)<br />
12:07 Warfarin and proton pump inhibitors. 138<br />
– F. Andreotti (Rome, IT)<br />
11:00–12:30 | Bern - Village 7<br />
NEW FRONTIERS IN LIPID LOWERING<br />
Chairperson(s): F. Martinez (Cordoba, AR); K. Hirata (Kobe, JP)<br />
Abstract Session<br />
11:00 No genetic determinants <strong>of</strong> differential cardiovascular event reduction by pravastatin in the<br />
PROSPER/PHASE study.<br />
– I.Postmus,S.Trompet,A.J.M.DeCraen,D.Shiffman,J.J.Devlin,I.Ford,N.Sattar,D.J.Stott,<br />
P.E. Slagboom, J.W. Jukema (Leiden, NL; Alameda, US; Glasgow, GB)<br />
11:15 SLCO1B1 polymorphisms affect atorvastatin pharmacokinetics and cholesterol-lowering effects in<br />
patients with hypercholesterolemia in a microdosing approach.<br />
– K. Kajinami, K. Takeda, K. Maeda, Y. Sugiyama, I. Ieiri, T. Masaugi, N. Fukizawa (Uchinada, Tokyo and<br />
Fukuoka, JP)<br />
11:30 HMG-CoA-reductase inhibitor co-therapy lowers the risk for incident heart failure in farmorubicin<br />
recipients for two cancer locations.<br />
– A.G. Tase, A. Tase, O. Tetiu, G. Savoiu, G. Stanciulescu, M. Mihaila (Pitesti, RO)<br />
11:45 Homogeneity <strong>of</strong> treatment effect <strong>of</strong> REGN727/SAR236553, a fully human monoclonal antibody<br />
against PCSK9, in lowering LDL-C: data from three phase 2 studies.<br />
– P. Moriarty, G. Lecorps, C. Hanotin, R. Pordy, E.M. Roth (Kansas City, Tarrytown and Cincinnati, US; Paris,<br />
FR)<br />
12:00 The ABCA1 gene variant and heart disease risk reduction in the elderly during pravastatin<br />
treatment.<br />
– H. Akao, E. Polisecki, K. Kajinami, S. Trompet, I. Ford, J.W. Jukema, A.J.M. De Craen, R.G.J. Westendorp,<br />
C. Packard, E.J. Schaefer (Boston and Framingham, US; Uchinada, JP; Leiden, NL; Glasgow, GB)<br />
12:15 Effect <strong>of</strong> coenzyme Q 10 supplementation on myalgia induced by HMG-CoA reductase inhibitors.<br />
A randomized, double-blind,placebo controlled study.<br />
– D. Rott, D. Leibowitz (Jerusalem, IL)<br />
139<br />
140<br />
141<br />
142<br />
143<br />
144<br />
11:00–12:30 | Oslo - Village 8<br />
PITFALLS IN DETERMINING THE SEVERITY OF HEART VALVE DISEASE<br />
Clinical Seminar<br />
Chairperson(s): S. Rahimtoola (Los Angeles, US); R. Sicari (Pisa, IT)<br />
11:00 Low flow low gradient aortic stenosis. 145<br />
– R. Rosenhek (Vienna, AT)<br />
11:22 Pressure recovery in aortic stenosis. 146<br />
– S. Ray (Manchester, GB)<br />
11:45 Mitral regurgitation in low cardiac output. 147<br />
–J.L.MoyaMur(Madrid,ES)<br />
12:07 Patient prosthesis mismatch. 148<br />
– M. Galderisi (Naples, IT)<br />
26
SATURDAY, <strong>31</strong> AUGUST 2013 – MORNING SESSIONS<br />
11:00–12:30 | Ljubljana - Village 8<br />
NON-INVASIVE IMAGING IN PULMONARY HYPERTENSION<br />
Chairperson(s): A. Manes (Bologna, IT); L.M. Rincon (Madrid, ES)<br />
Clinical Seminar<br />
11:00 Right heart non-invasive haemodynamics: how reliable is it? 149<br />
– A. Linhart (Prague, CZ)<br />
11:22 A multimodality approach to assess right ventricular remodelling. 150<br />
– D. Muraru (Padua, IT)<br />
11:45 How to rule out pulmonary hypertension secondary to left heart disease? 151<br />
– J.L. Vachiery (Brussels, BE)<br />
12:07 Non-invasive prognostic parameters: old and new. 152<br />
– V. Delgado (Leiden, NL)<br />
11:00–12:30 | Stockholm - Village 8<br />
NUCLEAR AND COMPUTED TOMOGRAPHY CARDIAC IMAGING TO PREDICT CORONARY Abstract Session<br />
RISK<br />
Chairperson(s): P. Knaapen (Amsterdam, NL); H. Sakuma (Tsu, JP)<br />
11:00 Assessing the pretest likelihood <strong>of</strong> coronary artery disease - maximizing clinical information in the 153<br />
age <strong>of</strong> high tech.<br />
– A. Silva Ferreira, C.M. Santos, P. De Araujo Goncalves, H. Marques, H. Dores, M.S. Carvalho, N. Cardim,<br />
F.P. Machado (Lisbon, PT)<br />
11:15 Augmented inflammation in pericoronary adipose tissue is associated with future acute coronary 154<br />
syndrome in patients with coronary artery disease.<br />
– K. Nakanishi, S. Fukuda, A. Tanaka, T. Ikuta, K. Otsuka, K. Matsumoto, H. Inanami, J. Yoshikawa,<br />
K. Shimada, M. Yoshiyama (Osaka, Tanabe, Higashiosaka and Nishinomiya, JP)<br />
11:30 Coronary computed angiography screening on asymptomatic type 2 diabetic patients. 155 (W)<br />
– M. Chang, I.J. Choi, S. Lim, M. Kang, B.H. Hwang, Y.S. Koh, J.M. Lee, S.H. Ihm, K. Chang, K.B. Seung<br />
(Seoul, KR)<br />
11:45 Prognostic value <strong>of</strong> routine cardiac stress imaging 5 years after percutaneous coronary<br />
156<br />
intervention.<br />
– M.J. Zellweger, G. Fahrni, C.A. Kaiser, M.E. Pfisterer (Basel, CH)<br />
12:00 Long term outcome <strong>of</strong> patients with high -risk exercise testing and normal myocardial perfusion 157<br />
imaging.<br />
– M.R. Wanderley, C.L. Pereira Da Cunha, C. Cunha, J.A. Da Silva, A. Stier, O. Franca Neto, O.J. Kormann,<br />
I. Shin Ike, R. Cerci, J. Vitola (Curitiba, BR)<br />
12:15 Prognostic value <strong>of</strong> coronary CT angiography for the prediction <strong>of</strong> major cardiovascular events. 158<br />
– P. De Araujo Goncalves, A. Silva Ferreira, H. Marques, H. Dores, M.S. Carvalho, M.S. Santos, N. Cardim<br />
(Lisbon, PT)<br />
SATURDAY – MORNING<br />
27
SATURDAY, <strong>31</strong> AUGUST 2013 – LUNCH TIME SESSIONS<br />
13:00–14:00 | Chisinau - Central Village<br />
NURSE-LED INITIATIVES IN THE NETHERLANDS<br />
Chairperson(s): J.M.L. Hendriks (Maastricht, NL); T. Van Hecke (Ghent, BE)<br />
Clinical Seminar<br />
13:00 Renal failure, a complicating factor in cardiology patients. 159<br />
– K. De Haan (Rotterdam, NL)<br />
13:18 Responsible steps to expand the field <strong>of</strong> cardiovascular nursing. 160<br />
– A. Van Goor (Utrecht, NL)<br />
13:36 Is there a role for allied pr<strong>of</strong>essionals in pacemaker implantation? 161<br />
– J. Elders (Nijmegen, NL)<br />
13:54 Comments from the chairs. 162<br />
– J.M.L. Hendriks (Maastricht, NL), T. Van Hecke (Ghent, BE)<br />
13:00–14:00 | Skopje - Village 5<br />
RECENT ADVANCES IN MANAGEMENT OF ATRIAL FIBRILLATION<br />
Sponsored by Cardiome Pharma Development AG<br />
Chairperson(s): H.J.G.M. Crijns (Maastricht, NL); J.L. Merino (Madrid, ES)<br />
Satellite Symposium<br />
13:00 The 2012 ESC Guidelines for atrial fibrillation. 163<br />
– D.Atar(Oslo,NO)<br />
13:20 Economic aspects <strong>of</strong> atrial fibrillation. 164<br />
– P. Kirchh<strong>of</strong> (Birmingham, GB)<br />
13:40 Real-life experience with vernakalant – What is the right patient for this drug? 165<br />
– J. Hartikainen (Kuopio, FI)<br />
13:00–14:30 | Warsaw - Village 7<br />
NEW FRONTIERS, NOVEL MECHANISMS, AND EVOLVING PARADIGMS FOR OPTIMIZING Satellite Symposium<br />
CARDIOVASCULAR RISK REDUCTION IN PATIENTS WITH TYPE 2 DIABETES AND ACUTE<br />
CORONARY SYNDROME<br />
Sponsored by Roche<br />
Chairperson(s): A.M. Linc<strong>of</strong>f (Cleveland,US);P.G.Steg(Paris,FR)<br />
13:00 Cardiovascular risk reduction in patients with type 2 diabetes: unique challenges for the<br />
166<br />
cardiovascular specialist.<br />
– A.M. Linc<strong>of</strong>f (Cleveland, US)<br />
13:15 Mechanisms <strong>of</strong> macrovascular disease in high risk type 2 diabetes: critical, time-dependent<br />
167<br />
pathobiologic processes affecting atherogenic and thrombogenic heart disease in the setting <strong>of</strong><br />
type 2 diabetes.<br />
– B. Staels (Lille, FR)<br />
13:35 The pivotal roles <strong>of</strong> insulin resistance, glycemic target goal attainment, and lipid pr<strong>of</strong>ile<br />
168<br />
management in the setting <strong>of</strong> type 2 diabetes: identifying optimal cardiometabolic target goals to<br />
maximize cardiovascular risk reduction in patients with ACS and CAD.<br />
–P.G.Steg(Paris,FR)<br />
13:50 The potential foundation role <strong>of</strong> dual peroxisome proliferator-activated receptor agonists for 169<br />
cardiovascular risk reduction in the diabetic patient with acs: addressing insulin resistance,<br />
glycemic regulation, and dyslipidemia to optimize atheroprotection in T2D.<br />
– A.M. Linc<strong>of</strong>f (Cleveland, US)<br />
14:20 New therapeutic paradigms for optimizing cardiovascular risk reduction in patients with type 2 170<br />
diabetes: the pivotal role <strong>of</strong> multifactorial cardiometabolic-focused interventions.<br />
– G. Montalescot (Paris, FR)<br />
13:00–14:30 | Ljubljana - Village 8<br />
STATE OF THE ART AND FUTURE DIRECTIONS IN ADVANCED CARDIAC IMAGING Satellite Symposium<br />
Sponsored by Toshiba Medical Systems<br />
Chairperson(s): K. Nieman (Rotterdam, NL); J.L. Zamorano Gomez (Madrid, ES)<br />
13:00 2D wall motion tracking in non-STEMI. 171<br />
– S.I. Sarvari (Gjettum, NO)<br />
13:20 Coronary subtraction on 2nd generation 320 row detector CT. 172<br />
– K.F. K<strong>of</strong>oed (Copenhagen, DK)<br />
13:40 CORE320 in clinical practice. 173<br />
– J.A.C. Lima (Baltimore, US)<br />
14:00 Bringing it all together - Realtime fusion <strong>of</strong> ultrasound and CT. 174<br />
– J.L. Zamorano Gomez (Madrid, ES)<br />
14:20 Panel discussion: state <strong>of</strong> the art and future directions in advanced cardiac imaging. 175<br />
– K. Nieman (Rotterdam, NL), J.L. Zamorano Gomez (Madrid, ES)<br />
28
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON SESSIONS<br />
14:00–15:30 | Damascus - Central Village<br />
GENOMICS OF CONGENITAL HEART DISEASE<br />
Chairperson(s): D. Franco (Jaen, ES); R. Kelly (Marseille, FR)<br />
Symposium<br />
14:00 Genomic approaches to laterality in congenital heart defects. 176<br />
– M. Brueckner (New Haven, US)<br />
14:22 Functional genomics <strong>of</strong> cardiac development. 177<br />
– L.A. Larsen (Copenhagen, DK)<br />
14:45 Population genetics and congenital heart disease. 178<br />
–A.Postma(Amsterdam,NL)<br />
15:07 Systems biology to probe cardiac disease genes. 179<br />
– H. Schunkert (Munich, DE)<br />
14:30–16:00 | Chisinau - Central Village<br />
TAKE HOME MESSAGE FOR PRACTITIONERS<br />
In collaboration with the Council for <strong>Cardiology</strong> Practice<br />
Chairperson(s): G. Baron Esquivias (Seville, ES); M. Guenoun (Plan-De-Cuques, FR)<br />
Symposium<br />
14:30 Prevention, hypertension and peripheral artery disease - update 2013. 180<br />
– D.L. Clement (Ghent, BE)<br />
14:48 Heart failure update 2013. 181<br />
– K. Dickstein (Stavanger, NO)<br />
15:06 Coronary artery disease update 2013. 182<br />
– S. Silber (Munich, DE)<br />
15:24 Cardiovascular imaging update 2013. 183<br />
– L.A. Pierard (Liège, BE)<br />
15:42 Arrhythmia and pacing update 2013. 184<br />
– A. Moya I Mitjans (Barcelona, ES)<br />
SATURDAY – AFTERNOON<br />
14:45–16:15 | Vilnius - Village 1<br />
WHY DO GOAL RATES IN HYPERTENSION URGENTLY NEED TO IMPROVE?<br />
Sponsored by Daiichi Sankyo Europe GmbH and The Menarini Group<br />
Chairperson(s): S. Laurent (Paris, FR); B. Williams (London, GB)<br />
Satellite Symposium<br />
14:45 Chairperson’s introduction: why do goal rates in hypertension urgently need to improve? 185<br />
– S. Laurent (Paris, FR)<br />
15:00 How to effectively and simply treat your patients to goal. 186<br />
– R. Schmieder (Erlangen, DE), M. Volpe (Rome, IT)<br />
15:30 Highlights from the new <strong>European</strong> Guidelines on arterial hypertension: what is new? 187<br />
– J. Redon (Valencia, ES)<br />
15:45 No guts, no glory: how to get 70% <strong>of</strong> patients to goal. 188<br />
– J.-J. Mourad (Bobigny, FR)<br />
16:05 Discussion and summary: why do goal rates in hypertension urgently need to improve? 189<br />
– B. Williams (London, GB)<br />
14:45–16:15 | Lisbon - Village 1<br />
STROKE PREVENTION IN ATRIAL FIBRILLATION 2013: REGISTRY INSIGHTS AND Satellite Symposium<br />
PERSPECTIVES<br />
Sponsored by Thrombosis Research Institute London<br />
Chairperson(s): A. Kakkar (London, GB); J.-P. Bassand (Thise, FR)<br />
14:45 Introduction and status update <strong>of</strong> GARFIELD. 190<br />
– A. Kakkar (London, GB)<br />
14:55 Value <strong>of</strong> registries in understanding atrial fibrillation. 191<br />
– D. Fitzmaurice (Birmingham, GB)<br />
15:05 Coronary artery disease and atrial fibrillation. 192<br />
– A.G.G. Turpie (Dundas, CA)<br />
15:15 INRs in context <strong>of</strong> today’s clinical practice. 193<br />
– S. Haas (Munich, DE)<br />
15:25 The reality <strong>of</strong> persistence and compliance in atrial fibrillation. 194<br />
– S. Goto (Isehara, JP)<br />
15:35 Lessons learned from venous thromboembolism prevention. 195<br />
– S.Z. Goldhaber (Boston, US)<br />
15:45 Panel discussion: stroke prevention in atrial fibrillation 2013. 196<br />
– J.-P. Bassand (Thise, FR), A. Kakkar (London, GB), D. Fitzmaurice (Birmingham, GB), S.Z. Goldhaber<br />
(Boston, US), S. Goto (Isehara, JP), S. Haas (Munich, DE), W. Hacke (Heidelberg, DE), A.G.G. Turpie<br />
(Dundas, CA)<br />
29
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON SESSIONS<br />
14:45–16:15 | Luxembourg - Village 2<br />
ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROMES: EBAC Accredited Educational Programme<br />
TRANSLATING EVIDENCE INTO CLINICAL PRACTICE TO IMPROVE<br />
OUTCOMES<br />
Organised by the Sahlgrenska Academy – University <strong>of</strong> Gothenburg. Course Director: Pr<strong>of</strong>. Karl Swedberg<br />
Chairperson(s): C.B. Granger (Durham, US); F. Van de Werf (Leuven, BE)<br />
14:45 Evolving evidence: bridging the gaps among clinical trials, registries, and clinical practice. 197<br />
– F. Van de Werf (Leuven, BE)<br />
15:10 Appropriate risk stratification in the management <strong>of</strong> acute coronary syndromes. 198<br />
– A. Budaj (Warsaw, PL)<br />
15:25 Combining antiplatelet and anticoagulant therapy: is more necessarily better? 199<br />
–C.Bode(Freiburg,DE)<br />
15:40 Assessing variability <strong>of</strong> response to antiplatelet therapy: is there a role for platelet function and 200<br />
generic testing in clinical practice.<br />
– P.A. Gurbel (Baltimore, US)<br />
15:55 Panel and general discussion: antiplatelet therapy in acute coronary syndromes. 201<br />
– C.B. Granger (Durham, US)<br />
“This educational programme is accredited by the <strong>European</strong> Board for Accreditation in <strong>Cardiology</strong> (EBAC) for one<br />
hour <strong>of</strong> External CME credits. Each participant should claim only those hours <strong>of</strong> credit that have actually been spent<br />
in the educational activity. EBAC works in cooperation with the <strong>European</strong> Accreditation Council for Continuing<br />
Medical Education (EACCME), which is an institution <strong>of</strong> the <strong>European</strong> Union <strong>of</strong> Medical Specialists (UEMS).”<br />
Supported by an unrestricted educational grant from AstraZeneca<br />
14:45–16:15 | Bucharest - Village 2<br />
CLINICAL CROSSROADS IN THROMBOSIS: STROKE PREVENTION IN AF; SECONDARY Satellite Symposium<br />
PREVENTION IN ACS<br />
Sponsored by theheart.org / Medscape Education<br />
Chairperson(s): E. Braunwald (Boston, US); F.W.A. Verheugt (Amsterdam, NL)<br />
14:45 Acute coronary syndrome: atrial fibrillation - an update from TIMI. 202<br />
– E.Braunwald(Boston,US)<br />
15:05 Management <strong>of</strong> the patient with atrial fibrillation: is there still a role for vitamin K antagonists? 203<br />
– A.J. Camm (London, GB)<br />
15:20 Should CT angiography be routine in patients with suspected acute coronary syndrome? 204<br />
– J.J. Bax (Leiden, NL)<br />
15:35 Key clinical decisions in patients with acute coronary syndromes. 205<br />
– C.W. Hamm (Bad Nauheim, DE)<br />
15:50 Case presentation: the approach to the patient with chronic atrial fibrillation who develops an 206<br />
acute coronary syndrome.<br />
– F.W.A. Verheugt (Amsterdam, NL)<br />
14:45–16:15 | Belgrade - Village 5<br />
COMPLEX INTERVENTIONAL CARDIAC THERAPIES<br />
Satellite Symposium<br />
Sponsored by Siemens AG Healthcare Sector<br />
Chairperson(s): O. Bruder (Essen, DE); U. Sechtem (Stuttgart, DE)<br />
14:45 Without imaging no cardiac interventions - Opening remarks. 207<br />
– U. Sechtem (Stuttgart, DE)<br />
14:50 Stent enhancement in clincal practice. 208<br />
– K. Cornelis (Gent, BE)<br />
15:10 How to identify the patient that will benefit from coronary revascularization? 209<br />
– C. Tillmanns (Berlin, DE)<br />
15:30 Non-invasive imaging for structural heart disease interventions. 210<br />
– S. Achenbach (Erlangen, DE)<br />
15:50 Intracardiac volume echocardiography for guidance <strong>of</strong> transcatheter aortic valve implantation 211<br />
(TAVI).<br />
– T. Bartel (Innsbruck, AT)<br />
16:10 The role <strong>of</strong> imaging for patient management - Closing remarks. 212<br />
– O. Bruder (Essen, DE)<br />
30
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON SESSIONS<br />
14:45–16:15 | Bern - Village 7<br />
CAN WE IMPROVE MORBIDITY AND MORTALITY WITH TAILORED STRATEGIES IN Satellite Symposium<br />
ACUTE HEART FAILURE?<br />
Sponsored by theheart.org / Medscape Education<br />
Chairperson(s): S.D. Anker (Berlin, DE); A.A. Voors (Groningen, NL)<br />
14:45 Introduction: can we improve morbidity and mortality with tailored strategies in acute heart<br />
213<br />
failure?<br />
– S.D. Anker (Berlin, DE)<br />
14:55 Reality <strong>of</strong> AHF treatments today: lesson from observational data. 214<br />
– D.Atar(Oslo,NO)<br />
15:10 Vascular mechanism <strong>of</strong> acute heart failure. 215<br />
– G.M. Felker (Durham, US)<br />
15:25 Pr<strong>of</strong>iling and strategizing care in AHF: what the clinician needs to know. 216<br />
– P. Ponikowski (Wroclaw, PL)<br />
15:40 New evidence on morbidity and mortality: future prospects and strategies. 217<br />
– A.A. Voors (Groningen, NL)<br />
15:55 Panel discussion: can we improve morbidity and mortality with tailored strategies in acute heart 218<br />
failure?<br />
– A.A. Voors (Groningen, NL)<br />
SATURDAY – AFTERNOON<br />
14:45–16:15 | Oslo - Village 8<br />
NEW METHODS TO ADDRESS COMMON 2D AND 3D ECHO CHALLENGES. PANEL Satellite Symposium<br />
DISCUSSIONS ILLUSTRATED BY CLINICAL CASES.<br />
Sponsored by Philips Healthcare<br />
Chairperson(s): M.J. Monaghan (London, GB); J.-L. Vanoverschelde (Brussels, BE)<br />
14:45 How anatomical intelligence can help assess the heart function. Panel discussion illustrated by 219<br />
clinical cases.<br />
– T. Buck (Essen, DE), R.M. Lang (Chicago, US), J.L. Zamorano Gomez (Madrid, ES)<br />
15:45 Latest advances in periinterventional imaging. Panel discussion illustrated by clinical cases. 220<br />
– K. Tiemann (Munich, DE), R.S. Von Bardeleben (Mainz, DE)<br />
14:45–15:45 | Ljubljana - Village 8<br />
PCSK9: THE NEW LIPID TARGET IN PREVENTIVE CARDIOLOGY? EBAC Accredited Educational Programme<br />
Organised by University College London. Course Director: Pr<strong>of</strong>. John Deanfield<br />
Chairperson(s): J.J.P. Kastelein (Amsterdam, NL); E. Stein (Cincinnati, US)<br />
14:45 Introduction: familial hypercholesterolemia: why are we not reaching goals in these patients? 221<br />
– J.J.P. Kastelein (Amsterdam, NL)<br />
14:55 PCSK9 inhibition: mechanistic insights into a new therapeutic approach for the lowering <strong>of</strong> LDL-c. 222<br />
– G. Lambert (Le Kremlin-Bicêtre, FR)<br />
15:10 Monoclonal antibodies that target PCSK9: what the first clinical trial data are telling? 223<br />
– E. Stein (Cincinnati, US)<br />
15:25 The roadmap <strong>of</strong> PCSK9 inhibitors towards the clinic: an overview <strong>of</strong> current development<br />
224<br />
programs & outcome studies.<br />
–H.N.Ginsberg(NewYork,US)<br />
15:40 Discussion & summary: PCSK9 – the new lipid target in preventive cardiology? 225<br />
– J.J.P. Kastelein (Amsterdam, NL)<br />
“This educational programme is accredited by the <strong>European</strong> Board for Accreditation in <strong>Cardiology</strong> (EBAC) for one<br />
hour <strong>of</strong> External CME credits. Each participant should claim only those hours <strong>of</strong> credit that have actually been spent<br />
in the educational activity. EBAC works in cooperation with the <strong>European</strong> Accreditation Council for Continuing<br />
Medical Education (EACCME), which is an institution <strong>of</strong> the <strong>European</strong> Union <strong>of</strong> Medical Specialists (UEMS).”<br />
Supported by an unrestricted educational grant from Amgen, Lilly, Regeneron/San<strong>of</strong>i<br />
<strong>31</strong>
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON SESSIONS<br />
15:30–16:30 | Moderated Posters - Village 9<br />
CHALLENGING CLINICAL ISSUES IN PULMONARY HYPERTENSION<br />
Moderated Posters<br />
Chairperson(s): O. Kozan (Izmir, TR);H.Shimokawa(Sendai,JP)<br />
Posters are on display from 14:00 to 18:00 and moderated by two Chairpersons between 15:30 and 16:30. The following<br />
abstracts were chosen for their outstanding quality – Presenters are in competition for the “best Moderated Poster” to win a free<br />
registration for next year’s ESC Congress.<br />
15:30 Demythologizing pulmonary artery aneurysm: prevalence and associated complications in a large P226<br />
pulmonary arterial hypertension population.<br />
– J.M. Montero Cabezas, M.J. Ruiz Cano, L. Alvarez Acosta, B. Barrios Garrido-Lestache, J. Delgado<br />
Jimenez, M.A. Gomez Sanchez, A. Jurado Roman, J. Molina Martin De Nicolas, E. Gomez Mariscal,<br />
P. Escribano Subias (Madrid, ES)<br />
15:37 Genotype to phenotype correlations in heritable pulmonary arterial hypertension. P227<br />
– F. Terzi, M. Palazzini, C. Bachetti, A. Albini, E. Monti, F. Dardi, G. Mazzanti, A. Manes, A. Branzi, N. Galie’<br />
(Bologna, IT)<br />
15:45 Myocardial and micro-vascular inflammation/infection in HIV/HCV associated pulmonary artery P228<br />
hypertension.<br />
– A. Frustaci, R. Verardo, F. Scopelliti, M. Francone, C. Grande, R. Badagliacca, D. Vizza, F. Fedele,<br />
N. Petrosillo, C. Chimenti (Rome, IT)<br />
15:52 Baseline hemodynamic predictors <strong>of</strong> treatment response in pulmonary arterial hypertension. P229<br />
– C. Gerges, M. Gerges, Y. Zhou, L. Zhang, M.B. Lang, I.M. Lang (Vienna, AT; Research Triangle Park, US)<br />
16:00 Right ventricular work increase during strenuous exercise is greater than for the left ventricle: P230<br />
results from a real-time exercise cardiac magnetic resonance study.<br />
– A. La Gerche, G. Claessen, A. Van De Bruaene, J. Bogaert, J. Van Cleemput, M. Gewillig, P. Claus,<br />
H. Heidbuchel (Leuven, BE)<br />
16:07 Shift in relative contribution <strong>of</strong> radial and longitudinal mechanics to right ventricular ejection P2<strong>31</strong><br />
fraction between normal subjects and patients with pulmonary hypertension.<br />
– A. Kovacs, D. Peluso, D. Muraru, L. Badano, S. Casablanca, L. Dal Bianco, G. Zoppellaro, S. Iliceto (Padua,<br />
IT)<br />
16:15 Diagnosis <strong>of</strong> right ventricular myocardial fibrosis using right ventricular myocardial CT<br />
P232<br />
attenuation, wall thickness and motion on ECG-gated 320 slice CT in subjects with pulmonary<br />
hypertension.<br />
– K. Ozawa, N. Funabashi, A. Kataoka, N. Yanagawa, N. Tanabe, K. Tatsumi, Y. Kobayashi (Chiba, JP)<br />
16:22 Standardized fluid-challenge testing to distinguish Pulmonary Arterial Hypertension (PAH) from P233<br />
pulmonary hypertension secondary to heart failure.<br />
– F.P.T. Oosterveer, K.M. Marques, C.P. Allaart, F.S. De Man, H.J. Bogaard, A.C. Van Rossum,<br />
N. Westerh<strong>of</strong>, A. Vonk-Noordegraaf, M.L. Handoko (Amsterdam, NL)<br />
32
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON SESSIONS<br />
15:30–16:30 | Moderated Posters - Village 9<br />
ANTITHROMBOTIC THERAPY: UNSOLVED PROBLEMS<br />
Moderated Posters<br />
Chairperson(s): J.A.C. Morais (Leiria, PT); B. Rocca (Rome, IT)<br />
Session moderated by two Chairpersons between 15:30 and 16:30. The following abstracts were chosen for their outstanding<br />
quality and will be discussed in a special area in the Poster Area (Village 9) – Presenters are in competition for the “best<br />
Moderated Poster” to win a free registration for next year’s ESC Congress. Posters are on display from 14:00 to 18:00 (set up<br />
13:30 – removed 18:00).<br />
15:30 Randomized trial to examine the effect <strong>of</strong> ASA dose or ASA dosing frequency on ASA resistance P234<br />
after coronary artery bypass graft surgery.<br />
– J.S. Paikin, J.W. Eikelboom, R.P. Whitlock, J.S. Ginsberg, J.I. Weitz, G. Pare, J. Hirsh (Hamilton, CA)<br />
15:37 The risk for stent thrombosis after discontinuation <strong>of</strong> clopidogrel for PCI patients waiting for P235<br />
surgery.<br />
– T.C. Godschalk, J.C. Kelder, J.M. Ten Berg (Nieuwegein, NL)<br />
15:45 The predictors <strong>of</strong> discharge without clopidogrel following admission with acute coronary<br />
P236<br />
syndrome in australia - the concordance registry.<br />
– M. Anastasius, J.K. Lau, K. Hyun, A. Patel, J. Rankin, D. Walters, C. Juergens, B. Costa, D. Brieger<br />
(Sydney, Perth and Brisbane, AU)<br />
15:52 Duration <strong>of</strong> dual anti-platelet therapy after acute myocardial infarction and impact on mortality. P237 (W)<br />
Landmark analyses from the 5 year follow-up <strong>of</strong> the FAST-MI 2005 registry.<br />
– F. Schiele, E. Puymirat, S. Cattan, P. Coste, Y. Cottin, B. Livarek, N. Meneveau, J. Ferrieres, T. Simon,<br />
N. Danchin (Besançon, Paris, Montfermeil, Bordeaux, Dijon, Versailles and Toulouse, FR)<br />
16:00 Intracranial hemorrhage in acute coronary syndrome: incidence, predictors, and outcomes from P238<br />
APPRAISE-2, PLATO, and TRACER.<br />
– K.W. Mahaffey, J. Horton, J.H. Alexander, P. Tricoci, R.A. Harrington, L. Wallentin (Durham and Stanford,<br />
US; Uppsala, SE)<br />
16:07 Clinical validation <strong>of</strong> BARC definitions <strong>of</strong> bleeding after an ACS in the TRACER trial. P239<br />
– P. Vranckx, P. Tricoci, Z. Huang, F. Van De Werf, L. Wallentin, P. Aylward, P.W. Armstrong, D.J. Moliterno,<br />
K.W. Mahaffey, H.D. White (Hasselt and Leuven, BE; Durham and Lexington, US; Uppsala, SE; Adelaide,<br />
AU; Edmonton, CA; Auckland, NZ)<br />
16:15 Lack <strong>of</strong> concordance between angiographic core laboratory and CEC in the assessment <strong>of</strong> stent P240<br />
thrombosis: results from the TRACER angiographic substudy.<br />
– C.M. Gibson, P. Tricoci, C. Abueg, K. Feeney, Z. Huang, M. Smith, E. Chen, K.W. Mahaffey (Boston,<br />
Durham and Whitehouse Station, US)<br />
16:22 PRT064445 reverses rivaroxaban induced anticoagulation in a rabbit liver laceration "treatment" P241<br />
model.<br />
– S. Hollenbach, S. Tan, F. Deguzman, J. Malinowski, A. Hutchaleelaha, M. Inagaki, J. Curnutte, G. Lu (South<br />
San Francisco, US)<br />
SATURDAY – AFTERNOON<br />
17:00–18:00 | Amsterdam - Central Village<br />
INAUGURAL SESSION<br />
We invite all delegates to join this Special Session which will be immediately<br />
followed by a networking reception in the ESC Plaza.<br />
Special Event<br />
Live from ESC Congress<br />
33
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
14:00–18:00 | Posters - Village 9<br />
POSTER SESSION 1<br />
Presenters will be by their poster during the c<strong>of</strong>fee break from 15:30 to 16:30 for posters viewing time and discussant<br />
interventions. Posters are on display from 14:00 to 18:00.<br />
COMPUTERS<br />
Poster Session<br />
Discussant(s): Computers.<br />
– T. Nieminen (Lahti, FI)<br />
A data-driven clinical prediction rule for pulmonary embolism.<br />
– L.G. Falsetti, E. Merelli, M. Rucco, C. Nitti, T. Gentili, M. Pennacchioni, A. Salvi (Ancona and Camerino, IT)<br />
Association <strong>of</strong> electronic order set usage for heart failure and early post hospital outcomes.<br />
– J. Howlett, A. Pattullo, J. Mandolesi, S. Aggarwal (Calgary, CA)<br />
The wealth <strong>of</strong> nations and the dissemination <strong>of</strong> cardiovascular research.<br />
– S.Winnik,D.A.Raptis,M.Komajda,J.J.Bax,M.Tendera,K.Fox,F.VanDeWerf,T.F.Luescher,<br />
B.K. Nallamothu, C.M. Matter (Zurich, CH; Paris, FR; Leiden, NL; Katowice, PL; London, GB; Leuven, BE;<br />
Ann Arbor, US)<br />
Association between endothelial shear stress and neointimal formation in bioresorbable vascular<br />
scaffolds. An OCT study.<br />
– C. Bourantas, M.I. Papafaklis, A. Kotsia, T. Muramatsu, K.K. Naka, R. Rapoza, H.M. Garcia-Garcia,<br />
Y. Onuma, L.K. Michalis, P.W. Serruys (Rotterdam, NL; Boston and Santa Clara, US; Ioannina, GR)<br />
Vascular modelling and wall motion analysis <strong>of</strong> ascending and descending aorta with 3D-ultrasound<br />
speckle tracking and finite element analysis.<br />
– K. Karatolios, A. Wittek, C. Blase, A. Shelke, R. Moosdorf, S. Vogt (Marburg and Frankfurt, DE)<br />
Finite element models <strong>of</strong> the left ventricle based on 3D speckle tracking echocardiography.<br />
– K. Karatolios, A. Wittek, C. Blase, B. Schieffer, R. Moosdorf, S. Vogt (Marburg and Frankfurt, DE)<br />
Is it important to monitor the percentage <strong>of</strong> cardiac resynchronization day by day?<br />
– M. Mazurek, A. Liberska, K. Przybylska, J. Boidol, T. Podolecki, E. Jedrzejczyk-Patej, J. Kowalczyk,<br />
R. Lenarczyk, O. Kowalski, Z. Kalarus (Zabrze, PL)<br />
Exploring the impact <strong>of</strong> telemonitoring on prescription <strong>of</strong> guideline-recommended heart failure<br />
medication.<br />
– R. Dierckx, J. Zhang, T. Mabote, P. Pellicori, R. Antony, Y. Zhang, P. Atkin, C. Whitehead, K. Goode,<br />
J.G.F. Cleland (Hull and York, GB)<br />
Utility <strong>of</strong> the ST-segment deviation score in the risk prediction <strong>of</strong> patients with suspected acute<br />
myocardial infarction.<br />
– R. Twerenbold, T. Reichlin, R. Abaecherli, S. Sou, K. Wildi, P. Haaf, T. Hochgruber, M. Reiter, S. Osswald,<br />
C. Mueller (Basel, CH)<br />
QRS duration overweighs the LBBB morphology to predict response to cardiac resynchronization<br />
therapy.<br />
– L.E. Sade, I. Atar, B. Ozin, S. Demirtas, H. Muderrisoglu (Ankara, TR)<br />
Selvester QRS score: an automated algorithm for the quantification <strong>of</strong> myocardial scar.<br />
– G. Giannakakis, P. Flevari, M. Dafni, D. Leftheriotis, E. Iliodromitis, M. Anastasiou-Nana (Athens, GR)<br />
Changes in spatial ventricular gradient and QRS-T angle induced by strict 5-days immobilization, and<br />
effects <strong>of</strong> exercise countermeasure.<br />
– E.G. Caiani, A. Pellegrini, J. Bolea, P. Vaida (Milan, IT; Zaragoza, ES; Bordeaux, FR)<br />
Non-invasive mapping <strong>of</strong> endocardial and epicardial activation: a validation study.<br />
– P. Oosterh<strong>of</strong>f, I.H. Gerrits, P.F.H.M. Van Dessel, A.C. Linnenbank, J.M.T. De Bakker, R. Coronel,<br />
T.F. Oosterndorp, P.M. Van Dam (Amsterdam and Nijmegen, NL)<br />
P242<br />
P243<br />
P244<br />
P245<br />
P246<br />
P247<br />
P248<br />
P249<br />
P250<br />
P251<br />
P252<br />
P253<br />
P254<br />
P255<br />
IMAGING OTHERS<br />
Discussant(s): Imaging others.<br />
– E.T. van der Velde (Leiden, NL)<br />
Detection <strong>of</strong> coronary artery disease in postmenopausal women: the significance <strong>of</strong> integrated stress<br />
imaging tests in a 4-year prognostic study.<br />
Top Score Poster<br />
– M.-M. Becker, C. Zwicker, E. Altiok, F.M. Mottaghy, J. Schroeder, N. Marx, R. H<strong>of</strong>fmann (Aachen, DE)<br />
Noninvasive compound ultrasound elastography for vulnerable plaque detection: in vivo validation.<br />
– H.H.G. Hansen, G.J. De Borst, M.L. Bots, F. Moll, G. Pasterkamp, C.L. De Korte (Nijmegen and Utrecht,<br />
NL)<br />
Impact <strong>of</strong> chronic kidney disease on carotid atherosclerotic plaque prevalence and morphology: results<br />
from the high-risk plaque bioimage study.<br />
– U. Baber, S. Sartori, R. Mehran, E. Falk, M. Garcia, H. Sillesen (New York, US; Aarhus and Copenhagen,<br />
DK)<br />
Age- and gender-related differences in non-culprit versus culprit coronary plaques assessed with<br />
intravascular ultrasound.<br />
– A.W. Schoenenberger, N. Urbanek, S. Toggweiler, A.E. Stuck, T.J. Resink, P. Erne (Berne, Lucerne and<br />
Basel, CH)<br />
P256<br />
P257<br />
P258<br />
P259<br />
P260<br />
34
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Cardiac iodine-123-Metaiodobenzylguanidine imaging predicts cardiac events in heart failure patients<br />
evaluated for implantable cardiac defibrillator.<br />
– P. Garcia-Gonzalez, O. Fabregat-Andres, P. Cozar-Santiago, J. Estornell-Erill, M. Ferrando-Beltran,<br />
B. Bochard-Villanueva, A. Quesada-Dorador, R. Paya-Serrano, J. Ferrer-Rebolleda, F. Ridocci Soriano<br />
(Valencia, ES)<br />
The Near Infra-Red (NIRF) molecular imaging <strong>of</strong> oxidised LDL in atherosclerosis with the native<br />
autoantibody LO1, and its molecularly expressed cysteine-tagged Fab construct (LO1-Fab-cys).<br />
– R. Khamis, K. Woollard, S.H. Chang, D.W. Granger, J.J.Boyle,M.Johns,P.M.Matthews,D.O.Haskard<br />
(London and Stevenage, GB)<br />
Non-invasive assessment <strong>of</strong> microvascular dysfunction in families with premature coronary artery<br />
disease.<br />
– T.A. Mulders, M. Nieuwdorp, E.S.G. Stroes, H. Vink, S.J. Pinto-Sietsma (Maastricht and Amsterdam, NL)<br />
Diabetic patients with cardiac syndrome x: methods to investigate coronary microvascular function and<br />
new angiography indexes.<br />
– V. Sucato, S. Evola, E. Bronte, G. Novo, S. Novo (Palermo, IT)<br />
Clinical evaluation <strong>of</strong> dynamic layer separation for coronary DSA and enhancement in fluoroscopic<br />
sequences.<br />
– J. Rieber, H. Rittger, S. Henrichs, M. Ostermeier, M. Baylacher, M. Schmidt, E. H<strong>of</strong>fmann (Munich, Coburg<br />
and Forchheim, DE)<br />
Total costs and outcomes <strong>of</strong> bare metal stent placement with intravascular ultrasound compared with<br />
angiography alone: a cost-effectiveness analysis from the perspective <strong>of</strong> the Italian health system.<br />
– M.Wasserman,V.Priest,A.Alberti,A.Gelera,L.Stefanini,M.Simmonds(London,GB;Singapore,SG;<br />
Milan, IT)<br />
Fatal and non-fatal cancer and medical radiation exposure in a population hospitalized for cardiovascular<br />
disease.<br />
– C. Carpeggiani, P.L. Landi, C.M. Michelassi, E.P. Picano (Pisa, IT)<br />
Validation <strong>of</strong> the aortic dissection detection risk score in the emergency department.<br />
– F. Morello, M. Castelli, S. Vanni, F. Giachino, A. Bono, D. Forno, F. Soardo, P. Nazerian, L. Betti, S. Grifoni<br />
(Turin and Florence, IT)<br />
P261<br />
P262<br />
P263<br />
P264<br />
P265<br />
P266<br />
P267<br />
P268<br />
SATURDAY – AFTERNOON<br />
MULTIMODALITY IMAGING VALVE<br />
Discussant(s): Multimodality imaging valve.<br />
– R. Sicari (Pisa, IT)<br />
Impact <strong>of</strong> angle between interventricular septum and ascending aorta on ellipsoid-shaped aortic annuls<br />
evaluated by three-dimensional transthoracic echocardiography.<br />
– N.Harada,Y.Wada,S.Okuda,Y.Nose,K.Uchida,W.Murakami,T.Ariyoshi,H.Tsutsumi,M.Yano(Ube,<br />
JP)<br />
Aortic annulus eccentricity before and after transcatheter aortic valve implantation: comparison <strong>of</strong><br />
balloon-expandable and self-expandable prostheses.<br />
– A. Schuhbaeck, C. Weingartner, M. Arnold, J. Schmid, T. Pflederer, M. Marwan, H. Nef, M. Uder,<br />
M. Weyand, S. Achenbach (Erlangen and Giessen, DE)<br />
Accuracy <strong>of</strong> aortic root annulus assessment with cardiac magnetic resonance in patients referred for<br />
transcatheter aortic valve implantation: a comparison with multidetector computed tomography.<br />
– G. Pontone, D. Andreini, E. Bertella, S. Mushtaq, P. Gripari, S. Cortinovis, M. Loguercio, A. Baggiano,<br />
E. Conte, M. Pepi (Milan, IT)<br />
Advanced diffuse fibrosis is associated with mid-wall fibrosis in patients with aortic stenosis.<br />
– C.W.L. Chin, S. Semple, T. Malley, A. White, S. Prasad, D.E. Newby, M.R. Dweck (Edinburgh and London,<br />
GB)<br />
Independent predictor CMR <strong>of</strong> mortality in patient with surgical aortic stenosis.<br />
– G. Barone-Rochette, S. Pierard, C. De Meester De Ravensteen, J. Melchior, F. Maes, A.-C. Pouleur,<br />
D. Vancraeynest, A. Pasquet, J.-L. Vanoverschelde, B.L. Gerber (Grenoble, FR; Brussels, BE)<br />
Optimization <strong>of</strong> T1 mapping at 3T in patients with aortic stenosis.<br />
– C.W.L. Chin, S. Semple, T. Malley, A. White, S. Prasad, D. Newby, M. Dweck (Edinburgh and London, GB)<br />
Inconsistent grading <strong>of</strong> severe chronic aortic and mitral regurgitation by cardiovascular magnetic<br />
resonance using current guideline cut-<strong>of</strong>f values.<br />
– C.L. Polte, K.M. Lagerstrand, S. Gao, U. Cederbom, O. Bech-Hanssen (Gothenburg and Trollhattan, SE)<br />
Aortic valve area, stroke volume,left ventricular hypertrophy, remodeling and fibrosis in aortic stenosis<br />
assessed by cardiac MRI.<br />
– G. Barone-Rochette, S. Pierard, S. Seldrum, C. De Meester De Ravensteen, J. Melchior, A.-C. Pouleur,<br />
D. Vancraeynest, A. Pasquet, J.-L. Vanoverschelde, B.L. Gerber (Grenoble, FR; Brussels, BE)<br />
Aortic valve sclerosis: an early marker <strong>of</strong> systemic atherosclerosis and coronary microvascular<br />
dysfunction.<br />
– A. Fisicaro, V. Tufaro, M. L<strong>of</strong>fi, A. Cappelletti, P.G. Camici, A. Margonato, E. Agricola (Milan, IT)<br />
Doppler-derived left ventricular negative dp/dt as a predictor <strong>of</strong> atrial fibrillation or ischemic stroke in<br />
patients with degenerative mitral regurgitation and normal ejection fraction.<br />
– J.E. Yi, J.Y. Chin, D.H. Lee, C.H.O. Ej, H.K. Jeon, H.O. Jung, H.J. Youn (Seoul, KR)<br />
Paravalvular leaks after double valve replacement with reconstruction <strong>of</strong> the mitral aortic intervalvular<br />
fibrosa for infective endocarditis.<br />
– F. De Torres Alba, T. Lopez Fernandez, S. Valbuena Lopez, U. Ramirez Valdris, A. Iniesta Manjavacas,<br />
N. Montoro Lopez, I. Moreno Gomez Limon, M. Moreno Yanguela, J.M. Mesa Garcia, J.L. Lopez Sendon<br />
(Madrid, ES)<br />
P269<br />
P270<br />
P271<br />
P272<br />
P273<br />
P274<br />
P275<br />
P276<br />
P277<br />
P278<br />
P279<br />
P280<br />
35
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Prosthetic meCHAnical mitral ring clot: clinical implication <strong>of</strong> utility <strong>of</strong> Serial real time three dimensional<br />
transesophageal Echocardiography in the evaluation <strong>of</strong> THRombus evolution (CHASE-THR trial).<br />
– M.O. Gursoy, S. Karakoyun, M. Kalcik, Z. Bayram, B. Cakal, M. Yesin, G. Kahveci, N. Eksi Duran, M. Yildiz,<br />
M. Ozkan (Istanbul, TR)<br />
Projected aortic valve area reflects true severity in patients with paradoxical low-flow low-gradient<br />
severe aortic stenosis: a Multicenter Aortic Stenosis Assessment (MASA) study.<br />
– M. Izumo, M. Takeuchi, Y. Seo, E. Yamashita, K. Suzuki, T. Ishizu, S. Oshima, K. Aonuma, F. Miyake,<br />
Y. Otsuji (Kawasaki, Kitakyusyu, Tsukuba and Maebashi, JP)<br />
Clinical utility and prognostic value <strong>of</strong> appropriateness criteria in stress echocardiography for evaluation<br />
<strong>of</strong> valvular heart disease.<br />
– S. Bhattacharyya, V. Kamperidis, B. Shah, I. Roussin, N. Chahal, W. Li, R. Khattar, R. Senior (London and<br />
Harrow, GB)<br />
P281<br />
P282<br />
P283<br />
CHRONIC PULMONARY HYPERTENSION<br />
Discussant(s): Chronic pulmonary hypertension.<br />
– R.N. Naeije (Brussels, BE), M. Beghetti (Geneva, CH), To be announced<br />
The role <strong>of</strong> vascular obstruction site on pulsatile afterload in patients with pulmonary hypertension.<br />
– M.J. Ruiz Cano, M. Vicente, L. Dos Subira, M. Lazaro, A. Lara, J.A. Barbera Mir, A. Roman Broto,<br />
M.J. Castillo, P. Escribano Subias (Madrid, Barcelona, Toledo, Santa Cruz de Tenerife and Seville, ES)<br />
Enhanced [18F]fluorodeoxyglucose accumulation in the right ventricular free wall predicts long-term<br />
prognosis <strong>of</strong> patients with pulmonary hypertension.<br />
– S. Tatebe, Y. Fukumoto, K. Sugimura, K. Satoh, Y. Miura, K. Nochioka, M. Miura, M. Oikawa-Wakayama,<br />
Y. Kagaya, H. Shimokawa (Sendai, JP)<br />
Long-term survival <strong>of</strong> patients with repaired Congenital Heart Disease associated Pulmonary Arterial<br />
Hypertension (CHD-PAH) in the modern management era.<br />
– M.-L. Sun, C.-Y. Cheng, D.-C. Wu, Q.-H. Zhao, Q.-Q. Liu, R. Jiang, X. Jiang, Z.-C. Jing (Shanghai, CN)<br />
In vivo assessment <strong>of</strong> pulmonary arterial vasculopathy by intravascular ultrasound in patients evaluated<br />
for lung transplantation.<br />
– G. Zavala, E. Domingo, C. Arredondo, G. Marti, M. Vazquez, M. Lopez-Messeguer, A. Roman (Barcelona,<br />
ES)<br />
Correlation between serum matrix metalloproteinase-2/tissue inhibitors <strong>of</strong> metalloproteinase-2 ratio and<br />
elevated pulmonary vascular resistance.<br />
– K. Hisazaki, H. Uzui, K. Arakawa, N. Amaya, K. Kaseno, K. Ishida, T. Morishita, T. Sato, J.D. Lee, H. Tada<br />
(Fukui, JP)<br />
Plasma cxc-chemokine ligand 10, 12 and 16 levels correlate significantly with patients’ clinical<br />
characteristics in idiopathic pulmonary arterial hypertension.<br />
– T. Yang, Z.N. Li, G. Chen, Q. Gu, X.H. Ni, Z.H. Zhao, Z.H. Liu, C.M. Xiong, J.G. He (Beijing, CN)<br />
Potential involvement <strong>of</strong> functional tricuspid regurgitation in the diagnostic error to assess pulmonary<br />
arterial pressure by doppler echocardiography.<br />
– S. Yamamoto, Y. Matsumoto, K. Nochioka, M. Miura, S. Tatebe, K. Sugimura, T. Suzuki, Y. Fukumoto,<br />
H. Shimokawa (Sendai, JP)<br />
Formation <strong>of</strong> typical vascular lesions in a new experimental model <strong>of</strong> pulmonary arterial hypertension.<br />
Top Score Poster<br />
– M.-P. Winter, A. Alimohammadi, A. Panzenboeck, M.K. Frey, M. Sibilia, S. Alias, D. Santer, B. Podesser,<br />
F. Nagel, I.M. Lang (Vienna, AT)<br />
Beta-3 adrenoreceptor stimulation reduces pulmonary vascular resistance in experimental models <strong>of</strong><br />
acute and chronic pulmonary hypertension in pigs.<br />
– A. Garcia-Alvarez, D. Pereda, M. Nuno-Ayala, R. Fernandez-Jimenez, D. Sanz-Rosa, J. Garcia-Prieto,<br />
L. Fernandez-Friera, J.M. Garcia-Ruiz, V. Fuster, B. Ibanez (Madrid, ES)<br />
The role <strong>of</strong> gas exchange measurements during exercise in the detection <strong>of</strong> early pulmonary arterial<br />
hypertension in scleroderma patients - a multi-center analysis.<br />
– D. Dumitrescu, G. Kovacs, C. Nagel, M. Halank, J. Winkler, E. Gruenig, H. Olschewski, R. Ewert,<br />
S. Rosenkranz (Cologne, Heidelberg, Dresden, Leipzig and Greifswald, DE; Graz, AT)<br />
Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease.<br />
– C. Gerges, M. Gerges, M.B. Lang, J. Mascherbauer, I.M. Lang (Vienna, AT)<br />
Specific targeting <strong>of</strong> Egr-1 reduces neointimal lesions and improves RV remodeling in PAH.<br />
– M.G.Dickinson,B.Bartelds,M.A.J.Borgdorff,P.Kowalski, J.A.A.M. Kamps, G. Molema, R.M.F. Berger<br />
(Groningen, NL)<br />
Troponin elevation correlates with pulmonary hypertension and hemolytic burden in sickle cell pain crisis.<br />
– S. Rajpal, J. Hilbun, A. Dwary, T. Smith, G. Mina, P.C. Reddy, N.I. Akkus (Shreveport, US)<br />
Efficacy <strong>of</strong> sildenafil therapy in children with pulmonary hypertension secondary to congenital<br />
systemic-to-pulmonary shunts.<br />
– I. Palii, E. Vataman, P. Stratulat (Chisinau, MD)<br />
Mode <strong>of</strong> death in patients with pulmonary arterial hypertension.<br />
– C.D.Vizza,B.Pezzuto,R.Poscia,M.Mezzapesa,M.Nocioni,M.D’Alto,S.Ghio,L.Scelsi,P.Vitulo,<br />
F. Fedele (Rome, Naples, Pavia and Palermo, IT)<br />
Role <strong>of</strong> mitochondrial dysfunction in cachexia secondary to pulmonary arterial hypertension.<br />
– J. Justino, A.I. Padrao, A.F. Silva, R. Nogueira-Ferreira, T. Henriques-Coelho, R. Ferreira, F. Amado,<br />
J.A. Duarte, A. Leite-Moreira, D. Moreira-Goncalves (Porto and Aveiro, PT)<br />
Pulmonary venous hypertension in end-stage chronic obstructive pulmonary disease with preserved<br />
systolic left ventricular function.<br />
– K.H. Andersen, J. Kjaergaard, M.P. Iversen, S. Boesgaard, J. Carlsen (Copenhagen, DK)<br />
P284<br />
P285<br />
P286<br />
P287<br />
P288<br />
P289<br />
P290<br />
P291<br />
P292<br />
P293<br />
P294<br />
P295<br />
P296<br />
P297<br />
P298<br />
P299<br />
P300<br />
P301<br />
36
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Survivin role in pulmonary arterial hypertension.<br />
– M.J. Ferreira-Pinto, A.F. Silva, R. Nogueira-Ferreira, A.I. Padrao, D. Moreira-Goncalves, F. Carneiro,<br />
R. Costa, L. Ribeiro, A.F. Leite-Moreira, T. Henriques-Coelho (Porto and Aveiro, PT)<br />
Protective effect <strong>of</strong> right ventricular mitochondrial damage by cyclosporine A in monocrtaline-induced<br />
pulmonary hypertension.<br />
– D. Lee, Y.W. Jung (Kyeongju, KR)<br />
Children with pulmonary arterial hypertension (PAH) associated with congenital heart disease are treated<br />
less intensively with PAH-targeted drugs compared to children with idiopathic/hereditary PAH.<br />
– W.M.H. Zijlstra, J.M. Douwes, E.B. Rosenzweig, S. Schokker, U. Krishnan, M.T.R. Ro<strong>of</strong>tho<strong>of</strong>t,<br />
K. Miller-Reed, H.L. Hillege, D.D. Ivy, R.M.F. Berger (Groningen, NL; New York and Aurora, US)<br />
Sildenafil add-on therapy to ERA mono-therapy is effective in paediatric pulmonary arterial hypertension.<br />
– J.M. Douwes, M.T.R. Ro<strong>of</strong>tho<strong>of</strong>t, B. Bartelds, M.D. Talsma, H.L. Hillege, R.M.F. Berger (Groningen, NL)<br />
Preliminary results <strong>of</strong> the determination <strong>of</strong> BMPR2 mutations and clinical implications in a Spanish<br />
population <strong>of</strong> patients with pulmonary arterial hypertension.<br />
– E. Barrios, J. Tenorio, P. Lapunzina, M. Vicente, N. Ochoa, A. Parra, M.J. Ruiz-Cano, J. Delgado,<br />
M.A. Gomez-Sanchez, P. Escribano (Madrid, ES)<br />
EPITOME-4, an open-label phase 3b study evaluating a new formulation <strong>of</strong> epoprostenol sodium in<br />
Japanese pulmonary arterial hypertension patients following switch from Flolan.<br />
– Y. Tamura, T. Ono, K. Fukuda, T. Satoh, S. Sasayama (Tokyo and Kyoto, JP)<br />
Hemodynamic assessment <strong>of</strong> patients with pulmonary hypertension due to lung disease and/or hypoxia.<br />
– M.Gerges,C.Gerges,M.B.Lang,I.M.Lang(Vienna,AT)<br />
Cardiovascular risk factors are associated with a reduced response to drug therapies in pulmonary<br />
arterial hypertension.<br />
– A.C. Charalampopoulos, I. Tzoulaki, L.S. Howard, R. Davies, W. Gin-Sing, M.R. Wilkins, J.S.R. Gibbs<br />
(London, GB)<br />
Geometry <strong>of</strong> the right heart and tricuspid regurgitation to exclude elevated pulmonary artery pressure:<br />
new insights.<br />
– P. De Meester, A. Van De Bruaene, P. Herijgers, J.-U. Voigt, M. Delcroix, W. Budts (Leuven, BE)<br />
Prevalence <strong>of</strong> iron deficiency in pulmonary hypertension and comparison according etiology.<br />
– N. Moreira, R. Baptista, G. Castro, A. Marinho, M.J. Ferreira, M. Pego (Coimbra, PT)<br />
Pulmonary artery wave reflection: observations in pulmonary hypertension.<br />
– S.D. Murch, T. Roberts, A. La Gerche, A.I. Macisaac, D.L. Prior, A.T. Burns (Melbourne, AU)<br />
Hypertrophy <strong>of</strong> right ventricular septomarginal trabeculation by cardiac magnetic resonance imaging<br />
predicts presence and severity <strong>of</strong> pulmonary hypertension and outcome.<br />
– G. Karakus, B.A. Marzluf, C. Tufaro, S. Pfaffenberger, J. Babayev, G. Maurer, D. Bonderman,<br />
J. Mascherbauer (Istanbul, TR; Vienna, AT)<br />
Clinical prediction rule for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary<br />
hemangiomatosis.<br />
– A. Ogawa, K. Miyaji, H. Matsubara (Okayama, JP)<br />
The impairment <strong>of</strong> pulmonary function is related to the development <strong>of</strong> pulmonary hypertension in<br />
patients with cystic fibrosis?<br />
– M.A. Prioli, R. Scarsini, G. Pesarini, A. Crist<strong>of</strong>aletti, C. Castellani, B. Assael, G. Tridello, E.G. Milano,<br />
G. Dolci, C. Vassanelli (Verona, IT)<br />
Predicting survival in pulmonary hypertension with echocardiography: insights from a French single<br />
centre cohort.<br />
– P. Moceri, O. Chiche, D. Baudouy, C. Checler, C. Sanfiorenzo, S. Leroy, R. Saady, P. Cerboni, E. Ferrari<br />
(Nice, FR)<br />
Left ventricular mass and volume in patients with idiopathic pulmonary arterial hypertension and<br />
Eisenmenger’s syndrome.<br />
– G. Kopec, D. Moertl, M. Waligora, A. Tyrka, T. Miszalski-Jamka, P. Podolec (Krakow, PL; St Poelten, AT)<br />
Thrombocytopenia in pulmonary hypertension, does it predict survival?<br />
– H. Weaver, R. Tulloh (Bristol, GB)<br />
A significant difference between survival estimates predicted by National Institutes <strong>of</strong> Health and<br />
Pulmonary Hypertension Connection equations in comparison to five-year observed survival.<br />
– S.Ozturk,C.Kaymaz,O.Akbal,H.C.TokgozDemircan,N.Poci,F.Yilmaz,T.Aktemur,N.Kirca,<br />
S. Kulahcioglu, N. Ozdemir (Istanbul, TR)<br />
Prognostic value <strong>of</strong> C-reactive protein in patients with Eisenmenger syndrome.<br />
– G. Scognamiglio, A. Kempny, R. Alonso-Gonzalez, R. Agra-Bermejo, A. Uebing, P. Marino, L. Swan,<br />
M.A. Gatzoulis, K. Dimopoulos, S.J. Wort (London, GB)<br />
Absence <strong>of</strong> acute vasoreactivity response in patients with pulmonary arterial hypertension associated<br />
with toxic oil syndrome.<br />
– E. Barrios, M.A. Gomez-Sanchez, C. Hernandez, M.T. Velazquez, N. Ochoa, J.M. Montero, J. Delgado,<br />
M.J. Ruiz-Cano, P. Escribano, J. Tascon (Madrid and Las Palmas de Gran Canaria, ES)<br />
Pulmonary artery size and intrinsic wall properties in patients with pulmonary hypertension.<br />
– C.-D. Botezatu, R. Enache, O. Nastase, B.A. Popescu, M. Rosca, C. Beladan, A. Calin, M.M. Gurzun,<br />
C. Ginghina (Bucharest, RO)<br />
Comparison <strong>of</strong> hemodynamic parameters in treatment-naive and pretreated patients with pulmonary<br />
arterial hypertension (PAH) in the Phase III PATENT-1 study.<br />
Top Score Poster<br />
– Z.-C. Jing, N. Galie, H.-A. Gh<strong>of</strong>rani, M. Humbert, D. Langleben, L.J. Rubin, M.M. Hoeper, A. Fritsch,<br />
N. Davie, A.M. Keogh (Shanghai, CN; Bologna, IT; Giessen, Hannover and Wuppertal, DE; Le<br />
Kremlin-Bicêtre, FR; Montreal, CA; La Jolla, US; Sydney, AU)<br />
P302<br />
P303<br />
P304<br />
P305<br />
P306<br />
P307<br />
P308<br />
P309<br />
P<strong>31</strong>0<br />
P<strong>31</strong>1<br />
P<strong>31</strong>2<br />
P<strong>31</strong>3<br />
P<strong>31</strong>4<br />
P<strong>31</strong>5<br />
P<strong>31</strong>6<br />
P<strong>31</strong>7<br />
P<strong>31</strong>8<br />
P<strong>31</strong>9<br />
P320<br />
P321<br />
P322<br />
P323<br />
SATURDAY – AFTERNOON<br />
37
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Echocardiographic evaluation <strong>of</strong> the impact <strong>of</strong> exercise training at different time points <strong>of</strong> the<br />
development <strong>of</strong> experimental pulmonary hypertension.<br />
– N. Moreno, D. Moreira-Goncalves, C. Shmidt, A. Bovolini, T. Henriques-Coelho, A. Leite-Moreira (Porto, PT)<br />
Right heart deformation mechanics in patients with pulmonary hypertension.<br />
– K. Keramida, N. Kouris, V. Kostopoulos, V. Karidas, D. Damaskos, C. Kairis, G. Makavos, C.D. Olympios<br />
(Athens, GR)<br />
Prognostic evaluation <strong>of</strong> patients with pulmonary hypertension by combined non-invasive assessment <strong>of</strong><br />
pulmonary vascular resistance and right ventricular function.<br />
– M. Kawamukai, M. Koyama, J. Nishida, H. Kouzu, A. Muranaka, N. Kokubu, S. Yuda, A. Hashimoto,<br />
K. Tsuchihashi, T. Miura (Sapporo, JP)<br />
The right to left atrial and ventricular area ratio, left ventricular area,TAPSE and right ventricular global<br />
strain can predict three-year survival in patients with pulmonary hypertension.<br />
– C. Kaymaz, S. Ozturk, N. Poci, T. Aktemur, O. Akbal, H.C. Tokgoz Demircan, T. Bezgin, F. Yilmaz,<br />
I.H. Tanboga, N. Ozdemir (Istanbul, TR)<br />
Plasma levels <strong>of</strong> soluble P-selectin predict survival in CTEPH.<br />
– R. Sadushi-Kolici, C. Ay, M.P. Winter, S. Panzer, A. Panzenboeck, N. Skoro-Sajer, W. Klepetko,<br />
I.Pabinger,I.M.Lang(Vienna,AT)<br />
Long-term survival and functional status <strong>of</strong> adult patient with Eisenmenger syndrome.<br />
– H. Joly, A. Soufi, R. Henaine, F. Sassolas, J. Ninet, A. Bozio, O. Metton, S. Di Filippo (Lyon, FR)<br />
Utility <strong>of</strong> acute improvement <strong>of</strong> peak oxygen consumption after adding bosentan for predicting<br />
hemodynamic parameters at mid-term follow-up in patients with pulmonary arterial hypertension.<br />
– R. Nishio, H. Tanaka, Y. Tsuboi, M. Shigeru, T. Sawa, H. Kinutani, Y. Taniguchi, Y. Sakai, N. Emoto,<br />
K. Hirata (Kobe, JP)<br />
Doppler echocardiography pulmonary artery flow acceleration time: an adjunctive parameter to select<br />
candidates with suspected pulmonary hypertension to proceed to right heart catheterization.<br />
– A.Fontana,A.Vincenzi,G.Paciocco,G.DeVito,A.Marinari,G.Trocino,A.Ciro’,C.DeCarlini,M.R.Pozzi,<br />
F. Achilli (Monza, Milan and Merate, IT)<br />
Myeloperoxidase, osteopontin and asymmetrical dimethylarginine as biomarkers <strong>of</strong> pulmonary<br />
hypertension severity.<br />
– A.V. Kazimli, A.V. Ryzhkov, N.S. Goncharova, A.V. Naymushin, O.M. Moiseeva (St. Petersburg, RU)<br />
Left ventricular rotational deformation is impaired in pulmonary hypertension: a speckle tracking- based<br />
study.<br />
– S. Yurdakul, Z.K. Bingol, T. Sahin, B. Cengiz, A. Bozkurt, E. Kiyan, S. Aytekin (Istanbul, TR)<br />
Can echocardiography discriminate between pulmonary arterial hypertension and pulmonary<br />
hypertension related to left heart disease in patients with cardiovascular risk factors?<br />
– A.C. Charalampopoulos, I. Tzoulaki, L.S. Howard, R. Davies, W. Gin-Sing, M.R. Wilkins, J.S.R. Gibbs<br />
(London, GB)<br />
Right ventricular wall hypertrophy predicts functional capacity in pulmonary hypertension. A cardiac<br />
magnetic resonance study.<br />
– S.A. Mouratoglou, G. Giannakoulas, A. Kallifatidis, V. Kamperidis, S. Hatjimiltiadis, H. Karvounis<br />
(Thessaloniki, GR)<br />
Diagnostic accuracy <strong>of</strong> the 100% oxygen method in detecting pulmonary right-to-left shunts compared to<br />
transthoracic contrast echocardiography.<br />
– S. Velthuis, V.M.M. Vorselaars, C.J.J. Westermann, R.J. Snijder, J.J. Mager, M.C. Post (Nieuwegein, NL)<br />
Pre-test probability <strong>of</strong> having a pre-capillary rather than a post-capillary pulmonary hypertension: an easy<br />
and integrated echocardiographic score.<br />
– M. D’Alto, E. Romeo, P. Argiento, A. D’Andrea, R. Vanderpool, A. Correra, N. Borrelli, M.G. Russo,<br />
R. Calabro’, R. Naeije (Naples, IT; Brussels, BE)<br />
Long-term safety and survival outcomes <strong>of</strong> patients with pulmonary arterial hypertension enrolled in an<br />
open label continuation study with tadalafil 40mg daily.<br />
– N. Galie, R.J. Barst, R.J. Oudiz, B. Li, A. Esler, G. Simonneau (Bologna, IT; New York, Torrance,<br />
Indianapolis and Ann Arbor, US; Clamart, FR)<br />
P324<br />
P325<br />
P326<br />
P327<br />
P328<br />
P329<br />
P330<br />
P3<strong>31</strong><br />
P332<br />
P333<br />
P334<br />
P335<br />
P336<br />
P337<br />
P338<br />
CHRONIC THROMBO EMBOLIC PULMONARY HYPERTENSION<br />
Discussant(s): Chronic trombo embolic pulmonary hypertension.<br />
– I.M. Lang (Vienna, AT)<br />
Hemodynamic improvement through beneficial vessel reaction following balloon pulmonary angioplasty<br />
for distal-type chronic thromboembolic pulmonary hypertension.<br />
– H. Kinutani, T. Shinke, H. Otake, Y. Taniguchi, N. Emoto, K. Nakayama, K. Hirata (Kobe, JP)<br />
The cause <strong>of</strong> lumen enlargement after balloon pulmonary angioplasty for patients with chronic<br />
thromboembolic pulmonary hypertension-intravascular ultrasound assessment.<br />
– H. Shimokawahara, A. Ogawa, H. Mizoguchi, S. Ikemiyagi, K. Miyaji, M. Munemasa, H. Matsubara<br />
(Okayama, JP)<br />
Assessment <strong>of</strong> right ventricular function by three-dimensional myocardial strain echocardiography in<br />
chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty.<br />
– T. Onishi, H. Tanaka, Y. Fukuda, Y. Motoji, Y. Taniguchi, T. Shinke, N. Emoto, J. Gorcsan, H. Kawai,<br />
K. Hirata (Kobe, JP; Pittsburgh, US)<br />
Hemodynamic parameters during exercise in patients with chronic thromboembolic disease after<br />
pulmonary endarterectomy. Is there a complete normalization <strong>of</strong> pulmonary vascular wall after surgery?<br />
– E. Barrios, P. Escribano, M. Vicente, M. Paradinas, C. Garcia, M.J. Martinez, N. Ochoa, J. Delgado,<br />
M.A. Gomez-Sanchez, M.J. Ruiz-Cano (Madrid, ES)<br />
P339<br />
P340<br />
P341<br />
P342<br />
P343<br />
38
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
D-dimer in chronic thromboembolic pulmonary hypertension.<br />
– A. Kurz, N. Skoro-Sajer, R. Ristl, I. Lang (Vienna, AT)<br />
Splenectomy delays thrombus resolution.<br />
– M.K. Renner, S. Alias, M.P. Winter, B. Redwan, G. Stuebiger, A. Panzenboeck, J. Jakowitsch,<br />
H. Bergmeister, K.T. Preissner, I.M. Lang (Vienna, AT; Münster and Giessen, DE)<br />
P344<br />
P345<br />
INTERVENTION – PERIPHERAL CIRCULATION – SURGERY<br />
Discussant(s): Intervention – peripheral circulation – surgery.<br />
– A.F. Gallino (Bellinzona, CH), E. Van Belle (Lille, FR), H. Gamra (Monastir, TN)<br />
One year clinical and angiographic outcomes after everolimus- and paclitaxel-eluting stent implantation<br />
for small coronary vessels in diabetic patients: sub-analysis from PLUM and SACRA registries.<br />
– K. Nasu, Y. Oikawa, M. Suzuki, H. Ota, Y. Nakagawa, T. Ozaki, Y. Takeuchi, J. Yamashita, T. Suzuki,<br />
M. Muto (Toyohashi, Tokyo, Sapporo, Hamamatsu and Koriyama, JP)<br />
Medial degenerative disease and atherosclerosis in bicuspid and tricuspid aortic valve-associated<br />
thoracic aortic aneurysm.<br />
– E. Malev, E. Luneva, V. Uspensky, L. Mitr<strong>of</strong>anova, M. Paydimirova, E. Zemtsovsky (St. Petersburg, RU)<br />
Bilateral retrograde radial approach in stenting <strong>of</strong> occluded subclavian artery.<br />
– D. Petkoska, B. Zafirovska, A. Jovkovski, S. Kedev (Skopje, MK)<br />
The impact <strong>of</strong> peripheral arterial disease on outcome after percutaneous transluminal angioplasty for<br />
arteriovenous fistula: a 1-year retrospective analysis.<br />
– M.M. Balci, K.G. Balci, A. Kirkpantur, A. Turkvatan, O. Er, S.K. Acikgoz (Ankara and Yozgat, TR)<br />
Gene therapy in peripheral arterial disease: a systematic review and meta-analysis <strong>of</strong> randomized,<br />
controlled trials.<br />
– S. Steiner, A. Hammer (Vienna, AT)<br />
Vascular flow reserve immediately after infrapopliteal intervention as a predictor <strong>of</strong> wound healing in<br />
patients with critical limb ischemia.<br />
– M. Fukunaga, K. Fujii, D. Kawasaki, K. Miki, H. Tamaru, T. Imanaka, M. Ohyanagi, T. Masuyama<br />
(Nishinomiya, JP)<br />
Long-term clinical outcome and predictors after femoropopliteal stenting with self-expandable nitinol<br />
stent for critical limb ischemia.<br />
– Y. Tomoi, Y. Soga, O. Iida, K. Hirano, K. Suzuki, Y. Miyashita, N. Suematsu, Y. Shintani, M. Nobuyoshi<br />
(Kitakyushu, Amagasaki, Yokohama, Sendai, Matsumoto, Fukuoka and Kurume, JP)<br />
Temporal pr<strong>of</strong>ile <strong>of</strong> brain injury and inflammatory serum markers in carotid artery stenting.<br />
– F.DellaPina,A.Rizza,M.S.Parri,G.Basta,C.Prontera,A.Mazzone,A.Clemente,S.Berti(Massaand<br />
Pisa, IT)<br />
Impact <strong>of</strong> 2010 Ghent criteria and subgroups definition to optimize diagnosis, avoid aortic dissection and<br />
choose the right surgical timing in the experience <strong>of</strong> the Tor Vergata Marfan Centre registry.<br />
– S. Grego, M. Russo, F. Versaci, P. Polisca, P. Nardi, L. Chiariello (Rome and Isernia, IT)<br />
The evaluation <strong>of</strong> pulse wave velocity using Arteriograph and Complior apparatus across different<br />
cardiovascular-related diseases.<br />
– I. Ikonomidis, K. Ntai, N.P.E. Kadoglou, I. Papadakis, C. Koukoulis, B. Tritakis, P. Trivilou, H. Triantafyllidi,<br />
M. Anastasiou-Nana, J. Lekakis (Athens, GR)<br />
Differences between short- and long-term outcome <strong>of</strong> type b acute aortic dissection vs intramural<br />
haematoma.<br />
– S. Moral Torres, A. Evangelista, D. Gruosso, H. Cuellar, V. Galuppo, A. Carro, J.A. Urbano-Moral,<br />
M.T. Gonzalez-Alujas, J.F. Rodriguez-Palomares, D. Garcia-Dorado (Barcelona, ES)<br />
Acute anemia and cardiovascular events after vascular surgery.<br />
– D. Calderaro, S.M. Gualandro, D.M. Gualandro, P.C. Yu, G.L.A. Carmo, A.C. Marques, E.A. D‘Amico,<br />
T.R.F. Rocha, B. Caramelli, A.F. Pastana (São Paulo, BR)<br />
Transfer metrics for patients with suspected acute aortic syndrome.<br />
– B. Aggarwal, C.E. Raymond, E. Roselli, J. Jacob, D.D. Holloway, K. Kormos, D. Kralovic, V. Menon<br />
(Cleveland, US)<br />
Reliability <strong>of</strong> the abdominal aortic aneurysm screening by novice physicians using handheld ultrasound<br />
device. A prospective study.<br />
– T. Bonnafy, T. Cautres, A. Labrunie, I. Desormais, P. Vignon, P. Lacroix, V. Aboyans (Limoges, FR)<br />
Drug-eluting stent for revascularization <strong>of</strong> infrapopliteal arteries: a meta-analysis <strong>of</strong> randomized trials.<br />
– S. Cassese, G. Ndrepepa, G. Tepe, I. Ott, L. King, T. Tada, A. Kastrati, M. Fusaro (Munich and Rosenheim,<br />
DE)<br />
Platelet aggregation decrease after vascular surgery and is related to cardiovascular events.<br />
– D. Calderaro, A.F. Pastana, T.R.F. Rocha, P.C. Yu, D.M. Gualandro, G.A.L. Carmo, E. D‘Amico,<br />
P. Puech-Leao, N. De Luccia, B. Caramelli (São Paulo, BR)<br />
Impact <strong>of</strong> stent placement compared with balloon angioplasty in small vessel <strong>of</strong> femoropopliteal disease.<br />
– N. Kamioka, Y. Soga, H. Aihara, H. Yokoi, M. Iwabuchi, M. Nobuyoshi (Kitakyushu, JP)<br />
Aortic stiffness assessed by pulse wave velocity is predictive <strong>of</strong> outcome after coronary artery bypass<br />
grafting: a prospective study.<br />
– T. Cautres, P. Lacroix, T. Bonnafy, A. Leclerc, M. Laskar, V. Aboyans (Limoges, FR)<br />
Clinical-pathogical correlation in surgically resected ascending aorta aneurysms.<br />
– S. Rizzo, M. Martin, R. Razzolini, G. Gerosa, G. Thiene, C. Basso (Padua, IT)<br />
Perivascular adipose tissue supresses superoxide production in internal mammary artery grafts by<br />
regulating Rac1-mediated activation <strong>of</strong> vascular NADPH-oxidase.<br />
– M. Margaritis, A. Antonopoulos, S. Reilly, R. Sayeed, R. Desilva, M. Petrou, D. Tousoulis, C. Stefanadis,<br />
K.M. Channon, C. Antoniades (Oxford, GB; Athens, GR)<br />
P346<br />
P347<br />
P348<br />
P349<br />
P350<br />
P351<br />
P352<br />
P353<br />
P354<br />
P355<br />
P356<br />
P357<br />
P358<br />
P359<br />
P360<br />
P361<br />
P362<br />
P363<br />
P364<br />
P365<br />
P366<br />
SATURDAY – AFTERNOON<br />
39
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Long-term follow-up after endovascular treatment in patients with femoropopliteal TASC II class A and B<br />
lesion.<br />
– N. Kamioka, Y. Soga, H. Aihara, Y. Kobayashi, K. Ichihashi, S. Hiramori, N. Murata, Y. Tomoi, H. Yokoi<br />
(Kitakyushu, JP)<br />
Characteristics and outcome <strong>of</strong> patients over 75 years old hospitalized for lower extremity peripheral<br />
artery disease in France.The COPART registry.<br />
– T.Mirault,C.Chamoin,J.P.Cambou,V.Aboyans,P.Lacroix,J.Constans,A.Rossi,A.Stansal,<br />
A. Bura-Riviere, E. Messas (Paris, Toulouse, Limoges and Bordeaux, FR)<br />
Characteristics and outcome <strong>of</strong> patients hospitalized for lower extremity peripheral artery disease in<br />
France and receiving betablockers. The COPART registry.<br />
– T.Mirault,A.Galloula,J.P.Cambou,V.Aboyans,P.Lacroix,J.Constans,A.Rossi,A.Stansal,<br />
A. Bura-Riviere, E. Messas (Paris, Toulouse, Limoges and Bordeaux, FR)<br />
Long-term experience in patients undergoing endovascular revascularisation procedures for Takayasu<br />
arteritis.<br />
– L. Wrotniak, A. Kablak-Ziembicka, T. Przewlocki, P. Pieniazek, M. Trystula, A. Roslawiecka, J. Podolec,<br />
P. Podolec (Krakow, PL)<br />
How long should cilostazol be prescribed following endovascular therapy in patients with peripheral<br />
artery disease?<br />
– K. Nanto, O. Iida, S. Okamoto, T. Dohi, T. Iida, T. Shiraki, Y. Soga, M. Uematsu (Amagasaki and Kokura, JP)<br />
Long-term results after endovascular therapy for femoropopliteal artery disease in patients with chronic<br />
heart failure.<br />
– Y.Kobayashi,Y.Soga(Kitakyushu,JP)<br />
Factors determining long term survival and risk <strong>of</strong> cardiovascular events in patients treated with<br />
subclavian artery angioplasty.<br />
– L. Wrotniak, T. Przewlocki, A. Kablak-Ziembicka, P. Pieniazek, A. Roslawiecka, P. Musialek, A. Kozanecki,<br />
L. Tekieli, P. Podolec (Krakow, PL)<br />
The impact <strong>of</strong> statin after endovascular treatment or surgical reconstruction for infrainguinal disease in<br />
patients with critical limb ischemia.<br />
– Y.Kobayashi,Y.Soga(Kitakyushu,JP)<br />
Direct flow utilizing the angiosome concept is valuable for salvaging limbs in critical limb ischemia<br />
patients.<br />
– T. Nishijima, T. Ono, K. Morihisa, F. Kugimiya, H. Fukushima, H. Sumida, K. Noda, S. Oshima (Kumamoto,<br />
JP)<br />
A ten year experience resolving traumatic endovascular pathology by firearms in cervical region.<br />
– S. Rizzone, S. Zolorsa, A. Bordenave, D. Di Nanno (Ciudad Autonoma de Buenos Aires, AR)<br />
Carotid artery stenting in clinical practice: first results <strong>of</strong> the multidisciplinary GECAS registry.<br />
– N. Werner, H. Mudra, U. Blacha, P. Von Flotow, I. Janicke, M. Leschke, V. Geist, M. Hochadel, R. Langh<strong>of</strong>f,<br />
R. Zahn (Ludwigshafen am Rhein, Munich, Bad Rothenfelde, Kaiserslautern, Duisburg, Esslingen, Bad<br />
Segeberg and Berlin, DE)<br />
Perioperative complications following aorto-iliac stenting in patients with peripheral artery disease.<br />
– O. Iida, S.O. Okamoto, K.N. Nanto, T.I. Iida, T.S. Shiraki, M.U. Uematsu (Amagasaki, JP)<br />
Endothelial dysfunction as a link between renal and coronary microvascular dysfunction in type II diabetic<br />
patients with normal coronary arteries: a transthoracic echocardiographic doppler study.<br />
– F. Lo Iudice, M. Galderisi, C. D’Amore, G. Savarese, C. Marciano, L. Casaretti, A.M. Pellegrino, I. Fabiani,<br />
L. La Mura, P. Perrone Filardi (Naples, IT)<br />
P367<br />
P368<br />
P369<br />
P370<br />
P371<br />
P372<br />
P373<br />
P374<br />
P375<br />
P376<br />
P377<br />
P378<br />
P379<br />
STROKE<br />
Discussant(s): Stroke.<br />
– S. Kownator (Thionville, FR), A. Kastrati (Munich, DE)<br />
Mitral and aortic calcifications are associated with cerebrovascular ischemic episodes in coronary<br />
patients.<br />
– I. Palka, M. Mostowik, A. Gackowski, J. Nessler (Krakow, PL)<br />
Temporal trends for cerebrovascular event in patients admitted with acute coronary syndrome 1997<br />
-2012.<br />
– D. Radovanovic, P. Erne, G. Pedrazzini, J.-C. Stauffer, R. Jeger, M. Essig, P. Urban (Zurich, Lucerne,<br />
Lugano, Fribourg, Basel, Zweisimmen and Geneva, CH)<br />
High-sensitivity troponin T is predictive <strong>of</strong> adverse outcome after acute ischemic stroke.<br />
– M. Furtner, A. Hammerer-Lercher, S. Kiechl, J. Mair (Innsbruck, AT)<br />
Early statin therapy reduces all-cause mortality in acute hemorrhagic stroke patients without prior statin<br />
use.<br />
– P.-S. Chen, Y.-H. Li, C.-L. Chang, Y.-H. Kao Yang (Tainan City, TW)<br />
Risk factors for ipsi- and contralateral cerebral ischemic lesions after carotid artery stenting with embolic<br />
protection.<br />
– K. Bijuklic, A. Wandler, T. Tuebler, J. Sch<strong>of</strong>er (Hamburg, DE)<br />
One-year outcomes in atrial fibrillation patients with versus without a previous stroke or transient<br />
ischaemic attack: findings from the international prospective GARFIELD registry.<br />
– A.K. Kakkar, J.-P. Bassand, S.Z. Goldhaber, G. Agnelli, D. Atar, E. Berge, F. Cools, S. Haas,<br />
S.K. Rushton-Smith, W. Hacke (London, GB; Besançon, FR; Boston, US; Perugia, IT; Oslo, NO;<br />
Brasschaat, BE; Munich and Heidelberg, DE)<br />
P380<br />
P381<br />
P382<br />
P383<br />
P384<br />
P385<br />
P386<br />
40
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Atrial fibrillation and treatment changes in cryptogenic stroke patients with an implantable loop recorder<br />
for continuous cardiac rhythm monitoring.<br />
– A. Ungar, G. Rieger, T. West, H. Purerfellner, J. Bucx, R.F. Topper, S. Kuster, H. Nagele, M. De Melis,<br />
F. Duru (Florence, IT; Maastricht and Utrecht, NL; Linz, AT; Hamburg, Ratzeburg and Reinbek, DE; Zurich,<br />
CH)<br />
Treatment with cilostazol prevents incidence <strong>of</strong> stroke in haemodialysis patients with peripheral artery<br />
disease: propensity score-adjusted analysis.<br />
– H. Ishii, T. Aoyama, Y. Kumada, D. Kamoi, T. Sakakibara, Y. Kawamura, S. Suzuki, M. Tanaka,<br />
D. Yoshikawa, T. Murohara (Nagoya, JP)<br />
Clinical characteristics <strong>of</strong> atrial fibrillation patients with anemia: from the Fushimi AF registry.<br />
– K. Takabayashi, T. Unoki, H. Ogawa, M. Esato, Y.H. Chun, H. Tsuji, H. Wada, K. Hasegawa, M. Abe,<br />
M. Akao (Kyoto, JP)<br />
Pulse wave velocity independently predicts incidence <strong>of</strong> stroke in patients with essential hypertension:<br />
data from a Greek 6-year-follow-up study.<br />
– I. Bafakis, C. Tsioufis, K. Dimitriadis, I. Andrikou, K. Kintis, L. Lioni, A. Kasiakogias, P. Vasileiou, A. Kordalis,<br />
C. Stefanadis (Athens, GR)<br />
Evaluation with optimal coherence tomography for vulnerable plaque detected by black-blood MRI for<br />
carotid artery stenting.<br />
– M. Suzuki, N. Doi, Y. Hashimoto, K. Hirai, Y. Dote, Y. Goryo, T. Isojima, M. Naito, H. Iwama, T. Nakai (Nara,<br />
JP)<br />
Fibrin monomers improves stroke risk stratification in chronic anticoagulated non-valvular atrial<br />
fibrillation patients.<br />
– V.Roldan,P.Gallego,M.Romera,V.Dominguez,J.A.Vilchez,M.Valdes,V.Vicente,G.Y.Lip,F.Marin<br />
(Murcia, ES; Birmingham, GB)<br />
Differences <strong>of</strong> morphological and functional characteristics <strong>of</strong> patent foramen ovale between patients<br />
with and without cryptogenic brain ischemia.<br />
– J. Dubrava (Bratislava, SK)<br />
Array-based pr<strong>of</strong>iling reveals biomarker and therapeutic potential for different microRNAs in patients with<br />
symptomatic carotid stenosis.<br />
– S.M.Eken,C.Osterholm,E.Chernogubova,H.Jin,A.Razuvajev,L.Perisic,U.Hedin,J.Roy,P.Eriksson,<br />
L. Maegdefessel (Stockholm, SE)<br />
Simultaneous or staged carotid artery stenting and coronary artery bypass grafting as the<br />
revascularization strategy for severe, concurrent carotid and coronary disease in TARGET-CAS study<br />
population.<br />
– K. Dzierwa, P. Pieniazek, L. Tekieli, P. Musialek, T. Przewlocki, J. Piatek, J. Konstanty-Kalandyk,<br />
M. Trystula, R. Kosobucka-Peszat, P. Podolec (Krakow, PL)<br />
ABCS2 risk scores and cardiovascular risk factors do not predict cerebral microemboli in patients with<br />
critical carotid artery stenosis.<br />
– M. Saedon, C. Hutchinson, C. Imray, D.R. Singer (Coventry, GB)<br />
Incidence and clinical features <strong>of</strong> stroke in HIV patients in HAART era: a meta-analysis.<br />
– G. Quadri, F. D’Ascenzo, E. Cerrato, P. Omede’, A. Calcagno, S. Bonora, A. Abbate, G. Biondi Zoccai,<br />
C. Moretti, F. Gaita (Turin and Rome, IT; Richmond, US)<br />
Female patients with non-valvular atrial fibrillation are susceptible to cardioembolic stroke because <strong>of</strong><br />
their left atrial enlargement.<br />
– M. Wanezaki, H. Tamura, T. Watanabe, C. Sato, S. Sasaki, M. Ishino, S. Nishiyama, I. Kubota (Yamagata,<br />
JP)<br />
Metabolic syndrome deteriorates aortic arch plaque in atherothrombotic stroke.<br />
– S. Nishiyama, T. Watanabe, H. Tamura, M. Ishino, S. Sasaki, M. Wanezaki, C. Sato, T. Shishido, I. Kubota<br />
(Yamagata, JP)<br />
Primary Sjogren’s syndrome and risk <strong>of</strong> ischemic stroke: a nationwide study.<br />
– C.-H. Chiang (Hsin-Chu, TW)<br />
Rationale and preliminary results <strong>of</strong> the Imaging <strong>of</strong> the plaque (IMPLAC) study. A multi-modality approach<br />
to identify vulnerable carotid plaques in relation to brain damage in asymptomatic patients.<br />
– E.Ammirati,A.C.Vermi,M.Magnoni,I.Scotti,E.Busnardo, M. Marrocco Trischitta, N. Anzalone, A. Falini,<br />
O.E. Rimoldi, P.G. Camici (Milan, IT)<br />
Decreased left atrial peak systolic strain evaluated by two-dimensional speckle tracking reflects left atrial<br />
appendage dysfunction in sinus rhythm patients with acute ischemic stroke.<br />
– S. Sasaki, H. Tamura, T. Watanabe, S. Nishiyama, M. Wanezaki, M. Ishino, C. Sato, I. Kubota (Yamagata,<br />
JP)<br />
The role <strong>of</strong> microwave radiometry in the prediction <strong>of</strong> concomitant carotid and coronary artery disease.<br />
– M. Drakopoulou, K. Toutouzas, G. Benetos, E. Tolis, A. Synetos, G. Latsios, E. Tsiamis, H. Grassos,<br />
E. Siores, C.H. Stefanadis (Athens, GR; Bolton, GB)<br />
Rheological differences <strong>of</strong> the pathogenetic variants <strong>of</strong> stroke.<br />
– M.V. Kruchinina, A.A. Gromov, V.M. Generalov, A.V. Rabko (Novosibirsk, RU)<br />
BNP but not Troponin is associated with cardioembolic aetiology and poor outcome after acute ischemic<br />
stroke or TIA.<br />
– K.S. Wildi, N. Nigro, C. Mueller, P. Schuetz, B. Mueller, F. Fluri, M. Christ-Crain, M. Katan (Basel, Aarau and<br />
Zurich, CH)<br />
Risk factors and clinical outcome in a stroke event depend on the patient’s age and sex.<br />
– J. Kolasa, M. Faryan, A. Lasek-Bal, P. Puz, K. Mizia-Stec (Katowice, PL)<br />
Left atrial appendage closure for stroke prevention - long term results from high volume center.<br />
– Y. Matsuo, S. Moebius-Winkler, M. Sandri, N. Mangner, N. Majunke, I. Daehnert, G. Schuler,<br />
M. Kurabayashi (Maebashi, JP; Leipzig, DE)<br />
P387<br />
P388<br />
P389<br />
P390<br />
P391<br />
P392<br />
P393<br />
P394<br />
P395<br />
P396<br />
P397<br />
P398<br />
P399<br />
P400<br />
P401<br />
P402<br />
P403<br />
P404<br />
P405<br />
P406<br />
P407<br />
SATURDAY – AFTERNOON<br />
41
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Serum 100B protein in detection <strong>of</strong> brain injury in patients undergoing transcatheter aortic valve<br />
implantation.<br />
– R. Pudil, M. Vasatova, J. Stasek, J. Bis, P. Polansky, J. Harrer, J. Vojacek (Hradec Kralove, CZ)<br />
Thoracic aortic circumferential strain and atherosclerosis in patients with cerebral infarction.<br />
– M.S. Shin, J.G. Kang, B.R. Kim, J. Moon, W.J. Chung, T.H. Ahn (Incheon and Seoul, KR)<br />
Platelet count, mean platelet volume and plasma fibrinogen level in the acute phase <strong>of</strong> different types <strong>of</strong><br />
stroke.<br />
– I. Scuric, F. Baborski, D. Cerovec (Krapinske Toplice, HR)<br />
P408<br />
P409<br />
P410<br />
INFARCTION ACUTE PHASE NON STEMI<br />
Discussant(s): Infraction acute phase non STEMI.<br />
– L.M. Biasucci (Rome, IT), H.A. Katus (Heidelberg, DE)<br />
Differences in incidence <strong>of</strong> hospital admissions for acute coronary syndromes in five Western countries.<br />
Top Score Poster<br />
– U. Zeymer, L. Eckert, I. Dubroca (Ludwigshafen am Rhein, DE; Paris, FR)<br />
Renal failure but not diabetes determines hospital mortality in patients with NSTE-ACS - results <strong>of</strong> the<br />
Euro heart survey ACS-registry.<br />
– A.K. Gitt, M. Hochadel, W. Wojakowski, U. Zeymer, M. Tendera, F. Schiele, R. Zahn, J.P. Bassand<br />
(Ludwigshafen am Rhein, DE; Katowice, PL; Besançon, FR)<br />
Blood transfusion per se does not impact survival in AMI patients. A propensity-score analysis from the<br />
French FAST-MI 2005 registry.<br />
– G. Ducrocq, E. Puymirat, N. Danchin, P. Henry, M. Martelet, P.V. Ennezat, F. Schiele, P.G. Steg,<br />
J. Ferrieres, T. Simon (Paris, Langres, Grenoble, Besançon and Toulouse, FR)<br />
Impact <strong>of</strong> early reperfusion therapy in patients with NSTEMI - results <strong>of</strong> the OPTAMI registry.<br />
– J.C. Karcher, K. Kouraki, T. Limbourg, U. Zeymer, R. Zahn, A. Gitt (Ludwigshafen am Rhein, DE)<br />
The effect <strong>of</strong> weekend admission on outcomes in patients with non-ST-segment elevation acute coronary<br />
syndrome.<br />
– Y.S.Cho,H.J.Kim,K.I.Kim,D.J.Choi(SeongnamandSeoul,KR)<br />
Optimal timing <strong>of</strong> coronary invasive strategy in non-st elevation acute coronary syndromes:<br />
a comprehensive meta-analysis <strong>of</strong> current evidence.<br />
– E.P. Navarese, F. Andreotti, P.A. Gurbel, G. Di Pasquale,D.Ardissino,G.W.Stone,J.Kubica(Bydgoszcz,<br />
PL; Rome, Bologna and Parma, IT; Baltimore and New York, US)<br />
Incidence <strong>of</strong> serious arrhythmias after successful revascularization in patients with NSTEMI.<br />
– K.S. Wildi, F. Cuculi, T. Reichlin, R. Twerenbold, K. Murray, B. Meller, M. Rubini-Gimenez, C. Mueller (Basel<br />
and Lucerne, CH; Boston, US)<br />
Rapid rule-out <strong>of</strong> NSTEMI using sensitive cardiac troponin I: evaluation <strong>of</strong> the safety <strong>of</strong> the ESC 2011<br />
guidelines.<br />
– K. Murray, B. Moehring, R. Twerenbold, M. Mueller, M. Rubini Gimenez, S.M. Sou, B. Meller, P. Haaf,<br />
T. Reichlin, C. Mueller (Basel, CH; Freiburg and Bad Krozingen, DE; Boston, US)<br />
Release kinetics <strong>of</strong> early ischemic biomarkers in patients undergoing transcoronary ablation <strong>of</strong> septal<br />
hypertrophy.<br />
– C. Liebetrau, O. Doerr, L. Gaede, S. Szardien, J. Rixe, A. Rolf, J. H<strong>of</strong>fmann, H. Nef, C. Hamm,<br />
H. Moellmann (Bad Nauheim and Giessen, DE)<br />
Myocardial injury after noncardiac surgery and short-term mortality.<br />
– J.A.R. Van Waes, H.M. Nathoe, J.C. De Graaff, H. Kemperman, G.J. De Borst, L.M. Peelen, W.A. Van Klei<br />
(Utrecht, NL)<br />
Invasive treatment strategy in elderly patients with non ST elevation acute coronary syndromes.<br />
A sensitivity analysis <strong>of</strong> a large monocentric retrospective study.<br />
– J.Passerini,E.Conti,M.B.Musumeci,D.Fusco,L.Zezza,M.Ventura,A.Romaniello,A.Berni,M.Volpe,<br />
C. Autore (Rome, IT)<br />
High-sensitivity troponin in evaluation <strong>of</strong> acute coronary syndrome: application <strong>of</strong> gender specific<br />
diagnostic thresholds.<br />
– A. Shah, M. Griffiths, K. Lee, D. McAllister, A. Hunter, F. Strachan, S. Walker, K. Fox, D. Newby, N. Mills<br />
(Edinburgh, GB)<br />
One-hour rule-out and rule-in <strong>of</strong> acute myocardial infarction using Siemens high-sensitivity cardiac<br />
troponin T.<br />
– R. Twerenbold, T. Reichlin, M. Rubini-Gimenez, M. Mueller, K. Wildi, P. Haaf, C. Mueller (Basel, CH)<br />
Optimal cut<strong>of</strong>f-value <strong>of</strong> Siemens cardiac troponin I assay in patients with kidney disease for the early<br />
diagnosis <strong>of</strong> acute myocardial infarction.<br />
– R. Twerenbold, S. Sou, M. Mueller, T. Reichlin, M. Rubini-Gimenez, T. Hochgruber, C. Mueller (Basel, CH)<br />
Chronic kidney disease epidemiology collaboration equations and global registry for acute coronary<br />
events risk score for the prediction <strong>of</strong> mortality in non-ST elevation acute coronary syndromes.<br />
– M. Navarro-Penalver, P.J. Flores-Blanco, A. Lopez-Cuenca, F. Marin, M. Sanchez-Martinez,<br />
M. Sanchez-Galian, A. Romero-Aniorte, J.A. Vilchez, M. Valdes, S. Manzano Fernandez (Murcia, ES)<br />
Baseline red cell distribution width and long term clinical outcomes in patients treated with primary<br />
percutaneous coronary intervention.<br />
– T. Akgun, V. Oduncu, C.Y. Karabay, A. Erkol, A. Guler, O. Tasar, A. Kalayci, O. Ozveren, M. Akcakoyun,<br />
C. Kirma (Istanbul, TR)<br />
Patients with NSTEMI have increased QT prolongation as compared to patients with acute coronary<br />
syndrome without MI.<br />
– R. Jubeh, D. Tzivoni, M. Moriel, M. Klutstein, S. Mtour, R. Farkash, A. Medina (Jerusalem, IL)<br />
P411<br />
P412<br />
P413<br />
P414<br />
P415<br />
P416<br />
P417<br />
P418<br />
P419<br />
P420<br />
P421<br />
P422<br />
P423<br />
P424<br />
P425<br />
P426<br />
P427<br />
P428<br />
42
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Electrocardiogram in Non-ST Elevation Myocardial Infarction: will always have the same meaning on<br />
prognosis?<br />
– B.C. Picarra, A.R. Santos, A.F. Damasio, M. Celeiro, A. Bento, J. Aguiar, SPC RNSCA (Évora, PT)<br />
The incidence <strong>of</strong> troponin elevation in non AMI patients in the unselected emergency room population.<br />
– P. Collinson, D.C. Gaze, S. Goodacre (London and Sheffield, GB)<br />
The clinical introduction <strong>of</strong> high sensitivity cardiac troponin will redefine patient categories in acute<br />
coronary syndromes and increase prognostic information.<br />
– M. Schoos, K. Iversen, M. Nielsen, J. Thode, S. Hansen, P. Clemmensen, R. Steffensen (Copenhagen and<br />
Hillerød, DK)<br />
Release kinetics <strong>of</strong> circulating micrornas in patients undergoing transcoronary ablation <strong>of</strong> septal<br />
hypertrophy.<br />
– C. Liebetrau, O. Doerr, H. Moellmann, S. Szardien, C. Troidl, L. Gaede, M. Willmer, J. Rixe, C. Hamm,<br />
H. Nef (Bad Nauheim and Giessen, DE)<br />
Derivatives <strong>of</strong> enzymatic injury kinetics in acute ST-elevation myocardial infarction. Cardiac magnetic<br />
resonance imaging validation study.<br />
– J. Zalewski, K. Zmudka, P. Lech, M. Durak, J. Nessler (Krakow, PL)<br />
One-hour rule-out and rule-in <strong>of</strong> acute myocardial infarction using siemens sensitive cardiac Troponin I<br />
ultra.<br />
– R. Twerenbold, B. Meller, M. Rubini, K. Wildi, M. Mueller, T. Reichlin, S. Osswald, C. Mueller (Basel, CH)<br />
Stem cell mobilization by granulocyte-colony Stimulating Factor in patients with acute myocardial<br />
infarction: five-year results <strong>of</strong> the REVIVAL-2 trial.<br />
– I. Ott, S. Schulz, M. Fusaro, S. Cassese, R. Byrne, M. Joner, A. Kastrati (Munich, DE)<br />
Copeptin as a part <strong>of</strong> the dual biomarker strategy for early diagnosis <strong>of</strong> non ST segment elevation<br />
myocardial infarction WILCOP study.<br />
– M. Tajsic, R. Jarai, M.A. Schwarz, J. Kitzbrecht, J. Koch, J. Wojta, K. Huber (Vienna, AT)<br />
Coronary artery plaque burden is a predictor <strong>of</strong> myocardial ischemia in non-ST elevation myocardial<br />
infarction in both genders.<br />
– I. Eskerud, E. Gerdts, J.E. Nordrehaug, M.T. Lonnebakken (Bergen, NO)<br />
P429<br />
P430<br />
P4<strong>31</strong><br />
P432<br />
P433<br />
P434<br />
P435<br />
P436<br />
P437<br />
SATURDAY – AFTERNOON<br />
INFARCTION ACUTE PHASE STEMI<br />
Discussant(s): Infarction acute phase STEMI.<br />
– A. Parkhomenko (Kiev, UA), A.K. Gitt (Ludwigshafen, DE), S. Agewall (Oslo, NO)<br />
P438<br />
Current use and clinical benefit <strong>of</strong> intraaortic balloon support in patients with ST-elevation myocardial<br />
infarction complicated by cardiogenic shock.<br />
– O. Koeth, S.K.G. Maier, C. Fleischmann, G.S. Werner, L.S. Maier, H.G. Olbrich, J. Jung, K.H. Scholz<br />
(Worms,Straubing,Wolfsburg,Darmstadt, Göttingen, Langen and Hildesheim, DE)<br />
Progress seen after the first year <strong>of</strong> "stent for life" Initiative in Portugal.<br />
– H. Pereira, R. Cale, E. Pereira, J. Marques, L. De Sousa, M. De Sousa Almeida, S. De Mello (Almada, Braga<br />
and Lisbon, PT)<br />
Gender-related mortality trends among diabetic patients with STEMI: insights from a nationwide registry<br />
1997- 2010.<br />
– M. R<strong>of</strong>fi, D. Radovanovic, P. Erne, P. Urban, S. Windecker, F.R. Eberli (Geneva, Zurich, Lucerne and Berne,<br />
CH)<br />
Effect <strong>of</strong> ischemic postconditioning on microvascular obstruction in reperfused myocardial infarction.<br />
Results <strong>of</strong> a randomized multicenter study in patients and data <strong>of</strong> an experimental model.<br />
– C. Bonanad, J.M. Ruiz-Nodar, E. Feliu, J. Nunez, J. Sanchis, J.M. Martinez-Elvira, G. Minana,<br />
J.V. Monmeneu, F.J. Chorro, V. Bodi Peris (Valencia and Alicante, ES)<br />
Acute kidney injury in the setting <strong>of</strong> acute ST-elevation myocardial infarction.<br />
– A. Sinkovic, M. Marinsek, F. Svensek (Maribor, SI)<br />
The effect <strong>of</strong> older age on receipt and outcomes <strong>of</strong> care in patients with acute coronary syndromes: a<br />
cohort study <strong>of</strong> 68,025 patients from the national acute coronary syndrome register <strong>of</strong> England/Wales.<br />
– M.J. Zaman, L. Shepstone, S. Stirling, M. Bachmann, P.K. Myint (Norwich, GB)<br />
GP IIb/IIIa inhibitors improve outcome in patients with primary PCI for STEMI. Results <strong>of</strong> the prospective<br />
ALKK-Registry.<br />
– U. Zeymer, M. Hochadel, A. Gitt, J. Brachmann, H. Schuehlen, R. Zahn (Ludwigshafen am Rhein, Coburg<br />
and Berlin, DE)<br />
Delayed postconditioning in STEMI patients.<br />
– F. Roubille, N. Mewton, O. Lairez, G. Rioufol, H. Thibaut, M. Elbaz, P. Croisille, F. Prunier, O. Roth, M. Ovize<br />
(Montpellier, Lyon, Toulouse, Angers and Mulhouse, FR)<br />
Intrapulmonary artery balloon counterpulsation (PABC) improves outcome in post-ischemic cardiogenic<br />
shock.<br />
– S. Nour, N. Magkoutis, G. Sideris, S. Voicu, R. Ouardani, C. Kang, M. Bonneau, O. Bailliart (Jouy-en-Josas<br />
and Paris, FR)<br />
The assessment <strong>of</strong> edema in magnetic resonance imaging in patients with acute myocardial infarction.<br />
– M. Lanocha, A. Kociemba, K. Karmelita-Katulska, A. Siniawski, M. Janus, M. Pyda, S. Grajek (Poznan, PL)<br />
Coronary artery bypass graft patients treated with primary percutaneous coronary intervention have high<br />
long-term adverse event rates (10,920 STEMI patients from the London heart attack group).<br />
– B.N. Modi, M.M. Akhtar, D.A. Jones, A. Wragg (London, GB)<br />
Microvascular integrity indexes were predictor <strong>of</strong> long-term adverse cardiac events in acute myocardial<br />
infarction.<br />
– M.H. Yoon, S.J. Tahk, H.S. Lim, J.S. Park, H.M. Yang, J.E. Her, Y.S. Kwon, B.J. Choi, S.Y. Choi, J.H. Shin<br />
(Suwon, KR)<br />
P439<br />
P440<br />
P441<br />
P442<br />
P443<br />
P444<br />
P445<br />
P446<br />
P447<br />
P448<br />
P449<br />
P450<br />
43
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
AVR the ignored lead in pre hospital management <strong>of</strong> STEMI patients.<br />
– F. Boutot, S. Da Costa, S. Parisse, J. Moro, K. Milojevic, J.M. Caussanel, Y. Lambert (Versailles, FR)<br />
Reducing door-to-balloon time in patients with ST-segment elevation myocardial infarction affect<br />
in-hospital and one-year mortality: a network experience in Italy.<br />
– U.Paradossi,U.Palmieri,M.Ravani,M.Vaghetti,G.Trianni,A.Rizza,A.M.Mazzone,A.Taddei,S.Maffei,<br />
S. Berti (Massa, IT)<br />
CD4+CD28null T-cell enrichment at the culprit lesion site in STE-ACS.<br />
– A. Mangold, T. Scherz, A. Falkinger, T. H<strong>of</strong>bauer, C. Adlbrecht, I.M. Lang (Vienna, AT)<br />
Gender differences in the use <strong>of</strong> invasive strategies and recommended medications for AMI in the EHS<br />
2009 snapshot registry.<br />
– B.Parapid,E.Puymirat,A.Battler,J.Birkhead,H.Bueno,K.A.A.Fox,B.Lindhal,F.Schiele,M.Tubaro,<br />
N. Danchin (Belgrade, RS; Paris and Besançon, FR; Tel Aviv, IL; London and Edinburgh, GB; Madrid, ES;<br />
Uppsala, SE; Rome, IT)<br />
The randomized physiologic assessment <strong>of</strong> thrombus aspirtion in patients with ST-segment Elevation<br />
acute Myocardial Infarction trial (PATA STEMI).<br />
– D. Orlic, M. Ostojic, B. Beleslin, D. Sobic-Saranovic, M. Tesic, V. Vukcevic, S. Stojkovic, M. Dobric,<br />
M. Nedeljkovic, G. Stankovic (Belgrade, RS)<br />
Trend <strong>of</strong> decreased incidence and mortality <strong>of</strong> right ventricular infarction in association with increased<br />
use <strong>of</strong> reperfusion therapy; results from over 30-year database <strong>of</strong> acute myocardial infarction.<br />
– S. Honda, S. Yasuda, T. Yamane, T. Adachi, T. Nagai, T. Miyagi, J. Kotani, H. Sakamoto, M. Ishihara,<br />
H. Ogawa (Suita, JP)<br />
Comparison <strong>of</strong> 30-day outcome in ST-elevation myocardial infarction patients treated in Sweden or<br />
Hungary: results from SWEDEHEART and the Hungarian myocardial infarction registry.<br />
– K. Szummer, A. Janosi, T. Breuer, P. Ofner, J. Sundstrom, T. Jernberg (Stockholm, SE; Budapest, HU;<br />
Sydney, AU)<br />
Impact <strong>of</strong> thrombectomy on the outcome <strong>of</strong> ST-segment elevation myocardial infarction patients treated<br />
with primary percutaneous coronary intervention.<br />
– P.S. Mateus, C. Ferreira, A. Ferreira, S. Carvalho, J.I. Moreira (Vila Real, PT)<br />
Low specificity <strong>of</strong> ST-segment elevation or left bundle branch block in the activation for primary<br />
percutaneous coronary interventions.<br />
– H. Reuter, S. Scholz, C. Wegmann, A. Markh<strong>of</strong>, H.W. Hoepp, R. Pfister (Cologne, DE)<br />
Novel potential biomarkers for ST-elevation myocardial infarction identified by proteomic analysis <strong>of</strong><br />
plasma-derived microparticles.<br />
– P. Velez, A. Parguina, I. Rosa, L. Grigorian, R. Ocaranza, S. Alonso-Orgaz, M. Barderas, J. Moreu,<br />
R. Gonzalez-Juanatey, A. Garcia (Santiago de Compostela, Vigo and Toledo, ES)<br />
Takotsubo cardiomiopathy: incidence, clinical features and prognosis in all comers patients referred for<br />
acute coronary syndrome.<br />
– D. Grosseto, S. Carigi, A. Santarelli, F. Baldazzi, N. Franco, S. Amati, D. Santoro, L. Marinelli, M. Marconi,<br />
G. Piovaccari (Rimini and Riccione, IT; San Marino, SM)<br />
Sedation with sev<strong>of</strong>lurane improves reperfusion in acute myocardial infarction.<br />
– S. Lavi, D. Bainbridge, S. Dalfonso, P. Teefy, G. Jablonsky, P. Garg, J. Syed, P. Diamantouros, K. Sridhar,<br />
R. Lavi (London, CA)<br />
The effect <strong>of</strong> esmolol on left ventricular haemodynamic, rotational mechanics and strain in intact and<br />
infracted myocardium. Experimental study.<br />
– J.A. Agrios, A.K. Kaladaridou, E.S. Skaltsiotes, D.B. Bramos, J.M. Matheos, C.P. Pamboucas,<br />
E.P. Papadopoulou, G.K. Kottis, S.T. Toumanidis (Athens, GR)<br />
Standard (180mg) vs high (360mg) loading dose <strong>of</strong> ticagrelor in patients with STEMI undergoing primary<br />
PCI.<br />
– D. Alexopoulos, I. Xanthopoulou, S. Patsilinakos, V. Gizas, A. Perperis, G. Makris, S. Karanikas,<br />
I. Chiladakis, G. Hahalis, P. Davlouros (Patras and Athens, GR)<br />
Automatic remote ischemic preconditioning procedure reduces reperfusion arrhythmias and<br />
contrast-induced nephropathy in patients with ST-elevation myocardial infarction.<br />
– T. Yamanaka, Y. Kawai, T. Mima, H. Ito (Imabari, Matsuyama and Okayama, JP)<br />
Impact <strong>of</strong> intraaortic counterpulsation on microcirculatory impairment in cardiogenic shock complicating<br />
myocardial infarction - an IABP-Shock II substudy.<br />
– C. Jung, G. Fuernau, M. Ferrari, B. Goebel, H.R. Figulla, S. Desch, G. Schuler, H. Thiele (Jena and Leipzig,<br />
DE)<br />
Intensive glucose regulation does not reduce enzymatic infarct size in hyperglycemic acute coronary<br />
syndromes: results <strong>of</strong> the randomized BIOMArCS-2 glucose trial.<br />
– M.DeMulder,V.A.Umans,J.H.Cornel,F.M.VanDer Zant, F. Stam, R.M. Oemrawsingh, K.M. Akkerhuis,<br />
E. Boersma (Alkmaar and Rotterdam, NL)<br />
Circumflex artery-related ST-elevation myocardial infarction is associated with an increased delay in<br />
primary PCI: data from the Austrian acute PCI registry.<br />
– J. Doerler, H. Alber, W. Benzer, G. Grimm, M. Juhasz, D.V. Levinski, F.X. Roithinger, H. Schuchlenz,<br />
P. Siostrzonek, F. Weidinger (Vienna, AT)<br />
Treatment delay in primary PCI in relation to marital status and distance from acute medical care.<br />
– D. Austin, A.T. Yan, S. Jamieson, A.G. Zaman, V. Kunadian, A.J. Bagnall (Middlesbrough and<br />
Newcastle-upon-Tyne, GB; Toronto, CA)<br />
Longitudinal strain provides prognositic value, incremental to that <strong>of</strong> cardiac magnetic resonance at the<br />
acute phase in patients with st-segment elevation myocardial infarction.<br />
– L. Biere, E. Donal, G. Terrien, G. Kervio, A. Furber, F. Prunier (Angers and Rennes, FR)<br />
P451<br />
P452<br />
P453<br />
P454<br />
P455<br />
P456<br />
P457<br />
P458<br />
P459<br />
P460<br />
P461<br />
P462<br />
P463<br />
P464<br />
P465<br />
P466<br />
P467<br />
P468<br />
P469<br />
P470<br />
44
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Determinants <strong>of</strong> infarct mass, assessed by cardiac magnetic resonance, in STEACS revascularized by<br />
primary-PCI: findings <strong>of</strong> the PROMISE randomized clinical trial.<br />
– I. Ferreira Gonzalez, B. Garcia-Del-Blanco, S. Moral, J. Barrabes, G. Marti, I. Otaegui, E. Domingo,<br />
J. Elizaga, H. Gutierrez, D. Garcia-Dorado (Barcelona, Madrid and Valladolid, ES)<br />
Can we improve duration <strong>of</strong> hospital stay in angioplasty treated ST-segment elevation acute myocardial<br />
infarction? The Zwolle risk score.<br />
– A. Tralhao, S. Madeira, M. Borges Santos, I. Rosario, M. Castro, A. Miguel Ferreira, J. Ferreira, M. Trabulo,<br />
M. Mendes (Carnaxide, PT)<br />
Survival rates and causes <strong>of</strong> death in contemporary primary percutaneous intervention for ST-segment<br />
elevation myocardial infarction - a mega-center experience.<br />
– S.B.E.W. Rader, F. Pedersen, K. Saunamaki, S. Helqvist, T. Engstroem, H. Kelbaek, L. Holmvang,<br />
J. Kastrup, P. Clemmensen, E. Joergensen (Copenhagen, DK)<br />
Left circumflex artery lesions in acute myocardial infarction.<br />
– H. Waziri, E.L. Fosbol, U.M. Mogensen, F. Pedersen, E. Jorgensen, H. Kelbaek, L. Kober, K. Wachtell<br />
(Copenhagen and Glostrup, DK)<br />
High cholesteryl ester transfer protein (CETP) activity in acute phase <strong>of</strong> myocardial infarction predicts<br />
short-term mortality by inducing endothelial dysfunction and reduced microvascular perfusion.<br />
– L.S.F. Carvalho, N.B. Panzoldo, S. Santos, V.V. Wilson, F. Amaral, E.C. De Faria, A.C. Sposito (Campinas<br />
and Brasilia, BR)<br />
Functional mitral regurgitation after a first non-st elevation acute coronary syndrome: very long term<br />
follow-up, prognosis, and contribution to left ventricular enlargement and atrial fibrillation.<br />
– I. Nunez-Gil, I. Estrada, G. Feltes Guzman, L. Perez De Isla, A. De Agustin, D. Vivas, A. Viana, P. Jimenez<br />
Quevedo, C. Macaya, A. Fernandez Ortiz (Madrid, ES)<br />
The relationship between preinfarction angina and serum sphingosine 1 phosphate levels.<br />
– E. Kiziltunc, A. Abaci, S. Ozkan, Y. Alsancak, S. Unlu, E.S. Simsek, S. Elbeg, M. Cemri (Ankara, TR)<br />
In-hospital mortality prediction for STEMI patients submitted to primary PCI.<br />
– M. Sladojevic, K. Pavlovic, L. Velicki, N. Cemerlic-Adjic, T. Popov, S. Tadic, S. Sladojevic, D. Culibrk (Novi<br />
Sad, RS)<br />
Epicardial adipose tissue thickness independently predicts myocardial infarction, and it is related to<br />
impaired coronary perfusion in patients with coronary artery disease.<br />
– A. Tanindi, S.A. Kocaman, A.F. Erkan, M. Ugurlu, H.F. Tore (Ankara, TR)<br />
Impact <strong>of</strong> glucose fluctuation and monocyte subsets on coronary plaque rupture.<br />
– I. Teraguchi, T. Imanishi, Y. Ozaki, T. Tanimoto, T. Yamano, Y. Ino, T. Yamagichi, K. Hirata, T. Kubo,<br />
T. Akasaka (Wakayama, JP)<br />
P471<br />
P472<br />
P473<br />
P474<br />
P475<br />
P476<br />
P477<br />
P478<br />
P479<br />
P480<br />
SATURDAY – AFTERNOON<br />
ACUTE CARDIAC CARE, OTHER<br />
Discussant(s): Acute cardiac care, other.<br />
– R.F.Storey(Sheffield,GB)<br />
Copeptin and troponin in patients with acute cardiac chief complaints in the emergency department.<br />
– A. Slagman, J. Searle, T. Lauterbach, J.O. Vollert, F. Holert, R. Muller, C. Mueller, M. Mockel (Berlin, DE;<br />
Townsville, AU)<br />
Copeptin in everyday clinical practice <strong>of</strong> an emergency department.<br />
– D. Menh<strong>of</strong>er, A. Sandh<strong>of</strong>er, A. Hammerer-Lercher, J. Mair (Innsbruck, AT)<br />
Diagnostic accuracy <strong>of</strong> highly sensitive troponin I versus highly sensitive troponin T assays for acute<br />
myocardial infarction within two hours <strong>of</strong> emergency department presentation.<br />
– L. Cullen, W. Parsonage, J. Greenslade, S. Aldous, P. George, A. Lamanna, J. Ungerer, M. Richards,<br />
C.J. Pemberton, M. Than (Brisbane, AU; Christchurch, NZ)<br />
Adherence to guidelines on management <strong>of</strong> acute coronary syndrome in Russian hospitals is better in<br />
lower risk patients and this is associated with better outcomes <strong>of</strong> hospitalization.<br />
– A. Erlikh, N.A. Gratsiansky (Moscow, RU)<br />
ARRHYTHMIAS – PACING – RESYNCHRONISATION<br />
Discussant(s): Arrhythmias – pacing – resynchronisation.<br />
– S. Ernst (London, GB), F. Arribas (Madrid, ES), A. Da Costa (Saint-Etienne, FR), G. Marinskis (Vilnius, LT)<br />
The incidence <strong>of</strong> new-onset atrial fibrillation in patients with stroke <strong>of</strong> unknown etiology is similar to the<br />
age- and gender-matched stroke-free population during 10-year follow up.<br />
– M.A. Baturova, A. Lindgren, J. Carlson, Y.V. Shubik, B. Olsson, P.G. Platonov (Lund, SE; St. Petersburg,<br />
RU)<br />
Focal impulse and rotor modulation for AF ablation: acute response in initial vs. rescue procedures.<br />
– D. Musat, S. Mittal, S. Narayan, K. Shivkumar, J.M. Miller, E. Buch, J. Gima, K. Mills, J.S. Steinberg<br />
(Ridgewood, San Diego, Los Angeles and Indianapolis, US)<br />
Left atrium regional voltage analysis in sinus rhythm in patients undergoing atrial fibrillation ablation.<br />
– I. Menduina, E. Caballero, M. Diaz-Esc<strong>of</strong>et, P. Martin, J. Novoa, A. Garcia, N. Castro, D. Valdivia, M. Leon,<br />
A. Medina (Las Palmas de Gran Canaria, ES)<br />
Significant decrease <strong>of</strong> pulmonary veins activity by stand-alone atrial-substrate ablation strategy in<br />
persistent atrial fibrillation.<br />
– J. Seitz, C. Bars, A. Maluski, G. Penaranda, J. Faure, M. Bremondy, A. Ferracci, L. Curel, A. Pisapia<br />
(Marseille and Paris, FR)<br />
P481<br />
P482<br />
P483<br />
P484<br />
P485<br />
P486<br />
P487<br />
P488<br />
P489<br />
P490<br />
45
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Comparison <strong>of</strong> lesion formation between contact force-guided and non-guided circumferential pulmonary<br />
vein isolation.<br />
– M.Kimura,S.Sasaki,D.Horiuchi,K.Sasaki,S.Owada,Y.Ishida,T.Kinjo,K.O.Okumura(Hirosaki,JP)<br />
Long-term (>10 years) clinical results and electroanatomic correlations <strong>of</strong> persistent atrial fibrillation<br />
ablation with a hybrid approach in patients with valvular heart disease.<br />
– F. Gaita, E. Ebrille, D. Caponi, L. Garberoglio, L. Vivada, A. Barbone, R. Gallotti, M. Scaglione (Turin, Asti<br />
and Rozzano, IT)<br />
Predictors <strong>of</strong> complete arrhythmia free survival in patients undergoing MAZE surgery. PRAGUE-12<br />
randomized study subanalysis.<br />
– P.Osmancik,P.Budera,Z.Straka,P.Cervinka,M.Hulman,T.Vanek,P.Widimsky(PragueandÚstínad<br />
Labem, CZ; Bratislava, SK)<br />
Ganglionated plexi ablation plus antral pulmonary vein isolation for paroximal atrial fibrillation: clinical<br />
outcome after a single procedure at one-year follow-up.<br />
– K. Yamashiro, Y. Sakamoto, K. Satoh, T. Suzuki (Toyohashi, JP)<br />
Mechanisms <strong>of</strong> pulmonary vein reconnection: insufficient catheter tissue contact and long<br />
lesion-to-lesion distance.<br />
– C.I. Park, H. Lehrmann, C. Keyl, R. Weber, J. Allgeier, J. Schiebeling, C. Herrera-Siklody, T. Arentz,<br />
A. Jadidi (Freiburg and Bad Krozingen, DE)<br />
Long-term radio frequency scar behavior after ablation <strong>of</strong> atrial fibrillation: lessons learned from LGE-MRI<br />
analysis.<br />
– K. Higuchi, M. Koopmann, A. Morris, M. Macgrath, N. Burgon, E. Kholmovski, R. Macleod, N. Marrouche<br />
(Salt Lake City, US)<br />
Is lone AF lonely yet? What about the atrial fibrosis in lone AF and implications on the cryoablation<br />
success?<br />
– U. Canpolat, A. Oto, H. Yorgun, M. Sahiner, H. Sunman, E.B. Kaya, L. Tokgozoglu, G. Kabakci, N. Ozer,<br />
K. Aytemir (Ankara, TR)<br />
New cryoballoon generation enhances procedural efficacy without compromising safety.<br />
– U. Dorwarth, M. Schmidt, F. Straube, M. Wankerl, J. Krieg, E. H<strong>of</strong>fmann (Munich, DE)<br />
Does termination predict the outcome at long term follow-up in patients with long standing persistent<br />
AF? results from a prospective randomized study.<br />
– L. Di Biase, P. Santangeli, R. Bai, P. Mohanty, G. Gallinghouse, R. Horton, J.E. Sanchez, S. Beheiry,<br />
J.D. Burkhardt, A. Natale (Austin and San Francisco, US)<br />
Initial impedance decrease as an indicator <strong>of</strong> good catheter contact: insights from radi<strong>of</strong>requency<br />
ablation with two different force sensing catheters.<br />
– T. Reichlin, S. Knecht, C. Lane, M. Kuehne, W.G. Stevenson, B. Schaer, S. Osswald, G.F. Michaud,<br />
C. Sticherling (Basel, CH; Boston, US)<br />
The COR trial: a randomized study with continuous rhythm monitoring comparing the efficacy <strong>of</strong><br />
cryoenergy and radi<strong>of</strong>requency for pulmonary vein isolation.<br />
– N. Perez Castellano, R. Fernandez, J. Moreno, A. Conde, V. Canadas, J.J. Gonzalez-Ferrer, J.M. Aguirre,<br />
R. Bover, C. Macaya, J. Villacastin (Madrid, ES)<br />
Atrial fibrillation ablation using magnetic navigation: comparison with conventional approach during long<br />
term follow up.<br />
– P. Adragao, F. Moscoso Costa, D. Cavaco, H. Dores, P. Santos, P. Carmo, K. Santos, L. Parreira,<br />
F. Morgado, M. Mendes (Lisbon, PT)<br />
Left atrial radi<strong>of</strong>requency isolation for surgical treatment <strong>of</strong> persistent AF: the value <strong>of</strong> entrance block as<br />
procedural end-point on mid-term rhythm outcome.<br />
– C. Muneretto, G. Bisleri, F. Rosati, L. Bontempi, A. Curnis (Brescia, IT)<br />
AF ablation using novel non-fluoroscopic catheter tracking - experience <strong>of</strong> the first 100 patients treated<br />
with sensor-equipped ablation catheters.<br />
– S. Rolf, S. John, S. Kircher, T. Gaspar, S. Richter, A. Arya, B. Dinov, C. Piorkowski, G. Hindricks,<br />
P. Sommer (Leipzig, DE)<br />
The effect <strong>of</strong> treating dormant pulmonary vein conduction on the outcome <strong>of</strong> cryoballoon ablation.<br />
– M.G. Compier, K. Zeppenfeld, M. De Riva Silva, K. Dyrda, M.J. Schalij, S.A. Trines (Leiden, NL)<br />
Clinical experience with a diaphragmatic electromyographic-guided approach to monitor phrenic nerve<br />
integrity during cryoballoon-based atrial fibrillation ablation.<br />
– B.Mondesert,J.G.Andrade,P.G.Guerra,L.Rivard,L.Macle,B.Thibault,M.Talajic,D.Roy,P.Khairy,<br />
M. Dubuc (Montreal, CA)<br />
Renal dysfunction and stroke risk stratification scores as predictors <strong>of</strong> thromboembolic events in<br />
patients with atrial fibrillation after catheter ablation.<br />
– J. Kornej, J. Kosiuk, A. Arya, C. Piorkowski, D. Husser, G. Hindricks, G. Lip, A. Bollmann (Leipzig and<br />
Dresden, DE; Birmingham, GB)<br />
Incidence and characteristics <strong>of</strong> phrenic nerve palsy following pulmonary vein isolation with the novel<br />
second-generation cryoballoon as compared to the first-generation balloon.<br />
– A. Fuernkranz, S. Bordignon, B. Schmidt, A. Konstantinou, V. Urban, M.C. Boehmer, B. Schulte-Hahn,<br />
B. Nowak, J.K.R. Chun (Frankfurt, DE)<br />
Changes in pulmonary arterial pressure after atrial fibrillation ablation: incidence, causes, and<br />
implications on the stiff left atrial syndrome.<br />
– C. Witt, S.S. Kushwaha, G.C. Kane, Y.M. Cha, S.J. Asirvatham, J.K. Oh, D.L. Packer, B.D. Powell<br />
(Rochester, US)<br />
Evaluation <strong>of</strong> left atrial contractile function after successful ablation <strong>of</strong> long standing persistent atrial<br />
fibrillation utilizing combined epicardial and endocardial approach.<br />
– D.E. Pajitnev, T. Neumann, S.W. Zaltsberg, H. Greiss, J. Sperzel, Z. Szalay, M. Schoenburg, T. Walther,<br />
C.W. Hamm, M. Kuniss (Bad Nauheim, DE)<br />
P491<br />
P492<br />
P493 (W)<br />
P494<br />
P495<br />
P496<br />
P497<br />
P498<br />
P499<br />
P500<br />
P501<br />
P502<br />
P503<br />
P504 (W)<br />
P505<br />
P506<br />
P507 (W)<br />
P508<br />
P509<br />
P510<br />
46
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Catheter ablation for atrial arrhythmia recurrence following surgical atrial fibrillation ablation.<br />
– R.J. Beukema, A. Adiyaman, J.J.J. Smit, P.P.H.M. Delnoy, A.R. Ramdat Misier, A. Elvan (Zwolle, NL)<br />
Does extensive defragmentation really improve the success rate <strong>of</strong> long-lasting persistent atrial<br />
fibrillation: a study from a randomized controlled study.<br />
– Y.-J. Lin, S.-L. Chang, L.-W. Lo, Y.-F. Hu, C.-H. Li, T.-F. Chao, S.-A. Chen (Taipei, TW)<br />
Association <strong>of</strong> renal dysfunction and stroke risk stratification scores with rhythm outcomes in patients<br />
after catheter ablation <strong>of</strong> atrial fibrillation.<br />
– J.Kornej,J.Kosiuk,A.Arya,P.Sommer,S.Rolf,D.Husser,C.Piorkowski,G.Hindricks,G.Lip,<br />
A. Bollmann (Leipzig and Dresden, DE; Birmingham, GB)<br />
Radi<strong>of</strong>requency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality<br />
<strong>of</strong> life and symptom burden (The MANTRA-PAF trial).<br />
Top Score Poster<br />
– H. Walfridsson, J. Cosedis Nielsen, A. Johannessen, P. Raatikainen, J. Hartikainen, U. Walfridsson,<br />
L.A. Levin, M. Janzon, M. Aronsson, P.S. Hansen (Linköping, SE; Aarhus, Hellerup and Varde, DK;<br />
Tampere and Kuopio, FI)<br />
Pulmonary vein isolation in paroxysmal atrial fibrillation: comparison <strong>of</strong> three different techniques.<br />
– R.A. Providencia, J.P. Albenque, S. Fazaa, S. Combes, N. Combes, A. Bouzeman, B. Casteigt, H. Hireche,<br />
S. Boveda (Toulouse, FR)<br />
Real time assessment <strong>of</strong> pulmonary vein isolation using the novel Achieve mapping catheter during<br />
cryoablation.<br />
– R.P. Martins, O. Cesari, N. Behar, R. Bacquelin, J. Lacaze-Gadonneix, A. Behagel, P. Mabo, D. Pavin<br />
(Rennes and Tours, FR)<br />
AF ablation: evaluation <strong>of</strong> procedural parameters and acute results comparing ablation catheters with<br />
traditional and new irrigation design.<br />
– C. Raimondo, E. Ebrille, D. Caponi, P. Di Donna, F. Di Clemente, M. Appendino, A. Giorgetti, A. Battaglia,<br />
F. Gaita, M. Scaglione (Turin and Asti, IT)<br />
Preservation <strong>of</strong> luminal coronary artery diameter after epicardial irreversible electroporation ablation.<br />
– K. Neven, V. Van Driel, H. Van Wessel, P. Doevendans, F. Wittkampf (Utrecht, NL)<br />
Real-life treatment persistence with newer oral anticoagulants and potential strokes avoided in patients<br />
with atrial fibrillation.<br />
– T. Evers, A. Diamantopoulos (Wuppertal, DE; Elstree, GB)<br />
Evaluation <strong>of</strong> edoxaban in patients with atrial fibrillation and severe renal impairment.<br />
– Y. Koretsune, T. Yamashita, M. Yasaka (Osaka, Tokyo and Fukuoka, JP)<br />
Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary<br />
artery stenting with a low-moderate CHADS2 score?<br />
– M. Mutuberria Urdaniz, A. Sambola, E. Bosch, B. Garcia Del Blanco, A. Alonso, F. Alfonso, A. Cequier,<br />
H. Bueno, J.A. Barrabes, D. Garcia-Dorado (Barcelona and Madrid, ES)<br />
Platelet reactivity monitoring in patients with atrial fibrillation treated with dabigatran.<br />
– K. Kalantzi, M. Tsoumani, K. Pappas, P. Tatsidou, J. Goudevenos, A. Tselepis (Ioannina, GR)<br />
Identification <strong>of</strong> thrombus in left atrial appendage by 320-row ADCT is superior beyond CHADS2 score for<br />
initiating anticoagulation treatment in patients with atrial fibrillation.<br />
– M. Sato, Y. Abe, O. Yamaguchi, M. Takiguchi, N. Fujii, H. Moriya, T. Ishibashi (Fukushima, JP)<br />
Safety <strong>of</strong> dabigatran etexilate in frail older old patients with non-valvular atrial fibrillation.<br />
– C. Rodriguez Pascual, E. Paredes-Galan, A. Vilches-Moraga, M.C. Basalo-Carbajales, A. Guitian (Vigo, ES)<br />
The safety and efficacy <strong>of</strong> oral anticoagulation in non-valvular atrial fibrillation patients with liver<br />
cirrhosis.<br />
– S.J. Lee, J.Y. Kim, H.N. Pak, M.H. Lee, B.Y. Joung (Seoul, KR)<br />
Gender differences in the management <strong>of</strong> antithrombotic prescriptions among patients with atrial<br />
fibrillation by general practitioners in France.<br />
– P. Sabouret, L. Depret-Bixio, F.E. Cotte, P. Marie, N. Bedira, P. Blin (Paris, Rueil-Malmaison and Bordeaux,<br />
FR)<br />
Oral anticoagulation therapy during catheter ablation for atrial fibrillation: J-CARAF registry.<br />
– Y. Murakawa, A. Nogami, M. Shoda, S. Naito, K. Kumagai, K. Inoue, Y. Miyauchi, T. Yamane, N. Morita,<br />
K. Okumura (Kawasaki, Yokohama, Tokyo, Maebashi, Fukuoka, Osaka and Hirosaki, JP)<br />
Should we recommend triple therapy in elderly patients with atrial fibrillation submitted to coronary<br />
stenting?<br />
– M. Mutuberria Urdaniz, A. Sambola, E. Bosch, B. Garcia Del Blanco, A. Alonso, J.A. Zueco, A. Cequier,<br />
H. Bueno, J.A. Barrabes, D. Garcia-Dorado (Barcelona, Santander and Madrid, ES)<br />
Substantial differences in initiation <strong>of</strong> antithrombotic treatment and clinical outcome among non-valvular<br />
atrial fibrillation patients treated in inpatient and outpatient settings: a nationwide cohort.<br />
– A.P. Mikkelsen, M.L. Hansen, J.B. Olesen, M.W. Hvidtfeldt, S. Husted, S.P. Johnsen, A. Brandes,<br />
G. Gislason, C. Torp-Pedersen, M. Lamberts (Gent<strong>of</strong>te, Herning, Aarhus, Odense and Aalborg, DK)<br />
Use <strong>of</strong> anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial<br />
fibrillation. Data from the international CLARIFY registry.<br />
– L. Fauchier, N. Greenlaw, R. Ferrari, I. Ford, K. Fox, J.C. Tardif, M. Tendera, P.G. Steg (Tours and Paris, FR;<br />
Glasgow and London, GB; Ferrara, IT; Montreal, CA; Katowice, PL)<br />
Comparative efficacy and safety <strong>of</strong> novel oral anticoagulants in patients with atrial fibrillation: a network<br />
meta-analysis with the adjustment for the possible bias from open label studies.<br />
– T. Morimoto, B. Crawford, K. Wada, S. Ueda (Nishinomiya, Tokyo and Nishihara, JP)<br />
Predictors <strong>of</strong> left atrial appendage thrombosis in patients with atrial fibrillation.<br />
– A. Rubanenko, Y. Shchukin, A. Germanov, O. Tereshina (Samara, RU)<br />
P511<br />
P512<br />
P513<br />
P514<br />
P515<br />
P516<br />
P517<br />
P518<br />
P519<br />
P520<br />
P521<br />
P522<br />
P523<br />
P524<br />
P525 (W)<br />
P526<br />
P527<br />
P528<br />
P529<br />
P530<br />
P5<strong>31</strong><br />
P532<br />
SATURDAY – AFTERNOON<br />
47
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Incidence <strong>of</strong> thromboembolic events in patients with atrial fibrillation in Japan: one-year follow-up from<br />
the Fushimi AF registry.<br />
– M. Akao, H. Ogawa, N. Masunaga, M. Ishii, M. Abe, M. Esato, Y.H. Chun, H. Tsuji, H. Wada, K. Hasegawa<br />
(Kyoto, JP)<br />
Vitamin e serum level, a new tool to stratify bleeding risk in patients receiving oral anticoagulant therapy.<br />
– D. Pastori, R. Carnevale, R. Cangemi, C. Nocella, S. Bartimoccia, T. Vicario, M. Saliola, F. Violi, P. Pignatelli<br />
(Rome, IT)<br />
Use <strong>of</strong> apixaban and warfarin in patients undergoing invasive procedures: insights from ARISTOTLE.<br />
– R.D. Lopes, D.A. Garcia, D. Wojdyla, P. Dorian, J.H. Alexander, L. Wallentin, F. Lanas, M. Hanna, C. Held,<br />
C.B. Granger (Durham, Seattle and Princeton, US; Toronto, CA; Uppsala, SE; Temuco, CL)<br />
Risk <strong>of</strong> events in the 30 days following a major bleed with Apixaban or Warfarin - experiences from the<br />
ARISTOTLE trial.<br />
– C. Held, E.B. Hylek, J.H. Alexander, M. Hanna, R.D. Lopes, D. Wojdyla, C.B. Granger, L. Wallentin<br />
(Uppsala, SE; Boston, Durham and Princeton, US)<br />
A 10-year prospective study <strong>of</strong> estimated glomerular filtration rate and outcomes with oral<br />
anticoagulation in patients with atrial fibrillation.<br />
– L. Fauchier, A. Banerjee, J.M. Halimi, S. Taillandier, D. Angoulvant, P. Vourc’h, D. Babuty, G.Y.H. Lip<br />
(Tours, FR; Birmingham, GB)<br />
Oral anticoagulant therapy management after successful atrial fibrillation ablation.<br />
– C. Gallo, A. Battaglia, D. Sardi, E. Toso, D. Castagno, M. Scaglione, F. Gaita (Turin and Asti, IT)<br />
Safety and efficacy <strong>of</strong> continuous periprocedural rivaroxaban for patients undergoing catheter ablation<br />
procedures: a retrospective registry analysis.<br />
– R. Dillier, S. Ammar, T. Reents, H. Pavaci, A. Buiatti, V. Semmler, C. Lennerz, C. Kolb, G. Hessling,<br />
I. Deisenh<strong>of</strong>er (Munich, DE)<br />
Early recurrence is a predictor <strong>of</strong> recurrence after catheter ablation in the patients with persistent atrial<br />
fibrillation.<br />
– Y. Ito, M. Igarashi, H. Yamasaki, K. Kuroki, T. Machino, N. Murakoshi, Y. Sekiguchi, K. Aonuma (Ibaraki, JP)<br />
Arrhythmia recurrence after pulmonary vein isolation for paroxysmal atrial fibrillation: there is more than<br />
the pulmonary veins.<br />
– S. Ammar, A. Buiatti, T. Reents, R. Dillier, S. Kathan, M. H<strong>of</strong>mann, V. Semmller, C. Kolb, G. Hessling,<br />
I. Deisenh<strong>of</strong>er (Munich, DE)<br />
Successful non-surgical treatment <strong>of</strong> esophagopericardial fistulas following atrial fibrillation catheter<br />
ablation - a case series.<br />
– C. Eitel, S. Rolf, M. Zachaeus, S. John, P. Sommer, A. Bollmann, C. Piorkowski, G. Hindricks, U. Halm<br />
(Leipzig, DE)<br />
Patient characteristics associated with the initiation <strong>of</strong> novel oral anticoagulants versus warfarin in<br />
patients with atrial fibrillation.<br />
– X. Pan, H. Kawabata, M. Hamilton, X. Liu (Princeton and New York, US)<br />
Use <strong>of</strong> simultaneous multielectrode single-beat electrocardiography for mapping <strong>of</strong> complex arrhythmias.<br />
– I. Suman Horduna, L. Mantziari, S. Ernst (London, GB)<br />
Diabetes as a comorbidity <strong>of</strong> atrial fibrillation in brady tachy syndrome: what impact on arrhythmia<br />
occurrence and outcome?<br />
– G. Boriani, M. Santini, L. Padeletti, A. Capucci, G.L. Botto, M. Gulizia, M. Biffi, R. Ricci, M. Vimercati,<br />
A. Grammatico (Bologna, Rome, Florence, Ancona, Como, Catania and Milan, IT)<br />
What is the optimal antithrombotic therapy <strong>of</strong> atrial fibrillation patients after coronary artery stent<br />
deployment?<br />
– H. Kawai, E. Watanabe, M. Yamamoto, T. Ichikawa, H. Harigaya, K. Okuda, Y. Sobue, S. Motoyama,<br />
M. Sarai, Y. Ozaki (Toyoake, JP)<br />
Triple therapy for all patients with atrial fibrillation undergoing coronary stenting?<br />
– M. Mutuberria Urdaniz, A. Sambola, E. Bosch, B. Garcia Del Blanco, A. Alonso, A. Cequier, H. Bueno,<br />
O. Rodriguez, J.A. Barrabes, D. Garcia-Dorado (Barcelona and Madrid, ES)<br />
Catheter ablation <strong>of</strong> atrial fibrillation in patients with hypertrophic cardiomyopathy.<br />
– Q. Yan, J.Z. Dong, D.Y. Long, R.H. Yu, R.B. Tang, X. Du, R. Bai, C.S. Ma (Beijing, CN)<br />
Management <strong>of</strong> dyspepsia symptoms on dabigatran during RELY-ABLE: long-term follow up study after<br />
RE-LY.<br />
– R. Nieuwlaat, J.S. Healey, M. Ezekowitz, P. Reilly, S. Formella, L. Wallentin, S. Yusuf, S. Connolly (Hamilton,<br />
CA; New York and Ridgefield, US; Ingelheim am Rhein, DE; Uppsala, SE)<br />
A novel morphology based algorithm for prediction <strong>of</strong> antitachycardia pacing success.<br />
– R. Matia Frances, A. Hernandez-Madrid, G. Sanchez-Huete, L. Carrizo, C. Pindado, S. Fernandez-Santos,<br />
C. Lazaro, L. Moran, C. Moro, J. Zamorano (Madrid, ES)<br />
Outcomes after rhythm versus rate control in patients with atrial fibrillation: the international prospective<br />
GARFIELD registry.<br />
– E. Berge, D. Atar, J.-Y. Le Heuzey, S. Connolly, D.A. Fitzmaurice, A.J. Camm, P. Jansky,<br />
S.K. Rushton-Smith, G. Kayani, A.K. Kakkar (Oslo, NO; Paris, FR; Hamilton, CA; Birmingham, London and<br />
St.Albans,GB;Prague,CZ)<br />
Hybrid ablation <strong>of</strong> long standing persistent atrial fibrillation utilizing minimally invasive surgical and<br />
endocardial catheter approach: one year results.<br />
– D.E. Pajitnev, M. Kuniss, M. Schoenburg, Z. Szalay, S.W. Zaltsberg, H. Greiss, J. Sperzel, T. Walther,<br />
C.W. Hamm, T. Neumann (Bad Nauheim, DE)<br />
Primary prevention <strong>of</strong> ischemic stroke: implication <strong>of</strong> multiple risk factors in patients with and without<br />
atrial fibrillation.<br />
Top Score Poster<br />
– C. Benn Christiansen, G. Gislason, C. Torp-Pedersen, M. Lamberts, S.L. Kristensen, J.B. Olesen<br />
(Copenhagen and Aalborg, DK)<br />
P533<br />
P534<br />
P535<br />
P536<br />
P537<br />
P538<br />
P539<br />
P540<br />
P541<br />
P542<br />
P543<br />
P544<br />
P545<br />
P546<br />
P547<br />
P548<br />
P549<br />
P550<br />
P551<br />
P552<br />
P553<br />
48
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Role <strong>of</strong> delayed enhancement MRI and detection <strong>of</strong> esophageal complication.<br />
– L. Navaravong, N.W. Akoum, N. Burgeon, N.F. Marrouche (Salt Lake City, US)<br />
Combined interventional cardiac procedures in pediatric patients with congenital heart abnormalities and<br />
cardiac arrhythmias.<br />
– I. Khamnagadaev, L. Kokov, S. Termosesov, I. Il‘Ich, I. Miklashevich, M. Shkolnikova (Moscow, RU)<br />
Adenosine-sensitive reentrant atrial tachycardia arising from atrioventricular annulus and atrial septum.<br />
– H. Miyazaki, M. Nakajima, K. Ashikaga, E. Nakano, T. Sasaki, K. Mizuno, T. Harada, F. Miyake (Kawasaki,<br />
JP)<br />
P554<br />
P555<br />
P556<br />
DRUGS AND DEVICES<br />
Discussant(s): Drugs and devices.<br />
– M.J. Schalij (Voorschoten, NL), S. Rahimtoola (Los Angeles, US)<br />
Anti-hypertensive effect <strong>of</strong> statins among NAFLD patients.<br />
– A. Laurinavicius, F.C. Nary, R.D.O. Conceicao, J.A.M. Carvalho, R.D. Santos (São Paulo, BR)<br />
Renal artery denervation affects the circulating microRNA pr<strong>of</strong>ile in patients with resistant arterial<br />
hypertension.<br />
– S.H.Schirmer,T.C.T.VanDerPouw-Kraan,S.I.Bettink,F.Mahfoud,U.Laufs,A.J.G.Horrevoets,M.Böhm<br />
(Homburg, DE; Amsterdam, NL)<br />
Beta-Blockade does not exert heart rate-independent effects on pulse wave reflection in men with high<br />
cardiovascular risk.<br />
– U. Fischer-Rasokat, J. Honold, D. Lochmann, C. Liebetrau, J. Leick, C.W. Hamm, S. Fichtlscherer,<br />
H. Moellmann, I. Spyridopoulos (Bad Nauheim and Frankfurt, DE)<br />
Renal denervation improves left ventricular efficiency by reducing afterload and contractility while<br />
increasing diastolic capacity - results <strong>of</strong> single beat pressure volume analysis.<br />
– J.-C. Reil, D. Lavall, T. Donate, G.-H. Reil, M. Hohl, S.H. Schirmer, F. Mahfoud, M. Böhm (Homburg/Saar<br />
and Oldenburg, DE)<br />
Acute endovascular stimulation <strong>of</strong> the carotid baroreceptors.<br />
– K. Fan, H.F. Tse, V. Splett, M. Wong, R.L. Lieberman (Hong Kong, HK; Minneapolis and Detroit, US)<br />
Renal sympathetic denervation inhibits postapneic blood pressure rises and renal hypoperfusion in a pig<br />
model for obstructive sleep apnea.<br />
– D. Linz, F. Mahfoud, M. Loehn, W. Linz, K. Wirth, M. Böhm (Homburg and Frankfurt, DE)<br />
Percutaneous renal denervation (RDN) improves central hemodynamics and arterial stiffness - results <strong>of</strong><br />
24h ambulatory measurements.<br />
– K.F. Franzen, K. Mortensen, T. Graf, J. Koester, J. Weil, M. Reppel (Lübeck, DE)<br />
Decrease <strong>of</strong> the norepinephrine release due to disconnection <strong>of</strong> sympathetic nerves during renal<br />
denervation.<br />
– K. Tiroch, J. Szymanski, A. Sause, M. Seyfarth (Wuppertal, DE)<br />
The effect <strong>of</strong> catheter based renal denervation on nocturnal blood pressure and nocturnal pulse pressure<br />
in patients with true resistant hypertension: National heart institute Malaysia experience.<br />
– A. Arshad, G.C. Lau, S.Z. Idris, A. Husin, A. Rahman, R. Zambahari (Kuala Lumpur, MY)<br />
Renal sympathetic denervation significantly reduces blood pressure but not cause orthostatic<br />
dysregulation in patients with resistant hypertension.<br />
– C. Gisbertz, C. Fatum, T. Graf, F. Bode, M. Reppel, K. Mortensen, J. Weil (Lübeck, DE)<br />
Persistent resistant hypertension during long term follow-up is related with lack <strong>of</strong> regression <strong>of</strong> left<br />
ventricular hypertrophy in essential hypertensives.<br />
– D. Tsiachris, C. Tsioufis, A. Kasiakogias, K. Dimitriadis, I. Andrikou, A. Kordalis, I. Bafakis, K. Kintis,<br />
D. Tousoulis, C. Stefanadis (Athens, GR)<br />
Prognostic values <strong>of</strong> different patterns <strong>of</strong> resistant hypertension for the incidence <strong>of</strong> new-onset atrial<br />
fibrillation.<br />
– K. Kintis, C. Tsioufis, D. Tsiachris, A. Kasiakogias, C. Thomopoulos, D. Flessas, I. Andrikou, I. Bafakis,<br />
D. Tousoulis, C. Stefanadis (Athens, GR)<br />
Usefulness <strong>of</strong> plasma renin activity value for therapeutic decisions among hypertensive subjects; is<br />
Laragh and Alderman idea helpful?<br />
– M. Rajzer, T. Pizon, D. Czarnecka (Krakow, PL)<br />
More drugs and better blood pressure control lead to improved cardiovascular outcomes: evidence from<br />
the "ACTION" database.<br />
– P. Meredith, S. Lloyd, I. Ford, H.L. Elliott (Glasgow, GB)<br />
Addition <strong>of</strong> spironolactone in patients with resistant arterial hypertension (ASPIRANT-EXT): a randomized,<br />
double-blind, placebo-controlled trial.<br />
– J. Vaclavik, R. Sedlak, J. Jarkovsky, E. Kocianova, M. Taborsky (Olomouc, Prostejov and Brno, CZ)<br />
Pharmacological inhibition <strong>of</strong> NHE3-mediated sodium absorption in the gut reduces blood pressure and<br />
attenuates impairment <strong>of</strong> left ventricular compliance.<br />
– D. Linz, H. Heuer, W. Frick, A. H<strong>of</strong>meister, U. Heinelt, P. Arndt, U. Schwahn, W. Linz, M. Böhm, H. Ruetten<br />
(Homburg and Frankfurt, DE)<br />
Renal denervation reduces blood pressure and attenuates impairment <strong>of</strong> left ventricular compliance in<br />
obese spontaneously hypertensive rats.<br />
– D. Linz, M. Hohl, F. Mahfoud, J. Schuetze, S. Ewen, D. Urban, H.P. Juretschke, C. Neumann-Haeflin,<br />
W. Linz, M. Böhm (Homburg and Frankfurt, DE)<br />
Medetomidine can selectively activate cardiac vagal nerve without vagal activation in gastrointestinal<br />
tract.<br />
– S. Shimizu, T. Akiyama, T. Kawada, Y. Sata, T. Shishido, A. Kamiya, M. Sugimachi (Osaka, JP)<br />
Dopamine withdrawal causes chemoreflex-related increase in minute ventilation.<br />
– S. Tubek, P. Niewinski, W. Banasiak, P. Ponikowski (Wroclaw, PL)<br />
P557<br />
P558<br />
P559<br />
P560<br />
P561<br />
P562(W)<br />
P563<br />
P564<br />
P565<br />
P566<br />
P567<br />
P568<br />
P569<br />
P570<br />
P571<br />
P572<br />
P573<br />
P574<br />
P575<br />
P576<br />
49<br />
SATURDAY – AFTERNOON
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
ENDOTHELIAL FUNCTION AND VASCULAR REMODELING<br />
Discussant(s): Endothelial function and vascular remodeling.<br />
– M. Volpe (Rome, IT), A. Pathak (Toulouse, FR), A.M. Heagerty (Manchester, GB)<br />
The EPA:DHA 6:1-evoked endothelium-dependent NO-mediated relaxation in the coronary artery involves<br />
a copper-dependent pro-oxidant response triggering the PI3-kinase/Akt-mediated activation <strong>of</strong> eNOS.<br />
– F.Zgheel,M.Alhosin,S.Rashid,C.Auger,V.B.Schini-Kerth(Illkirch,FR)<br />
A role <strong>of</strong> eNOS dimer stability in essential hypertension?<br />
– S. Pick, T. Suvorava, M. Oppermann, M. Weber, G. Kojda (Düsseldorf, DE; Atlanta, US)<br />
Contribution <strong>of</strong> extra-endothelial eNOS in regulation <strong>of</strong> blood pressure.<br />
Top Score Poster<br />
– T. Suvorava, J. Stegbauer, S. Friedrich, C. Rump, T. Hohlfeld, G. Kojda (Düsseldorf, DE)<br />
Erythropoiesis-stimulating agent improves flow-mediated dilation via reduction <strong>of</strong> oxidative stress in<br />
chronic kidney disease rats.<br />
– K. Serizawa, K. Yogo, Y. Tashiro, M. Hirata, K. Endo (Gotemba Shizuoka, JP)<br />
Shear stress and nitric oxide transport affect NFkB dynamics in endothelial cells.<br />
– S.M. Bovens, N. Foin, N. O’Clery, K. Van Der Heiden, S. Cuhlmann, H. Carlsen, M. Barahona, P.C. Evans,<br />
R. Krams (London and Sheffield, GB; Rotterdam, NL; Oslo, NO)<br />
Hydroxyamine chloridrate reduces oxidative-stress damage subsequent to balloon-injury rat model.<br />
– S. Muscoli, M. Macrini, D. Della Rocca, V. Cammalleri, C. Muscoli, V. Mollace, F. Romeo (Rome and<br />
Catanzaro, IT)<br />
Perfusion and microvascular adaptation in a rabbit model <strong>of</strong> developing heart failure assessed with a 3D<br />
imaging cryomicrotome.<br />
– M.G.J.T.B. Van Lier, N. Hakimzadeh, R. Coronel, J.A.E. Spaan, M. Siebes, J.P.H.M. Van Den Wijngaard<br />
(Amsterdam, NL)<br />
Effects <strong>of</strong> heart rate and selective heart rate reduction on vascular wall morphology and elastic<br />
properties in dyslipidemic mice.<br />
– F. Custodis, P. Fries, A. Mueller, C. Stamm, A. Sander, A. Ott, S.H. Schirmer, M. Böhm, U. Laufs<br />
(Homburg/Saar and Saarbrücken, DE)<br />
Hemodynamic shear stress regulates the apelin/APJ system in human endothelial cells.<br />
– A. Strohbach, S. Lang, S.B. Felix, R. Busch (Greifswald, DE)<br />
Acetyltransferase gene non-derepressible 5 mediates hyperglycemia-induced endothelial oxidative<br />
stressin patients with type 2 diabetes.<br />
– S. Costantino, F. Paneni, R. Battista, L. Castello, G. Capretti, S. Chiandotto, M. Volpe, T.F. Luscher,<br />
F. Cosentino (Zurich, CH; Sora and Rome, IT)<br />
Gene deletion <strong>of</strong> protein tyrosine phosphatase 1B limits cardiovascular dysfunction and mortality during<br />
endotoxinic shock.<br />
– D. Coquerel, E. Gomez, X. Marechal, D. Montaigne, I. Remi-Jouet, S. Renet, P. Mulder, R. Neviere,<br />
V. Richard, F. Tamion (Rouen and Lille, FR)<br />
High glucose-induced increased expression <strong>of</strong> endothelin-1 in human endothelial cells is mediated by<br />
activated CCAAT/enhancer-binding proteins.<br />
– S.-A. Manea, A. Todirita, C. Heltianu, A. Manea (Bucharest, RO)<br />
Pioglitazone prevents endothelial dysfunction induced by ischemia and reperfusion via up-regulating<br />
anti-oxidative effects: a human study.<br />
– Y. Sakatani, T. Miyoshi, H. Oe, K. Nakamura, Y. Saito, H. Morita, K. Kohno, S. Nagase, K. Kusano, H. Ito<br />
(Okayama, JP)<br />
Active vitamin D3 analog, eldecalcitol, improves flow-mediated dilation via PPAR gamma/NF-kappaB<br />
signaling pathway in ovariectomized rats.<br />
– K. Serizawa, K. Yogo, Y. Tashiro, S. Takeda, K. Endo (Gotemba, Shizuoka, Japan, JP)<br />
Isolation and characterisation <strong>of</strong> endothelial outgrowth from coronary arteries in patients with acute<br />
myocardial infarction.<br />
– M. Brittan, S. Gallogly, N.L. Mills (Edinburgh, GB)<br />
RNA-binding motif protein 38 inhibits re-endothelialization following vascular injury.<br />
– K. Sonnenschein, J. Fiedler, A. Just, J. Bauersachs, T. Thum (Hannover, DE)<br />
Deletion <strong>of</strong> peroxisome proliferator coactivator-1alpha accelerates angiotensin II induced endothelial<br />
dyfunction by increasing mitochondrial oxidative stress.<br />
– S. Kroeller-Schoen, T. Jansen, M. Hausding, M. Oelze, A. Daiber, T. Muenzel, E. Schulz (Mainz, DE)<br />
Genetic ablation <strong>of</strong> Platelet-Derived Growth Factor (PDGF) signaling protects from hypoxia-induced<br />
vascular remodeling and pulmonary hypertension.<br />
– H. Ten Freyhaus, E.M. Berghausen, W. Janssen, M. Leuchs, M. Zierden, A. Klinike, M. Vantler,<br />
R.T. Schermuly, M.D. Tallquist, S. Rosenkranz (Cologne and Giessen, DE; Dallas, US)<br />
Involvement <strong>of</strong> ephrinA1 in TNF-alpha-mediated monocyte adhesion.<br />
– G. Ende, D.M. Poitz, A. Augstein, E. Wiedemann, J. Friedrichs, C. Werner, R.H. Strasser, S. Jellinghaus<br />
(Dresden, DE)<br />
An adipokine omentin prevents pathological vascular remodeling.<br />
– Y. Uemura, R. Shibata, K. Ohashi, T. Enomoto, Y. Kataoka, M. Miyabe, D. Yuasa, K. Matsuo, N. Ouchi,<br />
T. Murohara (Nagoya, JP)<br />
AMPK preserves endothelial tight junctions in the coronary microcirculation during sepsis.<br />
– D. Castanares-Zapatero, C. Bouleti, T. Mathivet, L. Bertrand, J.-L. Vanoverschelde, P.F. Laterre,<br />
S.Horman,C.H.Beauloye(Brussels,BE;Paris,FR)<br />
P577<br />
P578<br />
P579<br />
P580<br />
P581<br />
P582<br />
P583<br />
P584<br />
P585<br />
P586<br />
P587<br />
P588<br />
P589<br />
P590<br />
P591<br />
P592<br />
P593<br />
P594<br />
P595<br />
P596<br />
P597<br />
P598<br />
50
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Role <strong>of</strong> class IA PI 3-kinase is<strong>of</strong>orms in neointima formation following balloon angioplasty: only<br />
p110alpha is important.<br />
– M. Vantler, J. Jesus, O. Leppaenen, X. Chen, M. Vantler, H. Ten Freyhaus, E. Caglayan, F. Blaschke,<br />
J.J. Zhao, S. Rosenkranz (Cologne and Berlin, DE; Uppsala, SE; Boston, US)<br />
Connection between myocardial oedema, inflammation and function during sepsis: role <strong>of</strong> alpha1<br />
AMP-activated protein kinase.<br />
– D. Castanares-Zapatero, B. Gerber, D. Communi, C. Oury, C. Lecut, J.-L. Vanoverschelde, L. Bertrand,<br />
P.F. Laterre, S. Horman, C.H. Beauloye (Brussels and Liège, BE)<br />
Hyperuricemia induces endothelial dysfunction by increasing reactive oxygen species.<br />
– A.H.P. Linke, A. Oberbach, N. Jehmlich, N. Schlichting, G. Schuler, V. Adams (Leipzig and Greifswald, DE)<br />
Inhibition <strong>of</strong> Sonic hedgehog signaling impedes perivascular stem cell signaling and prevents neointimal<br />
lesion formation.<br />
– J.-M. Daniel, J. Dutzmann, A. Koch, J. Bauersachs, D. Sedding (Hannover, DE)<br />
Vildagliptin, a dipeptidyl peptidase-4 inhibitor, ameliorates the development <strong>of</strong> CaCl2-induced abdominal<br />
aortic aneurysm in mice via anti-inflammatory effects.<br />
– Y. Noda, T. Miyoshi, T. Yonezawa, H. Oe, N. Toh, Y. Oono, K. Nakamura, H. Morita, K. Kusano, H. Ito<br />
(Okayama, JP)<br />
Macrohage depletion using clodronate liposomes delays exercise-induced collateral artery growth.3.<br />
– D.N. Millenaar, A. Degen, M. Böhm, U. Laufs, S.H. Schirmer (Homburg/Saar, DE)<br />
The protective effects <strong>of</strong> regulatory T cells in cardiac and skeletal muscles ischemia: reduce infarct size,<br />
improve LV remodeling and function and improve flow recovery.<br />
– R. Sharir, Y. Semo, S. Maysel-Auslender, N. Landa-Rouben, A. Shaish, R. Holbova, D. Kain, M. Entin-Meer,<br />
G. Keren, J. George (Tel Aviv, Ramat Gan and Rehovot, IL)<br />
Osteoprotegerin and osteopontin serum levels are associated with vascular function and inflammatory<br />
process in coronary artery disease.<br />
– K. Maniatis, G. Siasos, D. Tousoulis, E. Oikonomou, M. Zaromitidou, S. Kioufis, E. Kokkou,<br />
N. Gouliopoulos, S. Mazaris, C. Stefanadis (Athens, GR)<br />
Effects <strong>of</strong> the DPP-4 inhibitor saxagliptin on early vascular changes in the retinal and systemic circulation.<br />
– R. Schmieder, U. Raff, S. Schmidt, I. Kistner, S. Friedrich, P. Bramlage, C. Ott (Erlangen and Mahlow, DE)<br />
Bone marrow derived cells with defective c-Myb activity protect against neointimal remodeling following<br />
injury.<br />
– E. Shikatani, A. Momen, M. Husain (Toronto, CA)<br />
Reversal <strong>of</strong> age-related vascular dysfunction through dietary nitrate supplementation.<br />
– C.Rammos,U.B.Hendgen-Cotta,M.Totzeck,A.Bernard,J.Sobierajski,P.Stock,A.Goedecke,M.Kelm,<br />
T. Rassaf (Düsseldorf, DE)<br />
Circulating microRNAs in patients with myocardial bridging.<br />
– J. Wang, J.W. Wang, Y.Z. Zhong, Y.H.P. Pei, S.S.J. Jiang, J.B.G. Gong (Nanjing, CN)<br />
Effects <strong>of</strong> CYP2C19 genotype on vascular function in patients with coronary artery disease receiving<br />
clopidogrel.<br />
– M. Zaromitidou, D. Tousoulis, G. Siasos, S. Kioufis, E. Oikonomou, K. Maniatis, E. Kokkou, S. Mazaris,<br />
P. Tourikis, C. Stefanadis (Athens, GR)<br />
Current smoking aggravates intimal hyperplasia after arterial injury following transradial catheterization.<br />
– R. Sansone, E. Stegemann, D. Schuler, G. Oezaslan, M. Kelm, R. Westenfeld, T. Lauer, C. Heiss<br />
(Düsseldorf, DE)<br />
Elevated parathyroid hormone predicts high asymmetric dimethylarginine (ADMA) concentrations;<br />
independent <strong>of</strong> vitamin D status.<br />
– A.T. Amarasekera, A.L. Sverdlov, M.S. Roberts, J.D. Horowitz, D.T. Ngo (Adelaide, AU)<br />
Association <strong>of</strong> LpPLA2 activity with coronary and LV function in patients with coronary artery disease and<br />
coexistent rheumatoid arthritis: effects <strong>of</strong> Interleukin-1 inhibition.<br />
– I. Ikonomidis, S. Tzortzis, C. Tellis, I. Andreadou, P. Katsimbri, I. Paraskevaidis, J. Parissis,<br />
M. Anastasiou-Nana, A. Tselepis, J. Lekakis (Athens and Ioannina, GR)<br />
The interaction between circadian rhythms <strong>of</strong> endothelial function: resting versus recruitable endothelial<br />
function.<br />
– T. Gori, M. Vosseler, A. Al-Shazly, T. Munzel (Mainz, DE)<br />
Bone morphogenetic protein receptor activation plays a crucial role in endothelial dysfunction and<br />
osteogenic differentiation in mice with chronic kidney disease.<br />
– H. Kajimoto, H. Kai, H. Aoki, H. Uchiwa, Y. Aoki, Y. Iwamoto, T. Imaizumi (Kurume, JP)<br />
Increased plasma Glucagon Like Peptide-1 improves endothelial dysfunction immediately after Roux-en-Y<br />
gastric bypass prior to body weight loss inhibiting the c-Jun N-terminal Protein Kinase Signaling.<br />
– E. Osto, P. Doytcheva, C. Corteville, K. Splieth<strong>of</strong>f, M. Bueter, L. Rohrer, U. Landmesser, C. Matter, T. Lutz,<br />
T. Luscher (Zurich, CH)<br />
Does cellular sex matter? Dimorphic transcriptional differences between female and male endothelial<br />
cells.<br />
– M. Lorenz, J. Koschate, K. Kaufmann, C. Kreye, M. Mertens, W.M. Kuebler, G. Baumann, G. Gossing,<br />
K. Stangl, V. Stangl (Berlin and Bergisch Gladbach, DE)<br />
P599<br />
P600<br />
P601<br />
P602<br />
P603<br />
P604<br />
P605<br />
P606<br />
P607<br />
P608<br />
P609<br />
P610<br />
P611<br />
P612<br />
P613<br />
P614<br />
P615<br />
P616<br />
P617<br />
P618<br />
SATURDAY – AFTERNOON<br />
51
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
MECHANISMS OF HEART FAILURE DETERIORATION<br />
Discussant(s): Mecanisms <strong>of</strong> heart failure deterioration.<br />
– E. Roig (Barcelona, ES), J. Nanas (Athens, GR)<br />
Natriuretic peptide/cyclic guanosine monophosphate pathway exerts compensatory roles against<br />
endothelin system in the pulmonary circulation <strong>of</strong> left heart disease.<br />
– Y. Ohashi, J. Ejiri, S. Hirayama, H. Kato, K. Yamawaki, K. Hyogo, D. Kashiwagi, K. Nakayama, N. Emoto,<br />
K. Awano (Miki City and Kobe, JP)<br />
Left ventricular contraction pattern in asymptomatic patients with moderate to severe aortic<br />
regurgitation.<br />
– S. Urheim, K. Broch, R. Massey, S. De Marchi, S. Aakhus, L. Gullestad (Oslo, NO; Berne, CH)<br />
Radial function correlates with heart failure symptoms in hypertrophic cardiomyopathy with normal<br />
ejection fraction.<br />
– D. Muraru, C. Calore, L.P. Badano, P. Melacini, S. Mihaila, S. Casablanca, U. Cucchini,<br />
M. Haertel-Miglioranza, A. Polo, S. Iliceto (Padua, IT; Bucharest, RO; Porto Alegre, BR)<br />
Noninvasive and mainstream end-tidal carbon dioxide monitoring via nasal cannula is a unique and useful<br />
technique for diagnosing pulmonary hypertension in patients with heart failure.<br />
– O. Seguchi, A. Nakano, M. Hieda, T. Watanabe, T. Sato, H. Sunami, Y. Murata, M. Yanase, M. Kitakaze,<br />
T. Nakatani (Osaka, JP)<br />
VO2max/kg in heart failure patients is an unreliable indicator <strong>of</strong> the severity <strong>of</strong> cardiac dysfunction.<br />
– S. Hothi, D.K. Tan, S. Chinnappa, N. Lewis, L.-B. Tan (Cambridge, Newcastle and Leeds, GB)<br />
Copper serum levels in patients with heart failure correlate with parameters <strong>of</strong> left ventricular systolic<br />
and diastolic dysfunction.<br />
– I. Alexanian, J. Parissis, S. Athanaselis, L. Pappas, G. Gavrielatos, C. Michas, A. Sideris, D. Kremastinos,<br />
M. Anastasiou-Nana, G. Filippatos (Athens, GR)<br />
The effects <strong>of</strong> blood components modulation on load-dependent cardiac function during an acute<br />
hemodilution.<br />
– S. Chatpun, P. Cabrales (Hatyai, TH; La Jolla, US)<br />
Changes <strong>of</strong> portal vein flow in heart failure patients with liver congestion.<br />
– E. Goncalvesova, I. Varga, M. Tavacova, P. Lesny (Bratislava, SK)<br />
Impact <strong>of</strong> stress on myocardial function in postmenopausal women and its relationship with endothelial<br />
dysfunction.<br />
– K.I. Cho, I.K. Shim, J.H. Heo, H.S. Kim, T.J. Cha, J.W. Lee (Busan, KR)<br />
Pulmonary hypertension in patients with left heart disease: the relationship with left ventricular systolic<br />
function.<br />
– T. Ibe, H. Wada, K. Sakakura, N. Ikeda, Y. Sugawara, J. Ako, S. Momomura (Saitama, JP)<br />
Acute effects <strong>of</strong> adaptive servo-ventilation on hemodynamics in advanced chronic heart failure patients.<br />
– M. Hieda, Y. Murata, M. Yanase, O. Seguchi, T. Sato, H. Sunami, T. Watanabe, T. Shishido, T. Nakatani<br />
(Suita, JP)<br />
Adults with growth hormone deficiency have subclinical left ventricular dysfunction without vascular<br />
dysfunction, suggesting intrinsic myocardial disease.<br />
– S. Mihaila, R. Mincu, R.C. Rimbas, N. Patrascu, M. Cinteza, C. Badiu, D. Vinereanu (Bucharest, RO)<br />
Hypoperfused interventricular septum in left bundle branch block is due to reduced septal work.<br />
– K. Russell, M. Eriksen, J.G. Fjeld, S.I. Sarvari, T. Edvardsen, O.A. Smiseth (Oslo, NO)<br />
Cardiac functional consequences <strong>of</strong> chronic kidney disease: direct evidence <strong>of</strong> uraemic cardiomyopathy.<br />
– S. Chinnappa, S.S. Hothi, A. Mooney, M. El Nahas, L.-B. Tan (Leeds, Cambridge and Sheffield, GB)<br />
The fibroblast growth factor-23/vitamin D axis, left ventricular mass and mortality in elderly people.<br />
– S. Masson, R. Latini, G.F. Mureddu, N. Agabiti, M. Miceli, F. Forastiere, G. Cesaroni,<br />
U.H. Wienhues-Thelen, T. Vago, A. Boccanelli (Milan and Rome, IT; Penzberg, DE)<br />
Prognostic value <strong>of</strong> pulmonary hypertension in ambulatory patients with non-ischemic left ventricular<br />
systolic dysfunction.<br />
– A.Hirashiki,T.Kondo,T.Okumura,S.Adachi,R.Morimoto,S.Shimazu,S.Shimizu,T.Murohara(Nagoya,<br />
JP)<br />
Renal arterial resistance index is independently associate to high diuretic dose in chronic heart failure<br />
outpatients.<br />
– A. Doronzo, M.M. Ciccone, M. Iacoviello, A. Puzzovivo, F. Monitillo, V. Antoncecchi, G. Citarelli, V. Paradies,<br />
N. Corrieri, S. Favale (Bari, IT)<br />
Renal resistance index: a new marker reflecting cardiorenal syndrome independently associated with<br />
heart failure progression.<br />
– A. Puzzovivo, M.M. Ciccone, M. Iacoviello, A. Doronzo, V. Antoncecchi, F. Monitillo, G. Citarelli, V. Paradies,<br />
N. Corrieri, S. Favale (Bari, IT)<br />
Structural abnormality <strong>of</strong> the hippocampus and depressive symptoms in a rat model <strong>of</strong> heart failure.<br />
– H. Suzuki, A. Sumiyoshi, Y. Matsumoto, T. Yoshikawa, Y. Fukumoto, K. Yanai, Y. Taki, R. Kawashima,<br />
H. Shimokawa (Sendai, JP)<br />
Longitudinal strain in Friedreich Ataxia: a potential marker for early left ventricular dysfunction.<br />
– M. St John Sutton, B.K. Ky, S.R. Regner, K.S. Schadt, T.P. Plappert, B.D. D’Souza, D.R.L. Lynch<br />
(Philadelphia, US)<br />
Long-term therapy with Bendavia (MTP-1<strong>31</strong>), a novel mitochondria-targeting peptide, reverses<br />
mitochondrial abnormalities in left ventricular myocardium <strong>of</strong> dogs with advanced heart failure.<br />
– H.N. Sabbah, R.C. Gupta, S. Rastogi, M. Wang, K. Zhang (Detroit, US)<br />
P619<br />
P620<br />
P621<br />
P622<br />
P623<br />
P624<br />
P625<br />
P626 (W)<br />
P627<br />
P628<br />
P629<br />
P630<br />
P6<strong>31</strong><br />
P632<br />
P633<br />
P634<br />
P635<br />
P636<br />
P637<br />
P638<br />
P639<br />
P640<br />
52
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
HEART FAILURE CARE AND QUALITY OF LIFE<br />
Discussant(s): Heart failure care and quality <strong>of</strong> life.<br />
–A.N.Neskovic(Belgrade,RS)<br />
P641<br />
Quality <strong>of</strong> life and heart rate according to the presence <strong>of</strong> sinus rhythm or atrial fibrillation in heart failure<br />
patients.<br />
– M. De Antonio, J. Lupon, M. Domingo, R. Cabanes, B. Gonzalez, L. Cano, A. Urrutia, E. Zamora, R. Coll,<br />
A. Bayes-Genis (Badalona, ES)<br />
Nurse-based educational intervention in a heart failure unit improves outcomes in self-care, quality <strong>of</strong> life<br />
and depression <strong>of</strong> high-risk patients with chronic heart failure.<br />
– S. Lopez-Fernandez, M. Puga-Martinez, M. Jimenez-Fernandez, M.J. Molina-Lerma, V. Alcalde-Martinez,<br />
E. Lopez-Moreno, R. Melgares-Moreno (Granada, ES)<br />
Disease management program in implementing the guidelines <strong>of</strong> heart failure.<br />
– C.P.Amorim,R.Bosquetti,E.P.V.Felix,F.Dalpicolo,R.B.Madeo,J.Dinkhuysen,V.S.Issa,F.Ramires<br />
(São Paulo, BR)<br />
Renal failure in patients with heart failure - analysis based on ESC-HF Pilot survey.<br />
– M.M.Stasiak,P.Rozentryt,E.Jankowska,A.Retwinski, E. Straburzynska-Migaj, E. Nowalany-Kozielska,<br />
P. Ponikowski, E. Mirek-Bryniarska, L. Polonski, J. Drozdz (Lodz, Zabrze, Wroclaw, Poznan and Krakow,<br />
PL)<br />
Heart rate control in chronic systolic heart failure patients in Germany: results <strong>of</strong> a nationwide survey.<br />
– C. Zugck, P. Martinka, G. Stoeckl, C. Tschoepe, S. Stoerk (Straubing, Munich, Berlin and Würzburg, DE)<br />
Guiding decongestion treatment in chronic heart failure patients. Clinical assessment or serial laboratory<br />
evaluation?<br />
– A. Karavidas, K. Konstantinou, M. Nikolaou, V. Matzaraki,N.Papoutsidakis,V.Pyrgakis,J.Parissis(Athens,<br />
GR)<br />
Self-care and renal dysfunction in patients with chronic heart failure.<br />
– D.E.F. Kessing, J. Denollet, J. Widdershoven, N. Kupper (Tilburg, NL)<br />
Comparison <strong>of</strong> in-hospital course and long-term follow-up in apical and mid-ventricular takotsubo<br />
patients.<br />
– M. Pawlak, M. Roik, Z. Huczek, J. Kochanowski, R. Piatkowski, P. Scislo, R. Kowalik, M. Krakowian,<br />
G. Opolski (Warsaw, PL)<br />
Impaired LV systolic function in lymphoma survivors after mediastinal radiotherapy.<br />
– K. Murbraech, K.H. Smeland, J.H. Loge, H. Holte, C.E. Kiserud, S. Aakhus (Oslo, NO)<br />
The effect <strong>of</strong> heavy meal on left ventricular function during exercise in patients with stable coronary<br />
artery disease.<br />
– J. Patel, S.A. Wayangankar, P. Lozano, J. Stoner, H.D. Dao, U. Thadani (Oklahoma City, US)<br />
Quality <strong>of</strong> life and frailty in an outpatient population with heart failure.<br />
– P. Gastelurrutia, J. Lupon, M. De Antonio, B. Gonzalez, R. Cabanes, L. Cano, A. Urrutia, M. Domingo,<br />
S. Altimir, A. Bayes-Genis (Badalona, ES)<br />
Clinical features <strong>of</strong> patients with decompensated heart failure after the Great East Japan Earthquake.<br />
– Y. Hiroyuki, A. Yoshihisa, T. Owada, T. Yamaki, K. Sugimoto, H. Kunii, K. Nakazato, H. Suzuki, S. Saitoh,<br />
Y. Takeishi (Fukushima City, JP)<br />
The state <strong>of</strong> reduced glutathione in patients with impaired glycemic states and coronary heart disease.<br />
– O. Shyshko, T. Mokhort, I. Buko, E. Konstantinova, N. Tsapaeva, I. Lazareva (Minsk, BY)<br />
Can we improve quality <strong>of</strong> life in heart failure - results <strong>of</strong> the national educational study.<br />
– T.Rywik,P.Kurjata,M.Fedyk-Lukasik,P.Leszek,W.Piotrowski,R.Targonski,J.Korewicki,H.Rywik,<br />
G.Broda(Warsaw,KrakowandOlsztyn,PL)<br />
Ability <strong>of</strong> non-dependent elderly patients hospitalized for heart failure to perform the tasks required for<br />
self-care.<br />
– M.T. Vidan, D. Cimera, E. Sanchez-Garcia, G. Ferreira, F.J. Ortiz-Alonso, J.A. Serra, F. Fernandez-Aviles,<br />
H. Bueno (Madrid, ES)<br />
Prevalence <strong>of</strong> frailty in elderly non-dependent patients hospitalized for heart failure, and characteristics <strong>of</strong><br />
frail patients.<br />
– M.T. Vidan, D. Cimera, E. Sanchez-Garcia, G. Mendieta, F.J. Ortiz-Alonso, J.A. Serra, F. Fernandez-Aviles,<br />
H. Bueno (Madrid, ES)<br />
The relationship <strong>of</strong> tissue Doppler Tei index with invasive hemodynamic parameters in patients with heart<br />
failure.<br />
– M. Meric, O. Yesildag, S. Yuksel, I. Dursun, M. Arslandag, D. Koprulu, K. Soylu, O. Yilmaz<br />
(Kurupelit-Samsun, TR)<br />
Right ventricular systolic echocardiographic parameters in chronic systolic heart failure and prognosis.<br />
– K. Darahim (Cairo, EG)<br />
A novel minimally-invasive technique to predict pulmonary capillary wedge pressure utilizing jugular<br />
venous pressure and the tissue Doppler tricuspid/mitral annular velocities.<br />
– K. Uemura, T. Kawada, M. Sugimachi (Suita, JP)<br />
Noninvasive estimation <strong>of</strong> pulmonary capillary wedge pressure using speckle tracking echocardiography<br />
in patients with preserved or reduced ejection fraction.<br />
– M. Kawasaki, R. Tanaka, H. Yagasaki, K. Ono, T. Watanabe, M. Iwama, M. Arai, T. Noda, S. Watanabe,<br />
S. Minatoguchi (Gifu, JP)<br />
Regional cardiac dysfunction and outcome in patients with left ventricular dysfunction, heart failure, or<br />
both after myocardial infarction.<br />
Top Score Poster<br />
– N. Wang, A. Shah, G. Querejeta, D. Gupta, E. Velazquez, R. Califf, J. McMurray, M. Pfeffer, S. Solomon<br />
(Boston and Durham, US)<br />
P642<br />
P643<br />
P644<br />
P645<br />
P646<br />
P647<br />
P648<br />
P649<br />
P650<br />
P651<br />
P652<br />
P653<br />
P654<br />
P655<br />
P656<br />
P657<br />
P658<br />
P659<br />
P660<br />
P661<br />
P662<br />
SATURDAY – AFTERNOON<br />
53
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
DIAGNOSTIC TOOLS IN HEART FAILURE<br />
Discussant(s): Diagnostic tools in heart failure.<br />
– G. Ertl (Würzburg, DE)<br />
Barriers to accurate diagnosis and effective management <strong>of</strong> heart failure have not changed in 10 years.<br />
– H.C. Hancock, H. Close, A. Fuat, J.J. Murphy, A.P.S. Hungin, J.M. Mason (Durham and Darlington, GB)<br />
Pulmonary congestion evaluated by lung ultrasound predicts admission in patients with heart failure.<br />
– M.H. Miglioranza, L. Gargani, R.T. Sant’anna, M. Rover, V.M. Martins, L.P. Badano, R. Sicari, E. Picano,<br />
R.A.K. Kalil, T.L. Leiria (Porto Alegre, BR; Pisa and Padua, IT)<br />
Breathless catastrophizing score in heart failure patients: development and validation.<br />
– J.Hunt,G.Lloyd(Eastbourne,GB)<br />
Development <strong>of</strong> a <strong>European</strong> heart failure risk score in the general population.<br />
– A. Jagodzinski, F. Ojeda, T. Zeller, K. Sydow, S. Blankenberg, T. Jorgensen, K. Kuulasma, R.B. Schnabel,<br />
V. Salomaa (Hamburg, DE; Copenhagen, DK; Helsinki, FI)<br />
Suboptimal accuracy <strong>of</strong> the ED physician and NT-proBNP levels to diagnose heart failure in elderly<br />
patients with dyspnoea: the Akershus Cardiac Examination (ACE) 2 Study.<br />
– J. Brynildsen, A.D. Hoiseth, S. Nygard, T.A. Hagve, G. Christensen, T. Omland, H. Rosjo (Lørenskog and<br />
Oslo, NO)<br />
Repeated echocardiography after first ever ST segment elevation myocardial infarction treated with<br />
primary percutaneous coronary intervention, is it necessary.<br />
– H. Soeholm, J. Loenborg, M.J. Andersen, N. Vejlstrup, T. Engstroem, J.E. Moller, C. Hassager<br />
(Copenhagen, DK)<br />
Echocardiographic indices <strong>of</strong> right heart function affecting ventilatory efficiency during exercise in left<br />
and right ventricular failure.<br />
– M. Jasiewicz, M. Knapp, K. Ptaszynska, A. Szpakowicz, W.J. Musial, K. Kaminski (Bialystok, PL)<br />
The role <strong>of</strong> heart failure in hospital management program upon mortality.<br />
– C.P. Amorim, R. Bosquetti, E.P.V. Felix, M.B. Carli, R.A. Gomes, V.S.G. Ribeiro, V.S. Issa, F.J.A. Ramires<br />
(São Paulo, BR)<br />
Defining the best echocardiographic parameter to predict acute rejection after heart transplantation.<br />
– S. Mingo Santos, V. Monivas Palomero, C. Mitroi, I. Garcia Lunar, M. Sanchez Garcia, E. Gonzalez Lopez,<br />
P. Beltran Correas, J. Gonzalez Mirelis, B. Rivero, J. Segovia Cubero (Madrid, ES)<br />
Multiple circulating microRNAs improve prognostication in subjects with stable heart failure.<br />
– A.Bayes-Genis,J.Lupon,J.Lenders,S.J.Pinto-Sietsma, Y.M. Pinto (Badalona, ES; Amsterdam, NL)<br />
N-terminal proB-type natriuretic peptide testing: practical diagnostic value in a emergency department.<br />
– P. Villa, R. Dominici, A. Dolci, M. Panteghini, S. Guzzetti (Milan, IT)<br />
Evaluation <strong>of</strong> plasma brain natriuretic peptid levels in patients with isolated left bundle branch block and<br />
preserved left ventricular systolic function.<br />
– H. Hamur, M. Acikel, E.M. Bakirci, H. Degirmenci, H. Duman, S. Demirelli, F. Erol, M.H. Tas, E. Aksakal,<br />
S. Karakelleoglu (Erzurum, TR)<br />
Early detection and prediction <strong>of</strong> taxanes-induced cardiac dysfunction by assessment <strong>of</strong> myocardial<br />
deformation.<br />
– M. Florescu, D. Mihalcea, O.A. Enescu, L.S. Magda, L. Trasca, P. Balanescu, R.C. Rimbas, E. Radu,<br />
D. Jinga, D. Vinereanu (Bucharest, RO)<br />
Left ventricular performance and dyssynchrony in heart failure and normal ejection fraction: assessment<br />
by stress echocardiography.<br />
– J.I.N.G. Wang, F.A.N.G. Fang, W.E.I. Feng, C.M. Yu, Y.-Y. Lam (Hong Kong, CN)<br />
P663<br />
P664<br />
P665<br />
P666<br />
P667<br />
P668<br />
P669<br />
P670<br />
P671<br />
P672<br />
P673<br />
P674<br />
P675<br />
P676<br />
P677<br />
LIPID LOWERING STRATEGIES<br />
Discussant(s): Lipid lowering strategies.<br />
– Z. Reiner (Zagreb, HR)<br />
Effect <strong>of</strong> intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease<br />
patients with baseline elevations in alanine aminotransferase levels.<br />
– M.J. Tikkanen, R. Fayyad, O. Faergeman, A.G. Olsson, C.-C. Wun, R. Laskey, J.J. Kastelein, I. Holme,<br />
T.R. Pedersen (Helsinki, FI; New York, US; Aarhus, DK; Linköping, SE; Amsterdam, NL; Oslo, NO)<br />
The effect <strong>of</strong> high dose Cilostazol and Rosuvastatin on myocardial damage in patients with elective<br />
percutaneous coronary intervention (PREVENT trial).<br />
– H.Ari,N.Emlek,S.Cosar,C.Aydin,K.Doganay,A.Karakus,I.Zengin,T.Bozat,M.Melek(Bursa,TR)<br />
Statin therapy is a major determinant <strong>of</strong> PCSK9 plasma concentration: data from four clinical trials with<br />
AMG 145.<br />
– F. Civeira Otermin, F. Raal, E.A. Stein, M.B. Schou, D.C. Basart, M.J. Koren, R. Ceska, R. Somaratne,<br />
J. Yang, M.S. Sabatine (Zaragoza, ES; Johannesburg, ZA; Cincinnati, Jacksonville, Thousand Oaks and<br />
Boston, US; Ballerup, DK; Holland, NL; Prague, CZ)<br />
Intolerance to statins and response to PCSK9 inhibition with AMG 145.<br />
– D. Sullivan, F. Civeira, G.F. Watts, M.B. Shou, M.J. Tikkanen, L.A. Simons, L. Masana, J.B. Kim, A. Xue,<br />
E.A. Stein (Camperdown, New South Wales, Perth and Sydney, AU; Zaragoza and Reus, ES; Ballerup, DK;<br />
Helsinki, FI; Thousand Oaks and Cincinnati, US)<br />
Safety <strong>of</strong> AMG 145, a fully human monoclonal antibody to PCSK9: Data from four phase 2 studies in 1<strong>31</strong>4<br />
patients.<br />
– R.P. Giugliano, F. Raal, M.J. Koren, D. Sullivan, E.M. Roth, R. Weiss, R. Somaratne, J. Yang,<br />
M.S. Sabatine, E.A. Stein (Boston, Jacksonville, Cincinnati, Auburn and Thousand Oaks, US;<br />
Johannesburg, ZA; Camperdown, New South Wales, AU)<br />
P678<br />
P679<br />
P680<br />
P681<br />
P682<br />
P683<br />
54
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Impact <strong>of</strong> low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio as a risk factor <strong>of</strong><br />
cardiovascular event after percutaneous coronary intervention in men.<br />
– I. Matsumoto, R. Kawakami, M. Kurozumi, Y. Tagagi (Takamatsu, JP)<br />
Lipid-lowering therapy modification and LDL-C Goal achievement after an acute coronary syndrome: a<br />
prospective Swiss cohort.<br />
– B. Gencer, F. Mach, R. Auer, L. Raeber, D. Nanchen, P. Meyer, C.M. Matter, S. Windecker, T.F. Luescher,<br />
N. Rodondi (Geneva, Berne, Lausanne and Zurich, CH; San Francisco, US)<br />
Safety and tolerability <strong>of</strong> intensive lipid-lowering therapy after acute coronary syndromes: defining the<br />
role <strong>of</strong> ezetimibe in a comprehensive secondary prevention program.<br />
– F. Colivicchi, A. Aiello, M. Tubaro, M. Santini (Rome, IT)<br />
LDL goal achievement in 766 consecutive, unselected coronary heart disease patients, a comparison<br />
between usual care and a structured follow-up program in out <strong>of</strong> hospital cardiology practice.<br />
– M. Heldal, T.R. Pedersen (Oslo, NO)<br />
ROsuvastatin LOading and Clinical Outcomes (ROLOCO) trial.<br />
– S. Cay, G. Cagirci, S. Topaloglu, D. Aras, S. Aydogdu (Ankara and Antalya, TR)<br />
Eicosapentaenoic acid reduced the progression <strong>of</strong> the coronary atherosclerosis in the patients with<br />
optimal LDL cholesterol lowering therapy.<br />
– T.Domei,K.Amemiya,S.Enomoto,K.Ichihashi,H.Yokoi,M.Iwabuchi,M.Nobuyoshi(Kitakyusyu,JP)<br />
The statins benefit in prognosis after an acute coronary syndrome is independent <strong>of</strong> baseline<br />
LDL-cholesterol levels.<br />
– A. Cordero, D. Sirera, B. Miralles, M.D. Masia, P. Carrillo, V. Bertomeu-Gonzalez, J. Moreno-Arribas,<br />
R. Lopez-Palop, V. Bertomeu-Martinez (Alicante, ES)<br />
Assessment <strong>of</strong> lipophilic vs. hydrophilic statin therapy in Acute Myocardial Infarction (The ALPS-AMI<br />
study).<br />
– A.Izawa,Y.Kashima,S.Ebisawa,T.Miura,T.Saigusa,Y.Shiba,Y.Miyashita,T.Tomita,J.Koyama,<br />
U. Ikeda (Matsumoto, JP)<br />
Coronary artery calcium score to guide statin therapy in patients with elevated C-reactive protein and low<br />
LDL cholesterol levels: a cost-effectiveness analysis.<br />
– A. Silva Ferreira, P. De Araujo Goncalves, H. Marques, N. Cardim, F.P. Machado (Lisbon, PT)<br />
The association <strong>of</strong> elevated HDL levels (>70 mg/dl) with carotid atherosclerosis in middle-aged women<br />
with first diagnosed and untreated essential hypertension.<br />
– H. Triantafyllidi, I. Ikonomidis, P. Trivilou, K. Kontsas, S. Tzortzis, G. Pavlidis, F. Hlia, M. Anastasiou-Nana,<br />
J. Lekakis (Athens, GR)<br />
P684<br />
P685<br />
P686<br />
P687<br />
P688<br />
P689<br />
P690<br />
P691<br />
P692<br />
P693<br />
SATURDAY – AFTERNOON<br />
LIPIDS: RISK AND MANAGEMENT<br />
Discussant(s): Lipids: risk and management.<br />
– F.T. Lanas Zanetti (Temuco, CL)<br />
Highly purified eicosapentaenoic acid may increase the low-density lipoprotein particle size by improving<br />
triglyceride metabolism in patients with hypertriglyceridemia.<br />
– S. Tani, K. Nagao, M. Matsumoto, M. Onikura, T. Ashida, K. Kawauchi, A. Hirayama (Tokyo, JP)<br />
Association <strong>of</strong> a polymorphism <strong>of</strong> BTN2A1 with dislipidemia in community-dwelling Japanese individuals.<br />
– H. Horibe, T. Ueyama, T. Kawamiya, T. Fujimaki, M. Oguri, K. Kato, K. Yokoi, T. Murohara, S. Ichihara,<br />
Y. Yamada (Tajimi, Yokkaichi, Inabe, Nagoya and Tsu, JP)<br />
What factors affect the improvement <strong>of</strong> coronary artery lipid composition most? - assessed by<br />
integrated-backscatter intravascular ultrasound.<br />
– R. Kawakami, M. Kurozumi, I. Matsumoto, Y. Takagi (Takamatsu, JP)<br />
Does the determination <strong>of</strong> lipoprotein(a) help in the prediction <strong>of</strong> cardiovascular events?<br />
– Y.A. Kesaniemi, M. Santaniemi, 0. Ukkola (Oulu, FI)<br />
Sharp increase in statin use and large changes in lipids and hsCRP in adults >=55 years <strong>of</strong> age in Poland<br />
during the last decade.<br />
– P. Bandosz, T. Zdrojewski, M. Pencina, M. Rutkowski, B. Wyrzykowski (Gdansk, PL; Boston, US)<br />
Impact <strong>of</strong> the hypertriglyceridemic waist phenotype as a simplified model <strong>of</strong> screening to identify<br />
asymptomatic subjects at high cardiometabolic risk with increased subclinical atherosclerosis.<br />
– D.E. Monopoli, L. Bertelli, K. Rampino, G. Gorlato, A. Lattanzi, F. Coppi, F. Sgura, R. Rossi (Modena, IT)<br />
Lipoprotein associated phospholipase A2 and C-reactive protein as predictors <strong>of</strong> metabolic syndrome in<br />
subjects without cardiovascular disease.<br />
– M. Acevedo, P. Varleta, V. Kramer, T. Quiroga, C. Prieto, J. Parada, C. Navarrete (Santiago and La Serena,<br />
CL)<br />
Concordance and discordance between apolipoprotein B, LDL-C and Non-HDL-C in statin-treated<br />
subjects presenting with chest pain and elevated troponin.<br />
– R. Pitts, V. Varghese, K. Bhatt, J. Parag, Z. Qian, W. Odeh, J. Lee, S. Rinehart, J. Miller (Atlanta and<br />
Baltimore, US)<br />
High level <strong>of</strong> low density lipoprotein cholesterol in younger children <strong>of</strong> patients with premature coronary<br />
artery disease: relation to own and parental risk factors.<br />
– M.V. Konov, A.D. Deev, N.A. Gratsiansky (Moscow, RU)<br />
Dissecting the protective IgG anti-malondialdehyde-LDL (MDA-LDL) antibody response in a substudy <strong>of</strong><br />
the Anglo Scandinavian Cardiac Outcomes Trial (ASCOT).<br />
– R. Khamis, T. Batty, I. Wong, M. Johns, S. Thom, J. Mayet, A. Stanton, A.L. Hughes, D.O. Haskard<br />
(London, GB; Dublin, IE)<br />
P694<br />
P695<br />
P696<br />
P697<br />
P698<br />
P699<br />
P700<br />
P701<br />
P702<br />
P703<br />
P704<br />
55
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Supplementation with a pomegranate extract abrogates hypercholesterolemia-induced coronary<br />
endothelial dysfunction in swine.<br />
– G. Vilahur, T. Padro, L. Casani, G. Mendieta, J.A. Lopez, M. Penalver, L. Badimon (Barcelona and Murcia,<br />
ES)<br />
Fasting triglyceridemia influences postprandial endothelial response to a single Mediterranean-type meal<br />
compared to a high-saturated fat meal.<br />
– S. Lacroix, C. Desrosiers, M. Gayda, J.C. Tardif, A. Nigam (Montreal, CA)<br />
Incidence <strong>of</strong> simvastatin and strong CYP3A4 inhibitors co-prescription during hospital admission.<br />
– C.M. Santos, T. Laranjeira, L. Calixto, H. Dores, S. Madeira, A. Parrinha, A. Mirco, C. Aguiar, M. Mendes,<br />
F. Falcao (Lisbon, PT)<br />
Role <strong>of</strong> the relationship between dyslipidemia and genetic factors in the development <strong>of</strong> atherosclerosis.<br />
– S. Hata, M. Nakazato, T. Sekita, T. Maeda, T. Kanda (Sasebo, Goto and Nagasaki, JP)<br />
Impact <strong>of</strong> hyperlipidemia on development <strong>of</strong> new-onset diabetes mellitus in Asian population: 5-year<br />
clinical outcomes.<br />
– S.H.Park,S.W.Rha,W.Y.Shin,B.G.Choi,S.Y.Choi,C.U.Choi,E.J.Kim,C.G.Park,H.S.Seo,D.J.Oh<br />
(Cheonan and Seoul, KR)<br />
P705<br />
P706<br />
P707<br />
P708<br />
P709<br />
OBESITY: LOWERING RISK<br />
Discussant(s): Obesity: lowering risk.<br />
– W.J. Kop (Tilburg, NL)<br />
Leptin-adiponectin ratio and the extent <strong>of</strong> CAD in pre-diabetic patients undergoing PCI.<br />
– W.A. Heggermont, P.A.H. Nguyen, C. Dubois, T. Vydt, M. Coosemans, T. Adriaenssens, B. Ferdinande,<br />
W. Desmet, P.R. Sinnaeve (Leuven, BE)<br />
Does adiponectin protect against the cardiovascular dysfunction associated with central adiposity in<br />
young women with polycystic ovary syndrome?<br />
– E. Rees, R. Hocking, F. Dunstan, M. Lewis, K. Tunstall, J.P. Halcox, A.G. Fraser, D.A. Rees (Swansea and<br />
Cardiff, GB)<br />
Analysis <strong>of</strong> the obesity paradoxic according to the sex: relation between body mass index and mortality in<br />
the first year after an acute coronary syndrome.<br />
– S. Raposeiras Roubin, E. Abu Assi, N. Bouzas Cruz, A. Lopez Lopez, M. Castineiras Busto, E. Pereira<br />
Lopez, S. Gestal Romari, J.M. Garcia Acuna, J.R. Gonzalez Juanatey (Santiago de Compostela, ES)<br />
Despite a mixed reactivity to antiplatelet agents, obese patients have no benefit <strong>of</strong> platelet function<br />
monitoring: insight from the ARCTIC study.<br />
– E. Van Belle, J.P. Collet, S. O’Connor, J. Abtan, C. Saint-Etienne, M. Kerneis, H. Rousseau, J. Sylvain,<br />
E. Vicaut, G. Montalescot (Lille, Paris and Tours, FR)<br />
Serum omentin significantly predicts cardiovascular events both in patients with the metabolic syndrome<br />
and in subjects who do not have the metabolic syndrome.<br />
Top Score Poster<br />
– C.H. Saely, A. Leiherer, A. Muendlein, A. Vonbank, D. Zanolin, K. Geiger, H. Drexel (Feldkirch, AT; Triesen,<br />
LI; Philadelphia, US)<br />
Association <strong>of</strong> current carotid elastic modulus and prior body mass index in elderly people - results from<br />
the SAPALDIA cohort study.<br />
– S. Caviezel, J. Dratva, E. Schaffner, C. Schindler, N. Kuenzli, J.M. Gaspoz, T. Rochat, N. Probst-Hensch,<br />
A. Schmidt-Trucksaess (Basel and Geneva, CH)<br />
Volume-rendered regional adipose tissue depots correlated with circulating hs-CRP as an independent<br />
clinical predictor for left atrial remodeling beyond BMI in asymptomatic population.<br />
– Y.H. Lai, C.H. Yun, J.Y. Kuo, T.C. Hung, Y.J. Wu, H.I. Yeh, C.L. Hung (Taipei, TW)<br />
Increased levels <strong>of</strong> circulating arginase I in adolescents with overweight.<br />
– C. Jung, H.R. Figulla, M. Lichtenauer, M. Franz, J. Pernow (Stockholm, SE; Jena, DE)<br />
Association between erectile dysfunction severity and major adverse cardiovascular events in men with<br />
metabolic syndrome.<br />
– A. Aggelakas, C. Vlachopoulos, I. Iona, N. Ioakeimidis, M. Abdelrasoul, A. Aggelis, D. Terentes-Printzios,<br />
P. Pietri, S. Vaina, C. Stefanadis (Athens, GR)<br />
Risk factors for cardiovascular disease, metabolic syndrome and sleepiness in truck drivers.<br />
– A.P. Mansur, J.Y. Takada, S.D. Avakian, S.M.B. Lins, M.A.B.S. Rocha, A.J. Santos, A.M.C.A. Andrade,<br />
J.R. Vasconcelos Jr, L.B.M. Monteiro, V. Leyton (São Paulo and Brasilia, BR)<br />
Association <strong>of</strong> epicardial adipose tissue with cardiovascular risk factors in subjects free from clinical<br />
symptoms <strong>of</strong> coronary artery disease.<br />
– A.Jermendy,R.Vadas,A.Bartykowszki,Z.S.Bagyura,M.Karolyi,P.Soos,Z.S.Szelid,B.Merkely,<br />
P. Maurovich-Horvat (Budapest, HU)<br />
Lean mass, fat mass and eccentric left ventricular remodelling in obesity.<br />
– B. Corden, N.G. Keenan, T.J.W. Dawes, A.S.M. De Marvao, G. Durighel, T. Diamond, S.A. Cook,<br />
D.P. O’Regan (London, GB)<br />
Resting heart rate is an independent predictor <strong>of</strong> left ventricular diastolic dysfunction in obese patients<br />
with or without arterial hypertension.<br />
– F.L. Dini, F. Santini, D. Morrone, A. Huqi, G. Guarini, A. Simioniuc, V. Di Bello, M. Marzilli (Pisa, IT)<br />
Impact <strong>of</strong> serum adipocyte fatty acid-binding protein on clinical outcome in patients with stable angina<br />
undergoing percutaneous coronary intervention.<br />
– W. Takagi, T. Miyoshi, M. Kajiya, M. Iwamoto, K. Ohkawa, K. Nosaka, R. Nakayama, K. Takeda,<br />
S. Hirohata, M. Doi (Takamatsu and Okayama, JP)<br />
P710<br />
P711<br />
P712<br />
P713<br />
P714<br />
P715<br />
P716<br />
P717<br />
P718<br />
P719<br />
P720<br />
P721<br />
P722<br />
P723<br />
P724<br />
56
SATURDAY, <strong>31</strong> AUGUST 2013 – AFTERNOON POSTERS<br />
Differential responses <strong>of</strong> distinct adipose tissue depots to acute and chronic inflammation: novel insights<br />
into the complex mechanisms regulating adiponectin biosynthesis in humans.<br />
– A. Antonopoulos, R. Patel, M. Demosthenous, M. Margaritis, J. Digby, R. Sayeed, D. Tousoulis,<br />
C. Stefanadis, K.M. Channon, C. Antoniades (Oxford, GB; Athens, GR)<br />
P725<br />
OBESITY<br />
Discussant(s): Obesity.<br />
– N.Sattar(Glasgow,GB)<br />
Comparative effectiveness <strong>of</strong> weight loss interventions and prevention <strong>of</strong> cardiovascular disease in<br />
patients with abdominal obesity.<br />
– A. Berezina, O. Belyaeva, O. Berkovich, E. Baranova, E. Shlyakhto (St. Petersburg, RU)<br />
Waist circumference versus other obesity parameters as predictors <strong>of</strong> coronary artery disease in<br />
essential hypertensive patients: a 6-year-follow-up study.<br />
– K. Kintis, C. Tsioufis, K. Dimitriadis, I. Bafakis, A. Kefala, A. Kasiakogias, P. Vasileiou, A. Kordalis,<br />
I. Kallikazaros, C. Stefanadis (Athens, GR)<br />
Visceral fat is stronger associated with electrocardiographic measures <strong>of</strong> sympathetic activation than<br />
subcutaneous fat in individuals with structurally normal hearts: the NEO study.<br />
– S. Hillebrand, T. Christen, A.C. Maan, J.W. Jukema, H.J. Lamb, A. De Roos, F.R. Rosendaal, M. Den<br />
Heijer, C.A. Swenne, R. De Mutsert (Leiden and Amsterdam, NL)<br />
Successful long-term weight reduction improves left ventricular diastolic function and physical<br />
performance in severe obesity.<br />
– S. Fenk, A. Baessler, E. Rousseva, C. Strack, M. Manka, G. Schmitz, G. Riegger, T. Loew, C. Lahmann,<br />
M. Fischer (Regensburg and Munich, DE)<br />
Reclassification <strong>of</strong> LV geometric patterns in morbidly obese patients. A CRM study.<br />
– M. Luaces Mendez, V. Cach<strong>of</strong>eiro, L. Perez-Isla, A. Antequera-Perez, M. Medina-Garcia, A. Garcia-Munoz<br />
Najar, J.J. Gomez De Diego, J. Cabezudo, T. Matajira, C. Macaya (Madrid and Fuenlabrada, ES)<br />
Steeper increase <strong>of</strong> body weight and BMI in acute myocardial infarction patients than in control subjects<br />
from the general population: learning from a case control study.<br />
– G. Nilsson, A. Rosenblad, P.O. Hedberg, J. Leppert (Västerås, SE)<br />
Long term effects <strong>of</strong> bariatric surgery on peripheral endothelial function and on coronary microvascular<br />
function.<br />
– P. Tarzia, A. Villano, S. Figliozzi, G. Russo, R. Parrinello, P. Lamendola, A. Sestito, G.A. Lanza, F. Crea<br />
(Rome, IT)<br />
Short-term impact <strong>of</strong> bariatric surgery on structural and functional parameters <strong>of</strong> arterial remodeling in<br />
morbidly obese patients.<br />
– J. Domienik, O. Dzikowska-Diduch, W. Lisik, A. Chmura, P. Pruszczyk (Warsaw, PL)<br />
Clinic, metabolic and hemodynamic benefits <strong>of</strong> bariatric surgery.<br />
– M. Faustino, S. Baptista, E. Lourenco, P. Leal, C. Monteiro, R. Cabaco, M. Nedio, V. Gil (Amadora, PT)<br />
The impact <strong>of</strong> central obesity on accelerated progression <strong>of</strong> noncalcified coronary plaque assessed by<br />
coronary CT angiography: a 4-year-follow-up study.<br />
– A. Imai, S. Komatsu, T. Ohara, T. Kamata, J. Yoshida, K. Miyaji, M. Takewa, Y. Kobayashi, R. Ohe,<br />
K. Kodama (Amagasaki and Suita, JP)<br />
Cardiac structure and function and insulin resistance in morbid obese patients: does superobesity play a<br />
further role?<br />
– F. Antonini-Canterin, A.D. Mateescu, V. Di Bello, S. Carerj, C. Zito, S. La Carrubba, O. Vriz, C. Ginghina,<br />
B.A. Popescu, G.L. Nicolosi (Pordenone, Pisa, Messina, Palermo and San Daniele del Friuli, IT; Bucharest,<br />
RO)<br />
Association <strong>of</strong> cause-specific mortality with body mass index in Russian population.<br />
– S.A. Shalnova, A.D. Deev, A.V. Kapustina, J.A. Balanova (Moscow, RU)<br />
Age at first detection <strong>of</strong> overweight and adult lfe course BMI are associated with future increased left<br />
ventricular mass index.<br />
– A.K. Ghosh, R. Hardy, D.P. Francis, J. Mayet, N. Chaturvedi, D. Kuh, J. Deanfied, D. Pellerin, A.D. Hughes<br />
(London, GB)<br />
Age at first detection <strong>of</strong> overweight and adult life course BMI are associated with future diastolic<br />
dysfunction.<br />
– A.K. Ghosh, A.D. Hughes, D.P. Francis, N. Chaturvedi, J. Mayet, D. Kuh, J. Deanfield, D. Pellerin, R. Hardy<br />
(London, GB)<br />
Sex differences in the relationship between adiposity and left ventricular morphology.<br />
– B. Corden, N.G. Keenan, A.S.M. De Marvao, T.J.W. Dawes, T. Diamond, G. Durighel, S.A. Cook,<br />
D.P. O’Regan (London, GB)<br />
P726<br />
P727<br />
P728<br />
P729<br />
P730<br />
P7<strong>31</strong><br />
P732<br />
P733<br />
P734<br />
P735<br />
P736<br />
P737<br />
P738<br />
P739<br />
P740<br />
P741<br />
SATURDAY – AFTERNOON<br />
57
58<br />
NOTES